MAPPING OF GENES INVOLVED IN NEUROLOGICAL DISORDERS IN PAKISTANI FAMILIES by ILTAF AHMED, .
  
MAPPING OF GENES INVOLVED IN 
NEUROLOGICAL DISORDERS IN PAKISTANI 
FAMILIES 
 
  
 
 
 
 
 
 
  
 
ILTAF AHMED 
2009-NUST-DirPhD-V&I-14 
 
 
 
Atta-ur-Rahman School of Applied Biosciences 
National University of Sciences & Technology 
Islamabad-Pakistan 
2015 
 
 MAPPING OF GENES INVOLVED IN NEUROLOGICAL 
DISORDERS IN PAKISTANI FAMILIES 
 
 
Iltaf Ahmed 
2009-NUST-DirPhD-V&I-14 
A dissertation submitted in the partial fulfillment of the requirement for the  
degree of  
Doctor of Philosophy 
IN 
APPLIED BIOSCIENCES 
 
 
 
 
Supervisor 
  
Dr. Peter John 
 
 
 
 
Atta-ur-Rahman School of Applied Biosciences 
National University of Sciences & Technology 
Islamabad-Pakistan 
2015 
 
 
 
  
 
 
 
 
Dedication 
“TO MY LOVING PARENTS and BELOVED WIFE” 
Without whom none of my success would be possible  
 
 
 
i 
 
List of Tables…………………………………………………………………………. i 
List of Figures………………………………………………………………...……... iii 
List of Abbreviations……………………………………………………………...... xii 
Acknowledgments…………………………………………...………………..……. xiv 
Abstract……………………………………………………………………….……. xvi 
Chapter 1 
1-INTRODUCTION 
1.1 Background………………………………………………………………..... 01 
1.2 Mental Retardation/ Intellectual Disability (MR/ID)……………….………. 02 
1.2.1 Chromosomal Aberrations……………………………………….…. 04 
1.2.2 X-Chromosomal forms of ID…………………………………….…. 05 
1.3 Autosomal Intellectual Disability (AID)…………………………….…….... 07 
1.3.1 Autosomal dominant Intellectual Disability (ADID)……….………. 07 
1.3.2 Autosomal Recessive Intellectual Disability………….……. 08 
1.3.3 Diagnostic strategies for Mental Retardation…………….…. 09 
1.4 Mirror Movement……………………………………………………….…... 13 
1.4.1 Cause of MRMV and Diagnosis Criteria…………………..….……. 15 
1.5 Aims of this study…………………………………………………………... 15 
Chapter 2 
2-LITERATURE REVIEW 
2.1 Intellectual Disability……………………………………………………..… 17 
2.1.1 Protease, Serine, 12 (PRSS12)……………………………………… 18 
2.1.2 Cereblon (CRBN)………………………………………………....… 20 
2.1.3 Coiled-Coil and C2 Domains-Containing Protein 1A (CC2D1A)….. 21 
2.1.4 Nol1/Nop2/Sun Domain Family, Member 2 (NSUN2)……….…….  22 
ii 
 
2.1.5 Tumor Suppressor Candidate 3 (TUSC3)………………………...… 23 
2.1.6 Trafficking Protein Particle Complex, Subunit 9 (TRAPPC9)……... 24 
2.1.7 Mannosidase, Alpha, Class 1B, Member 1 (MAN1B1)………....….. 25 
2.1.8 Glutamate Receptor, Ionotropic, Kainate 2 (GRIK2) …………...….. 25 
2.1.9 ST3 Beta-Galactoside Alpha-2,3-Sialyltransferase 3 (ST3GAL3).... 27 
2.1.10 Mediator Complex Subunit 23 (MED23)…………………………... 28 
2.1.11 Trans-2,3-Enoyl-Coa Reductase (TECR)…………………………... 29 
2.2 Mirror Movement…………………………………………………………... 30 
2.2.1 Deleted in Colorectal Carcinoma (DCC)…………………………… 30 
2.2.2 RAD51……………………………………………………….……… 32 
Chapter 3 
3-MATERIALS AND METHODS 
3.1 Families studied……………………………………………….……………. 35 
3.2 Clinical and Physical Examination……………………...………………….. 35 
3.3 Blood Sampling…………………………………………….……………...... 37 
3.4 DNA extraction form whole blood ………………………………………… 37 
3.4.1 Nucleospin DNA Extraction Kit …………………………………… 37 
3.4.1.1 Lysis of blood Cells………………………………………… 37 
3.4.1.2 DNA binding…………………………………………..…… 38 
3.4.1.3 Washing and Drying of Silica Membrane………………...... 38 
3.4.1.4 DNA Elution………………………………………………... 38 
3.4.2 Non-Enzymatic Genomic DNA extraction from Blood..............…... 38 
iii 
 
3.5 Genetic Mapping of Genes Associated with Mental Retardation………….. 41 
3.5.1 Exclusion Mapping…………………………………………………. 41 
3.5.2 Whole Genome Homozygosity-by-Descent………….…………….. 42 
3.5.2.1 DNA Sample Preparation…………………………………... 42 
3.5.2.2 Restriction Enzyme Digestion…………………...…………. 42 
3.5.2.3 Ligation, PCR based Amplification and Purification……..... 42 
3.5.2.4 End labeling and Hybridization…………………………..… 42 
3.5.2.5 Microarray data analysis……………………………...…….. 43 
3.6 Whole Exome Sequencing (WES)………………………………………….. 43 
3.6.1 Library preparation………………………………………...……….. 43 
3.6.1.1 Shearing of Genomic DNA…………………………………. 43 
3.6.1.2 End-repair the DNA………………………………………… 44 
3.6.1.3 DNA Purification…………………………………………… 44 
3.6.1.4 Ligation of P1 and P2 Adaptors to the DNA……………….. 44 
3.6.1.5 Size-selected selection of the DNA…………………...……. 45 
3.6.1.6 Nick-translation and amplification of the library………...… 45 
3.6.2 Templated Bead Preparation……………………………………….. 45 
3.6.3 Instrument Operation……………………………………………….. 46 
3.6.3.1 Washing of beads…………………………………………… 46 
iv 
 
3.6.3.2 Beads Deposition…………………………………………… 46 
3.6.3.3 Installment of reagents on-instrument……………………… 47 
3.6.3.4 Installation of slides on the instrument and Analysis …….… 47 
3.6.3.5 Whole Exome Sequencing Data Analysis………………….. 47 
3.7 Confirmation of Candidate Genes/Variants……………………………….. 48 
3.7.1 Primer Designing…………………………………………………… 48 
3.7.2 Polymerase Chain Reaction (PCR)…………………………………. 48 
3.7.3 Horizontal Gel Electrophoresis………………………………….….. 48 
3.7.4 Sequencing of genes……………………………………………….... 49 
3.8 Establishment of Lymphoblast cell lines and RNA extraction……………... 49 
3.8.1  Epstein Bar Virus (EBV) transformation of lymphocytes………….. 50 
3.8.2 RNA Extraction………………………………….………………….. 51 
3.8.3 RNA Purification…………………………………………………… 51 
3.8.4 Washing of RNA………………………………………………...….. 51 
3.8.5 Elution of RNA……………………………………………………... 52 
3.9 Reverse Transcription and Polymerase Chain Reaction (RT-PCR)………... 52 
3.9.1 Reverse Transcription (RT)………………………………………… 52 
3.9.2 RT-PCR………………………………………………………….….. 53 
3.9.3 Gel Electrophoresis…………………………………………………. 53 
v 
 
3.9.4 Gel Elution………………………………………………………….. 53 
3.9.4.1 Gel Excision and Dissolving……………………………….. 53 
3.9.4.2 Binding of DNA to Column……………………………...… 54 
3.9.4.3 DNA washing……………………………………………….. 54 
3.9.4.4 DNA Elution………………………………………………... 54 
3.9.4.5 Sequencing of cDNA……………………………………….. 55 
3.9.4.6 Multiple Sequence Alignment…………………………..…... 55 
3.10 Cloning of DCPS gene ………………………………………………. 55 
3.10.1 pDrive Vector……………………………………….………………. 55 
3.10.2 Ligation……………………………………………………………... 55  
3.10.3 Preparation of LB/Agar Plates……………………………………… 57 
3.10.4 Transformation and White Blue Colony Selection…………………. 57 
3.10.5 Colony PCR………………………………………………………… 57 
3.10.6 Propagation of Transformed cells…………………………………... 58 
3.10.7 Plasmid Extraction and Purification………………………………... 58 
3.10.8 Cell culture Resuspension…………………………………………... 58 
3.10.9 Cell Lysis…………………………………………………………… 59 
3.10.10 Column Preparation……………………………………………….. 59 
3.10.11 Washing of Plasmid……………………………………………… 59 
vi 
 
3.10.12 Plasmid Elution……………………………………………………. 59 
3.10.13 Plasmid PCR………………………………………………………. 60 
3.10.14 Horizontal Gel Electrophoresis………………..………………….. 60 
3.10.15 Sequencing of Recombinant DNA or plasmid……………………. 60 
3.11 Expression and Purification of DCPS protein ………………………. 61 
3.11.1 cDNA Isolation from pDrive Vector………………………………... 61 
3.11.2 Sub-cloning of DCPS Gene in pET28……….……………………. 61 
3.11.3 Transformation……………………………………………………... 62 
3.11.4 Preparation for Induction and Cell Lysis……………………...……. 62 
3.11.5 Purification of protein …………………………………………….… 63 
3.11.6 Bradford assay……………………………………………………… 63 
3.11.7 Generation of labeled RNA and cap structures…………………….. 65 
3.11.8  In vitro decapping assays…………………………………………… 65 
3.11.9  Western Blot…………………………………………………...…… 66 
3.12 Quantification of Amino Acids………………………………………..…… 66 
3.13 Whole Genome Homozygosity-by-Descent Mapping of MRMV (Family D)…. 66 
3.13.1 Linkage Analysis……………………………………………………. 67 
2.13.2 Whole Exome Sequencing…..…………………………….……….. 67 
2.14 Bioinformatics Tools…………….………………………………………….. 68 
vii 
 
Chapter 4 
4-RESULTS 
4.1:-Family A…………………………………………………………..…………… 69 
4.1.1 Human Subjects and Clinical Findings………………………………. 69 
4.1.2 Genetic Mapping…………………………………………………….... 71 
4.1.2.1 Exclusion of Mapping …………………………………….… 71 
4.1.2.2 SNP Genotyping and Mutation Analysis…………………… 72 
4.1.3 Assessment of DCPS Enzymatic Activity……………………………. 75 
4.1.3.1 Decapping Activity of DCPS……...………………………... 75 
4.1.3.2 DCPS Activity in Total Lymphoblast Cell Extract………. 75 
4.1.3.3 Western Blotting……………………………………………. 76 
4.2:-FAMILY B 
4.2.1 Human Subjects and Clinical Findings……………………………….. 90 
4.2.2 Molecular Assessment and Mutation analysis…………………...…… 91 
4.2.3 Functional studies of PSPH gene…………………………………….. 92 
4. 3:-FAMILY C     
4.3.1 Human Subjects and Clinical Assesment………………………….. 100 
4.3.2-Molecular Assessment and Mutation Analysis..……………………. 101 
4.4:-Family D  
4.4.1 Human Subjects and Clinical Findings……………………………… 105 
viii 
 
4.4.2-Exclution Mapping and Molecular Assessment…………………….. 106 
Chapter 5 
Discussion…………………………………………………………………. 115 
Conclusion………………………………………………………………… 126 
Future Prospects…………………………………………………………… 127 
Chapter 6 
References…………………………………………………………………. 128 
Appendix 1………………………………………………………………… 162 
Appendix 1I………………………………………………………………... 164 
Appendix I1I……………..………………………………………………... 167 
 
 i 
 
List of Tables 
Table No. Titles Page No. 
1.1  Shows the various class of Neurological Disorders  02 
1.2 Genes involved in non-syndromic X-linked mental 
retardation 
06 
1.3 The known loci of NS-ARID 12 
3.1 Composition of Buffers and Solutions for DNA Extraction  39 
3.2 The amount of TKM2 required blood samples 40 
3.3 The ratio of 10% SDS required for each blood sample  40 
3.4 The ratio of NaCl per volume of blood sample   41 
3.5 The sequence of FMR1 gene primers and product size  41 
3.6 Primer sequence of whole transcript of DCPS gene  53 
3.7 The chemical preparation of ligation mixture 56 
3.8 The composition of PCR reaction mixture  58 
3.9 Sequence of the plasmid specific primers and product size 58 
3.10 Master mixture for colony PCR    60 
3.11 Primer Sequence for Full Length DCPS gene   64 
3.12 The composition reaction mixture for restriction 
endonculeases Activity  
64 
3.13 Chemical composition of ligation mixture and volume 
required for reaction  
64 
3.14 Sequence of primers for generation of labeled RNA  66 
4.1 The sex, ages and head circumference of affected individuals 
of Family A  
70 
4.2 Homozygous regions flanking between SNPs in Family A  72 
 ii 
 
4.3 The age, sex, head circumference and height of the affected 
individuals of Family B. 
90 
4.4 Amino Acid Profiling of affected individual (II:04)  93 
4.5 Amino Acid Profiling of affected individual (III:04) 94 
4.6 The sex, ages and head circumference of affected individuals 
of Family C. 
100 
4.7 List of genes on1q25.3-q31.1 locus with OMIM ID and 
function. 
102 
4.8 All HBD regions (hg19) determined by ChAS analysis for 
MM1-4,7,8,11,12, using filter cut-off of >100 markers and 
>1Mb. Homozygous coding variants from DNASTAR NGen 
analysis and ANNOVAR analysis of WES data for MM1-7 
are shown, excluding synonymous and known SNPs. 
Integrated Genome Viewer (IGV) was used to confirm the 
variant. For amino acid substitutions we used Condel- an 
integrated analysis that uses prediction from five different 
algorithms, including PolyPhen2, SIFT, and Mutation 
Assessor (Gonzalez-Perez & Lopez-Bigas, 2011). 
 
109 
   
   
 
 
iii 
 
List of Figures 
Figure No. Content Page No. 
 
1.1 The Possible pathways for MRMV. (A)  MRMV caused 
due to a common drive to bilateral homologous motor 
neuron pools. (B) Anomalous uncrossed ipsilateral 
corticospinal tracts. (C) Decreased transcallosal (dotted 
line) or increased facilitation (solid line) of the M1 
contralateral to the MRMV hand. (D) Altered 
interhemispheric inhibition of intracortical facilitation in 
the M1 contralateral to MRMV. The combination any of 
these mechanisms could lead in the generation of 
MRMV. M1more = more affected cortex; M1less = less 
affected cortex (Cox et al., 2012) 
14 
3.1 Map of Pakistan marked with circles showing the 
locations of families included in this study.  
36 
 
3.2 Diagrammatic structure of p-Drive Vector  56 
4.1 Pedigree of Family A. Individuals indicated with black 
shaded symbols are affected with apparent NS-ARID, 
whereas individual III:8 is shaded grey, indicating a 
syndromic form of ID.  Unfilled squares and circles are 
unaffected. The dotted squares and circles represent 
carrier individuals. Double lines show the consanguinity 
and single lines for non cousin marriages. Crossed lines 
77 
iv 
 
show deceased ones. 
4.2 Facial images, with front and side pose of patients of 
Family A. The facial photographs of affected individuals 
do not show any facial dysmorphism. The III:8 individual 
of this family was phenotypically quite different from 
others. 
78 
4.3 MRI images of affected individual V:3 showing lateral 
and top and dorso- lateral of view of brain. Overall 
structure of brain appears normal.  
79 
4.4  Whole genome homozygosity (WGH) picture of family 
A with significant homozygous peaks (indicated by red 
lines) at 01, 03, 05, 11, 14, 15 and 17 and heterozygous 
peaks are represented by black lines.  
80 
4.5 (A) The dChip analysed SNP data on chromosome  03, 
(B) Chromsome 05, (C) Chromosome 11, (D) 
Chromsome 14, (E) Chromsome 16 and (F)  chromosome 
17. Each individual was represented in columns (III:2 and 
V:3 are affected and III:3 is normal). Blue colour depicts 
homozygous region and yellow colour shows 
heterozygous region.  
81 
4.6 UCSC genome browser view of the 11q25.1-q25 locus.   82 
4.7 The whole exome sequencing of Family A showing the 
G> A transition.  The snapshot was obtained from IGV 
tool. 
82 
4.8 The DNA sequence chromatogram of DcpS gene of Family A.  83 
v 
 
A) The sequence showing the G>A mutation in affected 
individuals (III- and V-5). B) The sequence shows the 
heterozygous/carrier individuals of Family A. C). The sequence of 
normal individual.  The Green colour = Adenine, Red colour 
= Thymine, Blue colour = Cytosine, Black colour = 
Guanine. 
4.9 A) The affected individual (V:7) carries a heterozygous 
mutation on exon 6 of DcpS gene where C>T.  B) The 
mutant allele was sequenced from the cDNA of V:7 
showing the presence of C>T change. C)  The 
chromatogram shows the individual (IV-6) is 
heterozygous and carrier. D) The individual IV:5 was 
normal Green colour = Adenine, Red colour = Thymine, 
Blue colour = Cytosine, Black colour = Guanine. 
84 
4.10 The sequence of full transcript (cDNA) of DcpS gene 
were BLAT in UCSC genome browser showing G>A 
transition in mutant transcript.  
85 
4.11 Schematic representation of splice site mutation in Family 
A. A change in splice donor usage at exon 4/intron 4 for 
the splice variant allele resulting in splicing of transcript 
45 nucleotide down in intronic region. The resulting 
mRNA carries an additional 45 nucleotides. 
85 
4.12 Full transcript alignment of normal (norm) and mutant 
(alta) with 45 nucleotide insertion with ClustaLW2 an 
online tool. 
86 
vi 
 
4.13 Sequence alignment of amino acids of normal and mutant 
with 15 amino acid insertions.    
86 
4.14 3D-protein modelling of wild type and mutant with 15 
amino acid insertion was generated by using SWISS 
MODEL workplace and visualized with PyMol Molecular 
Graphics System (http://www.pymol.org/). The location 
of the inserted sequence (between residues 212 to 228  
mutant protein) is indicated with a yellow arrow. 
87 
4.15 Full transcript sequencing result showing 947C>T 
transition of affected individual (V:7). 
87 
4.16 DcpS catalyzes the hydrolysis of cap structure. Decapping 
assays were carried out with the indicated amounts of 
DcpS at the top of picture. 32P-labeled methylated cap 
structure (m7Gpppp) is used as substrate where red colour 
“p” in m7GpppG represented labelled phosphate and 
m7Gp as product of DcpS catalyzed reaction.  The 
quantitation for the decapping efficiency of each protein 
is presented as the percentage decapping using 
ImageQuant 5.2 software at the bottom of picture.   
88 
4.17 Decapping assays of wild type and mutant DcpS from 
whole cell extract. The quantitation for the decapping 
efficiency of each protein is presented as the percentage 
decapping using ImageQuant 5.2 software.  The standard 
m7Gppp and positive control are shown at left. rDcpS are 
wild type control second from left. 32P-labeled 
88 
vii 
 
methylated cap structure (m7Gpppp) is used as substrate 
where red colour “p” in m7GpppG represented labelled 
phosphate and m7Gp as product of DcpS catalyzed 
reaction.   
4.18 Western blot analysis showing expression concentration 
of DcpS in lymphoblast cell lines of generated from 
patient with homozygous 15 Amino Acid insertion in lane 
1 and 4 and heterozygous individuals of Family A in lane 
2 and 3. 293T was used for positive control and GAPDH 
as loading control.   
89 
 
4.19  Pedigree of Family B with autosomal recessive mental 
retardation where squares represent male and square are 
used for female. Completely filled squares and circled are 
for affected whereas unfilled squares and circles shows 
unaffected individuals. Squares and Circles with dots 
show carriers. Double lines show consanguineous 
marriage. Crossed lines show deceased ones.   
95 
4.20 Facial images of affected individual (II-4 and III-3) of 
Family B which did not show any facial dysmorphism.  
96 
4.21 Whole Genome Homozygosity image obtained from 
Homozygosity mapper of Family B showed significant 
homozygous peaks on chromosome 01, 05, 07, 10, 11, 14 
and 15. Homozygus regions are represented in red lines 
peaks and heterozygous regions are with black peaks. 
96 
4.22 (A) The dChip analysed image of SNP marker on 97 
viii 
 
chromosomes  01, (B) Chromosome 05, (C) chromsome 
07, (D) Crhomosome 10, (E) Chromsome  11,  (F) 
chromosome 14 and (G) Chromosome 15. The column 
represents individual Data  (II:4, III:3 and III:4 are 
affected and III:2 is normal) and SNP data is shown in 
rows The blue colour depicts homozygous regions and 
yellow colour shows heterozygous region.   
4.23  UCSC genome browser view of the 7p12.1-p11.2 locus 98 
4.24 Whole Exome Sequence data showing the substitution of 
C with T.  
98 
4.25 The sequencing result of PSPH gene of affected (II:4 and 
III:3 and III-4) and normal individuals (II:1, II:2 and 
III:2). The diagram A) and B) shows the C>T mutation in 
two affected (II-4 and III-4) individuals C) whereas one 
affected (III-3) was heterozygous for this mutation. D) 
Sequence of normal individual (III-2) was also 
heterozygous. 
99 
4.26 Pedigree of Family C with autosomal recessive mental 
retardation where squares represent male and square are 
used for female. Completely filled squares and circled are 
for affected whereas unfilled squares and circles shows 
unaffected individuals. Double lines show marriages 
between cousins and for non cousin marriage single is 
used. Crossed lines show deceased ones. 
102 
4.27 Facial images, with front and side pose of patients. The 103 
ix 
 
facial and limbs photograph did not show any facial or 
limbs dysmorphism. 
4.28 Whole genome homozygosity (WGH) picture of Family 
C showed HBD on chromosome 01 and 17. 
103 
4.29 The dChip analysed image of chromosome 01 of Family 
D in which the individual data is presented in the form of 
columns (III:3, III-4 and III:11 are affected and III:2 is 
normal). The blue colour in depicts homozygous region 
and yellow colour shows heterozygous region. individual 
at chromosome 17 shown in picture. 
104 
4.30 A snapshot of 1q25.3-q31.1 locus from UCSC Genome 
Browser. 
104 
4.31 Six generation Pedigree of Family D, showing most likely 
recessive form of inheritance. Filled Circles and Squares 
represent affected individuals. Partially filled squares and 
circle show carrier individuals.  Double lines represent 
consanguineous marriages whereas single line is for non 
cousin marriages. Crossed lines show deceased 
individuals. 
110 
4.32 Homozygosity Mapper output, showing complete HBD 
only on chromosome 22 (indicated by red arrow) 
111 
4.33. Ideogram of chromosome 22 indicating region of HBD, and 
the DNAL4 gene, indicating the location of the NM_005740.2 
c.153+2T>C variant at the exon 3/intron 3 splice site.. 
111 
4.34 Ideogram indicating location of the NM_005740.2 112 
x 
 
c.153+2T>C variant at the intron 3 donor splice site , and 
electopherograms showing the forward strand 
heterozygous wild type/mutant  sequence and the 
homozygous mutant (c.153+2T>C) sequence. 
4.35 Ideogrammatic representation of the resulting spliced 
mRNA showing exclusion of exon3, and the 
electropherogram of the resulting RT-PCR sequence of 
the exon 2/exon 4 splice junction. 
112 
4.36 A) Predicted 3D structures for wild type DNAL4, and B) the 
mutant DNAL4 with the 28 amino acid stretch encoded by 
exon 3 missing. The pink bars represent the sequence flanking 
the 28 residue deletion section in the wild type model and the 
mutant model 
113 
4.37 Linkage analysis using SIMWALK2. Position in Haldane cM 
is plotted on the x-axis, and Location Score (assuming no 
heterogeneity; alpha=1.0) on the y-axis. The significance 
threshold for linkage of 3.0 is indicated by the red dashed line. 
Maximum Location Score of 6.197 was achieved for the 
DNAL4 c.153+2T>C variant and microsatellite marker 
D22S423 
113 
4.38 Analysis of evolutionary conservation of DNAL4 protein using 
ClustalW2 alignment. The red bar above the alignment 
indicates the position of the 28 deleted amino acids. Yellow 
shading indicates amino acids that are conserved 100% across 
the species included in the alignment. Protein sequences used: 
human: NP_005731.1; rhesus: NP_001247540.1; pig: 
NP_001231596.1; elephant: XP_003419805.1; giant panda: 
XP_002914599.1; horse: XP_005606702.1; mouse: 
114 
xi 
 
NP_059498.2; rat: NP_001009666.1; rabbit: XP_002711436.1; 
opossum: XP_001367599.1; chicken: NP_001006242.1; finch: 
XP_005421907.1; anole: XP_003221024.1; Xenopus: 
NP_001087464.1; zebrafish: NP_001003603.1; fugu: 
XP_003976859.1; lancelet: XP_002595410.1; sea squirt: 
XP_002126866.1; hydra: XP_002162246.1; sea urchin: 
XP_794465.1; Trichloplax: XP_002110087.1; flour beetle: 
XP_967210.1; fruit fly: NP_610734.1; Chlamydomonas: 
ACC68802.1.  
5.1 The black and blue blocks show the wild type alleles. The 
green and red blocks represent mutant alleles. IV-6 is 
homozygous for 678G>A but heterozygous for 849C>T. 
IV-5 is heterozygous for 678G>A and homozygous for 
849C>T. Thus, affected daughter is inheriting 678G>A 
mutant allele from her father and 849C>T mutant allele 
from her mother. 
120 
5.2 mRNA degradation pathways and subsequent m7GpppN 
and m7GDP cap decomposition by DcpS. Picture was 
adopted from the paper Sabine Jemielity at al., (2010) 
with little modification.  
 
121 
   
 
xii 
 
List of Abbreviations 
ACD   Anticoagulant Citrate Dextrose 
BD   Becton, Dickinson 
BE   Buffer Elution 
Bp   Base pair 
cDNA   Complementary Deoxribonucleic Acid 
Cl   Chloride 
Ca   Calcium 
˚C   Celsius 
dNTPs   Dinucleotide Triphosphates 
dH2O   Distilled Water 
DNA   Deoxyribonucleic Acid 
DTT   Dithiothreitol  
EDTA   Ethylenediaminetetraacetic acid 
fmole   Femtmole  
HCl   Hydrochloric Acid 
IPTG   Isopropyl β-D-1-thiogalactopyranoside 
LB   Luria Broth 
Lac   Lactose 
MgCl2   Magnesium Chloride 
MnCl2   Manganese (II) Chloride 
M   Molar 
m7GpppG  Methyl Guanosine Triphosphate 
mM   millimolar 
NaCl2   Sodium Chloride 
KCl   Potassium Chloride 
xiii 
 
ml    millilitre 
Na2HPO4  Disodium Phosphate 
Nm   Nanometer 
ng    Nano-gram 
OD   Optical Density 
%   percentage 
pH   Power of Hydrogen 
RMP   Round Per Minute 
RNA   Ribonucleic acid 
RPM   Round Per Minute 
SDS   Sodium monododecyl sulfate  
SNP   Single Nucleotide Polymorphism 
SOC   Super Optimal broth with Catabolite repression 
Taq   Thermus aquaticus  
TA   Thymine and Adenine 
~   Tilde  
TLC   Thin Layer Chromatography 
U   Unit 
µl   microlitre 
µg   microgram 
USA   United States of America 
UTP   Uridine-5'-triphosphate 
UV   Ultra Violet 
xiv 
 
ACKNOWLEDGMENTS 
 
I am greatly honored to pay my deep gratitude to my teacher and research supervisor Dr. 
Peter John, Assistant Professor, Principal and Dean ASAB-NUST for establishing a 
scientific framework. I also appreciate his cooperation, dedication to research and 
intelligent leadership that under which I accomplished this strenuous work. 
 
I owe to express the deepest appreciation and respect to my co-supervisor Dr. John B. 
Vincent, whose advices and insight was invaluable to me. For all I learned from him and 
for providing the Neurogenetics Lab facilities for the experiments during IRSIP program 
in Centre for Addiction and Mental Health (CAMH), University of Toronto-Canada and 
financial support for staying extra time in Canada. His attitude to research inspired me 
and encouraged me a lot to shape my scientific approach and experimental design.  
I present my appreciation to the member of my GEC committee: Dr. Attya Bhatti, Dr. 
Muhammad Tahir and Dr. Shahid Mahmood Baig for their critical review, insightful 
comments and valuable suggestions for the improvement of my thesis draft. 
 
I extend my thanks to Dr. Muhammad Ayub and Dr. Muhammad Qasim Brohi for their 
help in neurological and Psychological assessment of families included in this study. 
I am thankful to Dr. Mike Kiledjian for his help in analysis of enzymatic activity of 
DCPS protein in his laboratory. 
 
I would like to thank my friend Dr. Muhammad Arshad Rafiq for his sympathetic 
attitude, encouragements and generous guidance at every step CAMH, Toronto-Canada. I 
always miss his company during coffee time at Tim Horton and long walk in summer. 
 
Many thanks to Anna Mikhailov for her technical support in cloning and helping to 
review the materials and methods chapters of my thesis. 
 
I owe my heartiest thanks to my friend Rosalind Law for her generous help in my thesis 
write up and her assistance in my experimental work. 
 
xv 
 
I am thankful to my friends Kumudesh Sritharan, Hameed, Kirti Mital, Taimoor Islam 
Shaikh and Bryan Degagne for their nice company during my stay at CAMH-Toronto, 
Canada. The good time spent with them can never be erased from my memories. 
 
I wish to express my sincere thanks to my colleague and class fellows Sayed Fazal Jalil, 
Samiullah,  Zeeshan Gauhar, Dr. Shamim Bhatti, Dr. Kashif Asghar, Muhammad Ali, 
Malik Shuja and my juniors especially Fahad Qadir and Usman for their nice company in 
NUST, Islamabad. 
 
I owe my thanks to my beloved college principal, Professor Habib-ur-Rehman Mangi and 
my colleagues especially Professor Fida Hussain Sarki, Professor Arbab Ali Kanrani and 
my heartiest friend Saen Shahzado Golo for their moral support and encouragement to 
bring this study at the end. 
 
I am thankful to my loving parents, younger brothers and sisters for their continuous 
prayers and patience during the period of my study. 
 
I wish to thank the family members for their willing participation and cooperation in this 
study. 
Many thanks Atta-ur-Rehman School of Applied Biosciences, National University of 
Sciences and Technology, Islamabad for providing peaceful educational environment for 
research and studies. 
I am really thankful to Higher Education Commission (HEC) in Pakistan for providing 
me funds for the study in Pakistan (under indigenous scholarship program) as well as in 
Canada (under IRSIP program). 
Many thanks to Education and Literacy Department Government of Sindh for granting 
me leave for my Ph.D study. 
Finally, I want to express my deep appreciation to my beloved wife for her continuous 
love and care which has made my life full of happiness and motivation. 
 
 
        Iltaf Ahmed Baloch  
xvi 
 
ABSTRACT 
Neurological disorders are diverse group of diseases mostly induced by specific 
genetic factors some of which are monogenic, while others are heterogeneous in nature. 
The present study was aimed to investigate the genetic basis of two hereditary 
neurological disorders in Pakistani Families: Non-Syndromic Autosomal Recessive 
Intellectual Disability (NS-ARID) and Congenital Mirror Movement.  
Mental retardation, now referred to as intellectual disability (ID), is a 
neurodevelopment disorder characterized by impairment in conceptual, practical, social 
skills and an intelligence quotient (IQ) below 70 before the age of eighteen. It is 
prevalent in 1-3% of population but presumed to be higher where consanguineous 
marriages are common.  
The Mirror Movement (MRMV) refers to involuntary, synkinetic mirror reversals 
of an intended movement of opposite side”. MRMV is found in young children and 
gradually disappears within the first decade of life.  If mirror movement persists after the 
first decade of life with no clinical features it is referred as congenital mirror movement. 
MRMV is a rare disorder, mainly inherited in an autosomal-dominant fashion although 
sporadic cases of recessive form may also exist.  
In this study four consanguineous Pakistani families with hereditary neurological 
disorder including three (A, B and C) of NS-ARID and one Family of MRMV (D) were 
investigated. In Families A, B, C and D, Whole Genome Single Nucleotide 
Polymorphism (SNP) Genotyping microarray (250K Affymatrix) identified 
homozygosity by decent (HBD) on chromosomes 11q25.1-q25, 7p12.1-p11.2 and 
xvii 
 
7p12.1-p11.2 in families A to C respectively, and a ~3.3Mb on chromosome 22q13.1 in 
Family D.  
In Family A, analysis of genes of locus 11q25.1-q25 with Whole Genome Exome 
Sequences followed by Sanger Sequences revealed 678G>A splice donor site mutation in 
the exon-intron junction of 4 and 5 of Decapping Scavenger (DCPS) gene on 
chromosome 11q24.2 which resulted in alteration of splice site from GT>AT and shifting 
to a cryptic splice site 45bp downstream which caused incorporation of 45 nucleotide in 
final transcript. Another heterozygous mutation was identified in one affected individual 
(V:7) of Family A, where 947C>T in DCPS gene and rendering that individual as 
compound heterozygous. In vitro, analysis of mutant DCPS protein showed reduced 
expression level and enzymatic activity as compared to wild type. 
The locus 7p12.1-p11.2 of the Family B showed 997C>T transition in 
Phosphoserine phosphatise (PSPH) gene in two affected individuals (II:4 and III:4) 
whereas one affected (III:3) and three normal individual (II:1, II:2 and III:2) were 
heterozygous for this mutation. Amino acid quantification assay showed normal serine 
and glycine level in blood plasma of affected individuals. In Family C, COLGALT2, 
C1orf21, NMNAT2, RGL1, RNF2, TSEN15, ARPC5, SHCBP1L, SMG7 and NPL gene of 
locus 1q25.3-q31.1 were sequenced however no pathogenic sequence variation was 
found.  
In Family D, the autozygous region of ~3.3Mb on chromosome 22q13.1 
(Chr22:36605976-39904648) was identified. Whole Exome Sequence (WES) reads  
identified a potential donor splice site mutation 2 nucleotides within intron 3 of the 
Dynein Axonemal Light chain 4 gene, DNAL4: chr22:39176929A>G; NM_005740.2 
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(DNAL4_vNM_005740): c.153+2T>C. This substitution destroys the canonical “GT” 
splice donor site and resulted in skipping of exon 3. The removal of exon 3 results in an 
open reading frame of just 77 amino acid residues instead of 105, effectively a deletion of 
28 amino acids (residues 24 to 51 inclusive). This variant was not in any SNP databases. 
Linkage analysis across the 22q region using Simwalk2 a maximum location score 
(directly comparable to multipoint LOD score) of 6.197 was calculated for markers 
D22S280 and DNAL4 (NM_005740): c.153+2T>C. Comparative protein sequence 
analysis for deleted stretch (residues from 24-51) of DNAL4 showed to be highly 
conserved across the Kingdom Animalia (or Metazoa). 
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Chapter 1 
1-INTRODUCTION 
1.1-Background:  
Neurological disorders represent a wide range of illnesses associated with 
varying clinical manifestations such as severity, age of onset, prognosis and treatment 
responses. Generally, neurological disorders are classified as neonatal 
neurodevelopmental disorders, childhood or adult onset of neuropsychiatric disorders 
as well as late onset of neurodegenerative diseases (Table 1.1). Most neurological 
disorders are induced predominantly by specific genetic factors that differ among 
varying classes of neurological diseases, some of which are caused by a single gene 
or locus i.e. monogenic disorders, while for others, disease predisposition is 
heterogeneous in nature, caused by the interplay between genetic and environmental 
factors. Accordingly, genomic variation plays a main role in disease susceptibility, 
age of onset and treatment option for different classes of neurological diseases (Foo et 
al., 2013).  
Most neurological disorders lead to ill-health but rarely result in direct deaths 
(WHO, 2006). To this end, disease pathogenesis is generally characterized by a 
progressive decline in health function and thus an overall decrease in the quality of 
life for affected individuals; this is corroborated by high healthcare costs and long-
term dependence on health and social care professionals throughout life (The Lancet 
Editorial, 2012).  
Advancements in molecular genetics is critical for understanding hereditary 
neurological disorders as they can lead to the development of therapeutic strategies 
for affected individuals, as for many disorders, there is currently no available 
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treatment. In this regard, a number of new genetic approaches are under investigation 
for correction of mutated genes and its regulation (Bowers et al., 2011).  
Table 1.1:  The various class of Neurological Disorders (Foo et al., 2013) 
Neurological Disorders Examples 
Childhood neurodevelopmental 
disorders 
 
Infantile epilepsy 
Infantile syndromic seizures 
Brain malformation 
Heterogeneous monogenic disorders 
disease 
 
Charcot–Marie–Tooth 
Spinal muscular atrophy 
Parkinsonism 
Cerebral palsy 
Mitochondrial diseases 
Trinucleotide expansion diseases 
Spinocerebellar Ataxia 
Huntington‟s disease 
Fragile X syndrome 
Neuropsychiatric diseases 
Autism 
Schizophrenia 
Intellectual disability 
Late-onset neurodegenerative diseases 
Parkinson‟s disease 
Alzheimer‟s disease 
Amyotrophic lateral sclerosis 
 
1.2-Mental Retardation/ Intellectual Disability (MR/ID) 
Mental retardation, now referred to as intellectual disability (ID), is a 
neurodevelopment disorder characterized by impairment in conceptual, practical, 
social skills and an intelligence quotient (IQ) below 70 before the age of eighteen. 
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Conceptual skills refer to receptive and expressive language, reading and writing, 
money concepts and self-directions. Social skills are responsibility, self-esteem, 
gullibility, i.e. likelihood of being tricked or manipulated, following the rules, obey 
laws and avoiding victimization. Practical adaptive skills are personal activities of 
daily living such as eating, dressing, mobility and toileting and instrumental activities 
of daily living such as preparing meals, taking medication, using the telephone, 
managing money, using transportation and doing housekeeping activities, 
occupational skills and maintaining a safe environment (American Psychological 
Association,  1994 and American Association on Mental Retardation, 2005). 
Intellectual Disability (ID) is highly heterogeneous in nature and one of the 
important unsolved problems in health care. It is prevalent in 1-3% of the general 
population (Roeleveld et al., 1997; Leonard, 2002; Ropers, 2006). ID can be 
subdivided into syndromic and non- syndromic forms. Syndromic ID is accompanied 
with either malformations or dysmorphic features or other neurological abnormalities 
whereas non syndromic form is characterized without any additional features. 
However, in many cases dysmorphic or neurological features may be too subtle to 
differentiate clinically both forms. In addition, ID can further be categorized in to four 
groups on the basis of severity (Ropers, 2006; Basel-Vanagaite, 2007). 
The assessment of severity or extent of ID is determined by measuring the 
intellectual ability of affected individuals with standardized tests i.e. Wechsler‟s test 
(Wechsler, 1981). Thus it is classified into four subgroups on IQ levels score of 
affected individuals: Mild MR (IQ: 50–70), Moderate MR (IQ: 36–49), Severe MR 
(IQ: 35–20), and profound MR (IQ<20) (Schroeder et al., 2001). It is believed that 
mild forms of ID correspond to the lowest perimeter of the normal IQ distribution and 
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caused by interaction of many genetic and environmental factors. Conversely, severe 
forms of ID (IQ <50), which has an incidence of about ~0.4%, might be caused by 
specific genetic factors such as chromosomal aberrations and defects in specific genes 
(Ropers, 2006).  
1.2.1-Chromosomal Aberrations: 
Chromosomal aberrations include numerical and structural abnormalities in 
chromosomes. The most common chromosomal aberration and the most frequent 
cause of ID is Down syndrome (trisomy 21), which unlike other chromosomal 
aberrations, can be easily detected by light microscopy. It is estimated that 1/750 to 
1/800 babies are born with Down‟s syndrome; this frequency is remarkably consistent 
in most parts of the world despite of prenatal diagnosis (Centers for Disease Control 
and Prevention 2006; Nazer et al., 2006; Besser et al., 2007; Collins et al., 2008).  
A retrospective study from the Dutch population comprising with idiopathic 
developmental delay, the frequency of large chromosomal aberrations was 
approximately 4.6% (Hochstenbach et al., 2009). The balanced chromosome 
rearrangements, such as inversions and reciprocal translocations were implicated in 
less than 1% of these findings.  Diseases caused by balanced chromosome 
rearrangements proved to be helpful in the mapping and explication of many 
monogenic ID as well as other related disorders (Ropers, 2006; Ropers, 2007; Fantes, 
et al., 2008; Vandeweyer and Kooy, 2009).  
The recurrent microdeletions causes haploinsufficieny of specific genes 
resulting some clinically recognizable phenotypes  like Angelman, Prader–Willi, 
Williams-Beuren Smith-Magenis, Miller Dieker, and DiGeorge syndromes (Ropers, 
2010).  
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1.2.2-X-Chromosomal forms of ID: 
X-chromosomal defects are the leading cause of moderate to severe 
intellectual disability in males and are referred to as X-linked ID (XLID). XLID is 
classified into Syndromic (S-XLID) and non-syndromic forms (NS-XLID). S-XLID 
is accompanied with specific pattern of physical, neurological and metabolic 
abnormalities. The term „„non-specific‟‟ or „„non-syndromic‟‟ X-linked ID (NS-
XLID) was coined by Kerr et al., (1991) and refers to the segregation of traits 
associated exclusively with the X chromosome in affected individuals with no 
consistent phenotypic manifestations other than ID. To date, about thirty nine genes 
have been attributed to causation of non-syndromic XLID (Table 1.2) and it is 
generally believed that non-syndromic XLID are more frequent than syndromic forms 
(Streissguth, 2004). However, this school of thought is still debatable because 
scientists have not yet been able to differentiate between SXLID and NS-XLID due to 
subtle differences.  
Fragile X-Syndrome is the most common cause of S-XLID is diagnosed with 
the presence of expanded trinucleotide repeat CGG within the first exon of the FMR1 
gene (Kremer et al., 1991; Oberle et al., 1991; Yu et al., 1991). This expansion results 
in hypermethylation of the promoter region as well as repeats itself (Bell et al., 1991; 
Vincent et al., 1991; Hansen et al., 1992), leading to loss of FMR1 gene expression 
(Pieretti et al., 1991; Sutcliffe et al., 1992). During  fetal developmental, the 
expression of FMR1 occurs in multiple tissues including neural cells (Pieretti et al., 
1991; Abitbol et al., 1993; Devys et al., 1993; Hinds et al., 1993). The FMR1 gene 
encodes the Fragile X Mental Retardation Protein (FMRP), which is engaged in 
kinesin-mediated dendritic transport of mRNAs (Dictenberg et al., 2008).  
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Table 1.2: Genes involved in non-syndromic X-linked mental retardation 
S. No. 
Gene OMIM Function Reference 
1 HUWE1  E3 ubiquitin-protein ligase (Turner et al., 1994) 
2 GDI 300104 RhoGTPase Pathway (D'Adamo et al., 1998) 
3 OPHN1 300127 
Repression of the Rho signalling pathway to 
maintain dendritic spine length 
(Billuart et al., 1998) 
4 PAK3 300142 RhoGTPase Pathway (Allen et al., 1998) 
5 
RPS6KA3 
(RSK2) 
300075 Chromatin remodeling (Merienne et al., 1999) 
6 IL1RAPL1 300206 Interleukin 1 receptor accessory protein-related (Carrie et al., 1999) 
7 MECP2 300005 Transcription repression 
(Meloni et al., 2000; 
Orrico et al.,2000; 
Klauck et al., 2002) 
8 ATRX 300032 Chromatin Remodeling 
(Guerrini et al., 2000) 
(Yntema et al., 2002) 
9 TM4SF2 300096 Control of neurite outgrowth (Zemni et al., 2000) 
10 FMR2 309548 Putative transcription Transactivation (Gecz, 2000) 
11 ARHGEF6 300267 Rho GTPase Pathway (Kutsche et al., 2000) 
12 SLC6A8 300036 
Sodium- and Chloride-Dependent 
Creatine Transporter 
(Salomons et al., 2001) 
13 
FACL4 
(ACSL4) 
300157 Fatty Acid CoA l Long chain (Meloni et al., 2002) 
14 ARX 300382 Aristaless-Related Homeobox Gene (Stromme et al., 2002) 
15 
AGTR2 
 
300034 
Dephosphorylation of Mitogen Activated 
Protein Kinase 
Vervoort et al. 2002) 
16 ACSL4 300157 Long-chain Acyl-CoA Synthetase (Meloni et al.,, 2002) 
17 FGD1 305400 CDC42-Specific GDP-GTP Exchange Factor. (Lebel et al., 2002) 
18 NLGN3 300336 Synaptic Vesicle Component (Jamain et al., 2003) 
19 NLGN4 300427 Synaptic Vesicle Component (Jamain et al., 2003) 
20 ZNF41 314995 Transcription Factor (Shoichet et al., 2003) 
21 PQBP1 300463 Transcriptional Activator (Kalscheuer et al., 2003) 
22 SYN1 313440 Regulation of Neurotransmitter Release (Garcia et al., 2004) 
23 DLG3 300189 
Membrane-associated Guanylate Kinase protein 
interacting with NR2 subunit of the NMDA receptor 
(Tarpey et al., 2004) 
24 SLC6A8 300036 SLC6A8 Creatine transporter (Rosenberg et al., 2004) 
25 SLC16A2 300523 Thyroid Hormone Transporter (Friesema et al., 2004) 
26 FTSJ1 300499 Methylase (Freude et al., 2004) 
27 ZNF81 314998 Transcription Factor (Kleefstra et al., 2004) 
28 SMCX 314690 Transcriptional Repressor (Jensen et al., 2005) 
29 AP1S2 300630 Assembly of Endocytic Vesicles (Tarpey et al., 2006) 
30 ZNF674 300573 Transcription Factor (Lugtenberg et al., 2006) 
31 RPL10 312173 Transcription Regulatory Protein (Klauck et al., 2006) 
32 UPF3B 300676 mRNA nuclear export and mRNA surveillance. (Tarpey et al., 2007) 
33 CASK 300172 
Calcium/Calmodulin-Dependent Serine Protein 
Kinase 
(Tarpey et al., 2009) 
34 SYP 313475 
Synaptophysin Regulates Synaptic Vesicle 
Endocytosis 
(Tarpey et al., 2009) 
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FMRP is synthesized upon activation of the metabotropic glutamate receptor 
(mGluR) by glutamate (Weiler, 1997). It is postulated that FMRP represses mRNAs 
translation and negatively regulate the internalization of α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid receptor (AMPA) receptors and fortifying synaptic 
connections (Huber, 2002; Bear, et al., 2004). 
Rauch, et al., (2006) reported in a representative study that cytogenetic 
anomalies and submicroscopic aberrations account for 15% of ID cases, while X-
chromosomal mutations are the cause for approximately 10% of ID cases. This 
suggests that for more than half of the cases the etiology of ID remain unsolved and 
that in majority of the cases, the genetic aberration is likely on autosomal 
chromosomes (Ropers, 2005). 
1.3-Autosomal Intellectual Disability (AID) 
Autosomal Intellectual Disability can be Autosomal dominant or Recessive. 
1.3.1-Autosomal dominant Intellectual Disability (ADID):  
The frequency of autosomal dominant forms of intellectual disability (ADID) 
is rare because most of the affected individuals do not reproduce. A significant 
portion of sporadic cases of ADID are due to dominant de novo mutations 
(Idiopathic), reported from out bred Caucasian populations (Hamdan et al., 2009; 
Vissers, et al., 2010; Hamdan, et al., 2011). Well-known examples of ADID include 
neurofibromatosis (incidence rate 1/4000), tuberous sclerosis (1/6000) and myotonic 
dystrophy (1/8000) (Nelson, 2009).   
To date, malfunction of only a few genes has been implicated to Idiopathic ID. 
A systematic mutation screening in a cohort of 94 unrelated patients by Hamdan 
(2009) identified three de novo heterozygous truncating mutations in the Synaptic Ras 
GTPase-activating protein 1 (SYNGAP1) gene. In another study, Hamdan, et al., 
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(2009) reported two heterozygous mutations in Syntaxin-binding protein 1 (STXB1) 
gene which were absent in healthy controls. STXBP1 regulates fusion of synaptic 
vesicles with the presynaptic membrane and the release of neurotransmitters into the 
synaptic cleft in the SNARE mediated pathway. The mutation in Forkhead box protein 
G1 (FOXG1) (Brunetti-Pierri, et al., 2011) and Methyl CpG Binding Protein 2 
(MECP2) (Van Esch, et al., 2005) gene was identified from the patients with 
idiopathic ID. The data from different studies suggests that in out bred Western 
populations with idiopathic ID, de novo mutations in autosomal brain expressed genes 
are surprisingly common among sporadic patients with idiopathic ID, but it is 
premature to estimate the prevalence of ADID and the contribution of individual gene 
defects (Ropers, 2010).  
1.3.2-Autosomal Recessive of Intellectual Disability: 
Compared with XLID, the molecular explication of autosomal recessive ID 
(ARID) is lagging behind as most of the research is primarily conducted in Western 
countries is hampered by small family sizes and infrequent parental consanguinity. In 
this situation, even the possibility of a genetic causation will often not be considered. 
Therefore, very little information is available concerning the role of autosomal 
recessive intellectual disability (ARID) (Najmabadi, et al., 2011). 
To date thirty two loci (Table 1.3) and ten genes have been identified from 
autosomal recessive form of ID cases. It is supposed that the burden of autosomal 
recessive disorders especially non-syndromic Autosomal Intellectual Disability (NS-
ARID) is significantly higher in countries where consanguineous marriages are more 
frequent.  In a demographic study conducted on a Pakistani population, Hussain and 
Bittles, (1998) demonstrated that there is 62.7% consanguinity in Pakistan population 
out of which 84% of marriages are between first cousins. Therefore, homozygosity 
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mapping is an ideal strategy to identify the genes responsible for NS-ARID in an 
individual or family will help in genetic counseling and the screening of carriers in 
order to reduce the number of affected babies. It also provides an opportunity to pre 
natal or pre-implantation diagnosis of disease.  
1.3.3-Diagnostic strategies for Mental Retardation: 
The diagnosis of MR is straightforward, but determining the underlying 
etiology is a great challenge to every specialist. Moreover, diagnostic guidelines 
provided by American College of Medical Genetics (Curry, et al., 1997) and 
American Academy of Neurology widely vary. The former places an emphasis on 
family history, dysmorphology examination and target gene testing whereas the latter 
(Shevell, et al., 2003) focuses on cranial imaging and Electroencephalography (EEG) 
interpretations as clues to the diagnosis. However, both institutions are in consensus 
to the basic evaluation of MR individuals, which includes Wechsler tests, 
measurements of adaptive behaviors etc. 
The diagnostic tests used in published studies differ in the range of 40% to 
60% (Hunter, 2000; Finck, et al., 2000; Kleefstra, et al., 2005). This variability is 
largely due to the different population based study, age of the patients, year of the 
study. Secondly, both institutions have different opinion regarding to the cause of 
retardation and the variability in the specificity of the diagnosis. 
The recommended strategies for diagnosis of MR are listed below. 
1. The investigation of MR begins with the parental history that includes 
tetragenic exposure such as alcohol, cigarettes and drugs like isotretinoin, 
warfarin and anticonvulsant drugs (Brent, 2004). Maternal diseases such as 
myotonic dystrophy and the pregnancy history are taken in account wherein 
fetal activity, amniotic fluid amount and the fetal presentation like utero 
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hypotonia are investigated. In addition to these, the prenatal problem in brain 
development, poor feeding, hypoglycemia, hypothermia, seizures, etc are 
important clues for MR. 
2. Family history also helps in providing evidence for MR.  The history of prior 
pregnancy loss due to stillbirth or miscarriage could suggest familial 
chromosomal imbalance. Furthermore, parental consanguinity, history of MR 
in maternal family; this may provide evidence for X-linked retardation. 
Psychological symptoms such as anxiety, obsessive-compulsive disorder, 
depression and progressive dementia in male or female relatives may be 
considered in   patient diagnosis. Female carriers of X-linked conditions such 
as Fragile X permutation (CGG repeats in the range of 50 to 200) may 
experience premature ovarian failure and psychological symptoms like 
excessive shyness, depression, and anxiety. Males with the permutation in 
Fragile X have increased risk for a condition termed FXTAS (Fragile X 
Associated Tremor Ataxia Syndrome) characterized by Parkinson- like ataxia 
and progressive dementia after age 50 (Hagerman and Hagerman, 2004). 
3. American College of Medical Genetics recommends screening of 20-29 
metabolic disorders such as hypothyroidism, phenylketonuria etc. in newborn. 
This has helped in identifying and treating inborn metabolic disorders in many 
children who might have otherwise died prematurely or become handicapped.  
4. The physical examination mainly focuses on assessment for dysmorphic 
features, neurological abnormalities, and behavioral phenotype. Indeed, many 
observations leading to a diagnosis may be obtained by merely watching the 
MR patient for stereotypic and/or classic behaviors. A notable example is 
hand-wringing associated with Rett Syndrome. However, it should be noted 
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that optimal information is gained when the patient is undressed: 
measurements of inner canthal distance, interpupillary distance, palpebral 
fissure length, ear length, hand and middle finger length and penile length as 
well as growth parameters are important in objectively assessing specific 
features. Furthermore, pictures of the affected individual should be obtained as 
during the assessment. The neurological status of the MR patient includes the 
assessment of gait and tone along with interpersonal interactions between the 
affected individual and others.  
5. A cytogenetic study is recommended for chromosomal anomalies and skin 
biopsy is performed for the presence of pigmentary abnormalities. 
6. Fragile X molecular testing, targeted FISH (fluorescent in situ hybridization) 
or CGH (Comparative genomic hybridization) are suggested for undiagnosed 
MR except in those with macrocephaly or multiple anomalies. 
7.  Cranial imaging, like Magnetic Resonance Imaging (MRI), shows the 
presence of cranial contour abnormalities, microcephaly, macrocephaly, and 
neurologic symptoms. 
    8.  Molecular testing is remarkable useful diagnosis tool when prenatal diagnosis 
is an option for the family.  
   9. Adjunctive testing such as hearing, vision, psychological testing as indicated 
by the affected individual‟s or patient presentation. The diagnosis is MR is 
often complex, requiring a multidisciplinary effort over time. 
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Table 1.3: The known loci of NS-ARID. 
S. No. 
Locus 
name 
OMIM 
ID 
Cytogenetic 
Location 
Reference 
1 *MRT1 249500 4q26 Molinari et al., 2002 
2 MRT2 607417 3p26.2 Higgins et al., 2000 
3 MRT3 608443 19p13.12 Basel-Vanagaite et al., 2003 
4 MRT4 611107 1p21.1-p13.3 Uyguner et al., 2007 
5 MRT5 611091 5p15.31 Najmabadi et al., 2007 
6 MRT6 611092 6q16.3 Najmabadi et al.,  2007 
7 MRT7/22 611093 8p22 Najmabadi et al.,  2007, Garshasbi et al., 2008 
8 MRT8 611094 10q22 Najmabadi et al.,  2007 
9 MRT9/26 611095 14q11.2-q12 Najmabadi et al.,  2007, Jamra et al., 2011 
10 MRT10/20 611096 16p12.2-q12.1 Najmabadi et al., 2007, Jamra et al.,  2011 
11 MRT11 611097 19q13.2-q13.3 Najmabadi et al.,  2007,  Kuss et al., 2011 
12 MRT12 611090 1p34.1 Uyguner et al.,  2007 
13 MRT13 613192 8q24.3 Mir et al., 2009,  Jamra et al., 2011, Marangi et 
al., 2013 etc. 
14 MRT14 614020 19p13.12 Nolan et al., 2008, Caliskan et al., 2011. 
15 MRT15 614202 9q34.3 Rafiq et al., 2010 
16 MRT16 614208 9p23-p13.3 Rafiq et al., 2010 
17 MRT17/21 614207 11p15 Rehman et al., 2011, Jamra et al., 2011 
18 MRT18 614249 6q23.2 Hashimoto et al., 2011 
19 MRT19 614343 18p11.3 Jamra et al., 2011 
20 MRT23 614344 11p13-q14.1 Jamra et al., 2011 
21 MRT24 614345 6p12.2-q12 Jamra et al., 2011 
22 MRT25 614346 12q13.11-q15 Jamra et al., 2011 
23 MRT27 614340 15q24.1-q26.1 Kuss et al., 2011, Jamra et al., 2011 
24 MRT28 614347 6q26-q27 Jamra et al., 2011 
25 MRT29 614333 4q27-q28.2 Jamra et al., 2011 
26 MRT30 614342 6q12-q15 Jamra et al., 2011 
27 MRT31 614329 4q12-q13.1 Kuss et al., 2011 
28 MRT32 614339 14q32.13-q32.2 Kuss et al., 2011 
29 MRT33 614341 17p13.2-p13.1 Kuss et al., 2011 
30 MRT34 614499 12q22 Puffenberger et al., 2012 
31 MRT35 615162 17q21.31-q22 Al-Owain et al., 2011 
32 MRT36 615286  19p13.3 Alazami et al., 2013 
*MRT stands for Mental Retardation 
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1.4- Mirror Movement 
The term “Mirror Movement” (MRMV) was first introduced by Erlenmeyer in 
1879 but coined by Cohen, et al., (1991), and “refers to involuntary, synkinetic mirror 
reversals of an intended movement of opposite side”. MRMV is found in young 
children and gradually disappears within the first decade of life; it is presumed that 
MRMV is a necessary developmental stage in the maturating motor network (Bonnet, 
et al., 2010). If mirror movement persists after the first decade of life with no other 
clinical features is referred as congenital mirror movement. MRMV is a rare disorder 
that is mainly inherited in an autosomal-dominant fashion although sporadic cases of 
recessive form may also exist (Rasmaussen, 1993).  
MRMV may be present in all limbs but it is predominantly found in upper 
limbs with muscles controlling the fingers and hands and their intensity increases with 
the complexity of the voluntary movement. Consequently, MRMV impairs the ability 
of an affected individual to perform tasks requiring skilled bimanual coordination 
such as tying shoe-laces, cutting vegetables or buttoning shirts etc. which more often 
than not, is associated with pain in the upper limbs during sustained manual activities. 
A severe form of MRMV, affecting both hands and forearms, was reported in 15 year 
old girl who complained about a painful contraction of left shoulder muscles when 
she wrote with her right hand. This patient shows that MRMV is caused by multiple 
and structural abnormalities of the motor network and altered decussation of the 
corticospinal tract (Regli, et al 1967; Cincotta, et al., 2003; Galle´a, et al., 2011). 
Two general mechanisms have been proposed to explain the occurrence of 
MRMV (Figure 1.1). First, MRMV might originate from the same hemisphere as 
their voluntary counterpart through an uncrossed fast-conducting corticospinal tract 
that descends from the hand area of one primary motor cortex (M1) to the ipsilateral 
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side of the spinal cord. This abnormal ipsilateral projection could depend on either a 
branching of crossed corticospinal fibers or a separate ipsilateral corticospinal 
projection.  In the second proposed pathway, an abnormal activation of both 
hemispheres during intended unimanual movement that could be due to dysfunction 
of the neural circuits that focus the generation of motor activity which is contralateral 
to the voluntary movement (Cox, et al., 2012). 
 
Figure 1.1. The Possible pathways for MRMV. (A)  MRMV caused due to a common drive 
to bilateral homologous motor neuron pools. (B) Anomalous uncrossed ipsilateral 
corticospinal tracts. (C) Decreased transcallosal (dotted line) or increased facilitation (solid 
line) of the M1 contralateral to the MRMV hand. (D) Altered interhemispheric inhibition of 
intracortical facilitation in the M1 contralateral to MRMV. The combination any of these 
mechanisms could lead in the generation of MRMV. M1more = more affected cortex; M1less = 
less affected cortex (Cox, et al., 2012).  
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1.3.1-Cause of MRMV and Diagnosis Criteria: 
Mirror Movement can be associated with several other neurologic conditions, 
including cervicomedullary junction anomaly, cerebral palsy, Parkinson‟s disease, 
cerebrovascular disease, symptomatic epilepsies, Friedreich‟s ataxia, phenylketonuria, 
Kallman‟s syndrome, high cervical spinal cord malformation, alien hand syndrome 
(vascular lesion) and can also be associated with certain psychiatric conditions such 
as obsessive-compulsive disorder and schizophrenia. In addition, familial and 
sporadic cases have been reported with autosomal dominant or autosomal recessive 
inheritance (Rasmaussen, 1993).  
Congenital Mirror Movement (MRMV) is not associated with another 
neurological disorder.  Diagnosis of MRMV is based on complete neurological 
examination, brain imaging by Magnetic resonance imaging (MRI) or Computed 
Tomography scan (CT scan) in order to exclude other neurological abnormalities 
associated with MRMV. 
1.5-Aims of the study 
Mental retardation (MR) is major a public health problem because only few 
therapeutic options are currently available and the resulting life-long harm to the 
affected persons, their families, and society as a whole. In fact, it can account for as 
much as 25% of the total health care budget of a society (Polder et al., 2002). 
According to Ropers (2007), autosomal recessive forms of mental retardation could 
be responsible for a large proportion of mental retardation cases. To date, only few 
genes has been identified that are responsible for Non syndromic form of Mental 
Retardation (NS-AMR). Assessing genetic causes for NS-AMR is particularly 
challenging in developed countries where family sizes are small, which in turn, makes 
ID cases sporadic in the general population and thus difficult to obtain enough data.  
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Furthermore, it is difficult to differentiate genetically distinct subtypes of ID based 
solely on a clinical basis; this not only precludes the pooling of data from unrelated 
families but also renders their elucidation complicated (Ropers, 2010).  
The aims of the present study are listed below: 
 Large scale homozygosity mapping in consanguineous Pakistani families to 
identify candidate loci for NS-ARMR and MRMV.  
 Homozygous intervals will be screened to find out novel genes and their 
potential sequence variants. 
 Functional studies will be carried out to confirm the pathogenic correlation of 
these changes in order to unveil the molecular mechanisms underlying NS-
ARMR and MRMV. It will help in future for therapy of affected individuals 
and genetic counseling.  
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Chapter 2 
2-LITERATURE REVIEW  
2.1-Intellectual Disability 
Intellectual disability (ID), or mental retardation (MR), is an unresolved 
healthcare problem that impacts both affected individuals and their families. For most 
ID cases, the underlying etiology is genetic in origin, therefore; it is frequently 
referred to genetic centers. The mild form of ID is characterized by intelligence 
Quotient (IQ) between 50-70 could be solely of genetic origin. However, severe 
forms of ID (IQ>50) have incidence of 0.4% is thought to be caused by 
environmental or genetic factors (Ropers 2010).  
In the last few years, it became obvious that genetic factors such as 
chromosomal abnormalities and point mutations play key roles in the etiology of ID. 
In an epidemiological study, Rauch et al., (2006) demonstrated that 15% of the cases 
of ID are caused by cytogenetic anomalies and 15% are due to submicroscopic 
aberrations. Mutations in X-chromosomes are the cause in about 10% of the cases 
(Ropers and Hamel 2005). This suggests that ID etiology remains unsolved in more 
than half of the cases and of which the majority of these cases are due to autosomal 
mutations. Accordingly, over 90 genes indentified are responsible for approximately 
40% of X-chromosomal recessive ID patients (Ropers 2010). It is predicted that about 
half of the human genes are expressed in brain so the total number of autosomal 
recessive intellectual disability (ARID) cases might run into the hundreds (Ropers 
2010).           
 Previous linkage studies reveal that ARID is heterogeneous in nature and the 
genes identified so for general cases do not account for the majority of cases. As such, 
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a systematic strategy is required to identify disorder causation (Najmabadi et al., 
2007; Rafiq et al., 2010; Kuss et al., 2011). In this case, large consanguineous 
families are needed to provide sufficient information to map loci, based on analysis in 
a single family and thus represent the best starting point.  
The prevalence of autosomal recessive non-specific ID or non sydnromic-
autosomal recessive intellectual disability (NS-ARID) is unknown, despite empirical 
data from mouse models suggesting that most gene defects are inherited as recessive 
forms (Priest et al., 1961; Bartley et al., 1978; Ropers 2010).  To date, numbers of 
significantly linked loci (Table 1.3) have been identified in NS-ARID and large 
number of genes has been reported (The updated lists of genes of ID are presented in 
Appendix I) but here few genes and their role in NS-ARID is discussed in detail. 
2.1.1-Protease, Serine, 12 (PRSS12): 
 
PRSS12 (MIM # 606709), also referred to as neurotrypsin, motopsin or brain 
specific serine protease 3 (BSSP3). It is mapped to chromosome 4q26, otherwise 
known as the MRT1 locus. PRSS12 is an extracellular serine protease and performs 
various physiological and pathological functions in the nervous system. This gene 
was reported by two independent groups simultaneously (Yoshida and Shiosaka 1999; 
Shiosaka and Yoshida 2000; Tomimatsu et al., 2002; Mitsui et al., 2007). Thus, 
Human Genome Organization (HUGO) nomenclature designed the names as PRSS12 
and neruotrypins as well as motopsin (Gschwend et al., 1997; Yamamura et al., 
1997).           
 The expression of PRSS12 is found in neural cells of various regions of the 
brain, including the cranial nerve nuclei and amygdala (Gschwend et al., 1997; Iijima 
et al., 1999); however, the highest expression of motopsin is observed in 
hippocampus and cingulated cortex during the first postnatal week. Its expression 
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level gradually declines throughout postnatal development but remains expressed in 
adult life (Iijima et al., 1999; Wolfer et al., 2001). Abundant expression of motopsin 
mRNA was also observed in other regions of brain like the olfactory system, cranial 
nerve nuclei, spinal cord, and peripheral nervous system during perinatal period. 
Suggesting the role of motopsin in development of nervous system (Mitsui et al., 
2009).           
 To understand the pathophysiologic effects of neurotrypsin, Taquila (Teq), the 
Drosophila neurotrypsin ortholog, was studied to analyse the correlation of   Taq 
inactivation with associative memory and behaviour of animal.  Didelot et al., 
(2006) reported that Teq inactivation causes defects in long-term memory formation 
and inhibition of Teq expression in adult mushroom bodies resulted in a reversible 
long-term memory defect and concluded that Teq pathway is important for 
information processing in Drosophila. 
A study on human subjects with NS-ARID identified homozygous 4-bp 
deletion in the four affected individuals from a consanguineous Algerian family with 
eight children suffering from severe cognitive impairment (Molinari et al., 2002). All 
the effected individuals had an IQ level <50; this mutation was not identified in 200 
unrelated control individuals. PRSS12 or neurotrypsin was the first gene identified to 
outcome of NS-ARID (Molinari et al., 2003).  
In situ hybridization study of the temporospatial expression of neurotrypsin in 
fetal human brain Molinari et al., (2002) reported that the neurotrypsin expression 
initiated from day 44 to 15 weeks of gestation and it is expressed prominently in the 
isthmic basal plate, the choroid plexus, the trigeminal nerve, and the facial-
statoacoustic ganglia at the day 47 of gestation.  The highest gene expression was 
detected in the cortical plate, the hippocampal formation and the tegmental nuclei of 
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the brainstem at the 15 week period of gestation. Furthermore, it also expressed 
significantly in intermediate zone of the cerebral mantle, a region containing late 
migrating neurons considered to be at the origin of some interneurons. Its expression 
was not detected in the spinal cord liver but in small amount it is expressed in 
kidney. By electron microscopy; neurotrypsin was also identified in the presynaptic 
nerve endings of cortical synapses but exact function of PRSS12 is yet unknown 
(Molinari et al., 2002). 
2.1.2-Cereblon (CRBN): 
Human CRBN (OMIM # 609262) gene is located on chromosome 3p26.2 of 
MRT2 locus. It encodes a cytosolic protein known as „cereblon‟ which is  an ATP 
dependednt Lon protease and  is highly conserved among higher mammals regulating 
the expression and colocalization of  surface expression of large-conductance Ca2
+
-
activated K
+
 channels (BKCa) in neurons. It controls the function of neuronal 
excitability and transmitter release (Higgins et al., 2004b; Jo et al., 2005).  CRBN was 
identified in an autosomal recessive nonsyndromic mental retardation that was 
mapped to chromosome 3pter-p25 in a large American family of German ancestry. 
The gene was named 'cereblon' based on its putative role in cerebral development and 
abundant expression in the human brain (Higgins et al., 2004a). CRBN shows 98% 
identity with mouse ortholog and is expressed significantly in the brain, liver, kidney 
and testis of rat. In the brain, strong expression of CRBN was identified in 
hippocampus, habenula and the cortex (Jo et al., 2005).     
CRBN mutation was reported in an Algerian family with NS-ARID. The 
affected individuals had IQ level between 50 and 70 without any physical and 
neuropsychatric abnormalities (Higgins et al., 2000; Higgins et al., 2004a, 2004b). 
Lymphoblast cell lines from patients with CRBN mutation showed continued 
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expression of an immature BKCa channel splice variant and disturbed Ca
2+
-mediated 
signal transduction (Higgins et al., 2008 and MacDonald et al., 2008). It was 
concluded that CRBN mutation disturb that development of large-conductance of 
Ca
2+
-activated K
+
 channels that result in increased intracellular Ca
2+
 sensitivity and 
faster activation and slower deactivation kinetics of neurons.  
2.1.3-Coiled-Coil and C2 Domains-Containing Protein 1A (CC2D1A): 
CC2D1A (MIM # 610055) gene, mapped on chromosome 19p13.12 in MRT3 
locus, encodes a calcium-regulated transcriptional repressor that regulates several 
components of the canonical NF-κB activating pathway (Matsuda et al., 2003; Basel-
Vanagaite et al., 2006; Zhao et al., 2010). CC2D1A is a positive regulator of I-kB 
kinase/NF-κB cascade in signal transduction pathway and induce the four-fold 
transcription of NF-κB (Matsuda et al., 2003). Although, no direct interaction of 
CC2DA1 protein to NF-κB p65 and p50 subunit in vivo has been found. It suggests 
CC2DA1 regulates NF-κB expression through other signaling proteins related to the 
IKK/I-ĸB dependent or the IKK/IκB independent pathway (Basel-Vanagaite et al., 
2006). 
In nine interrelated consanguineous Israeli-Arab families with NS-ARID, a 
homozygous deletion mutation in CC2D1A gene was identified that introduces a 
frameshift, resulting in creation of 30 amino acid nonsense peptide and a stop codon 
at position 438 of the mutant protein (Basel-Vanagaite et al., 2003 and 2006). Further 
investigation of this mutation on lymphoblast cell lines showed truncated CC2DA1 
protein.  Animal model studies on mouse embryo showed the expression of CC2DA1 
in ventricular zone, cortical plate and ganlionic eminences of day 12 of mouse 
embryo brain. At day 16, CC2DA1 expression was found in whole mouse brain but 
higher concentration was identified in hippocampus. The expression of CC2DA1 gene 
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significantly increases in the cortex and hippocampus at postnatal day 3 and continues 
to be expressed into adulthood. But the function of CC2D1A is still unknown (Basel-
Vanagaite et al., 2006). 
2.1.4-NOL1/NOP2/SUN Domain Family, Member 2 (NSUN2): 
NSUN2 (MIM # 610916), located on chromosome 5p15.31 of MRT5 locus. It 
encodes a methyltransferase which catalyzes the intron-dependent formation of 5-
methylcytosine at C34 of tRNA-leu (CAA) (Brzezicha et al., 2006). The 
pathogenecity of NSUN2 mutations in NS-ARID have been well-established by 
genome wide studies from unrelated families from different part of world (Brzezicha 
et al., 2006; Kuss et al., 2011; Abbasi-Moheb et al., 2012; Khan et al., 2012; 
Martinez et al., 2012) .  
Modified methylation patterns of tRNAs effects the overall structural 
integrity, fidelity and translational efficiency (Frye and Watt, 2006). A well-
established function of NSUN2 is the nucleotide modification in the wobble position 
of tRNA leu (CAA). Therefore, defects in NSUN2 function may cause decreased 
expression of tRNA-leu (CAA) in various tissues and can affect its codon usage 
which in turn impairs translation rate, particularly during cell differentiation in 
mammals (Plotkin et al., 2004)   
The expression of NSUN2 in the fetal brain with disease phenotype results 
from a proteomic shift due to absence of NSUN2 in crucial stage of brain 
development. It is supposed that NSUN2 may regulate gene translation required for 
appropriate synaptic plasticity and the process of learning and memory (Richter, 
2010; Abbasi-Moheb et al., 2012). 
Another function of NSUN2 is methylation of hemimethylated DNA. The 
perturbation in NSUN2 might impair the methylation process which ultimately 
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resulted in alteration of gene transcription pattern and also promotion of mutational 
events (Jones and Baylin 2002; Robertson et al., 2005). Such epigenetic changes can 
modify certain brain functions (Zschocke et al., 2002; Zhao et al., 2003; Hong et al. 
2003) that are of particular interest with respect to the cognitive phenotype observed 
in affected individuals.  
2.1.5-Tumor Suppressor Candidate 3 (TUSC3): 
TUSC3 (MIM # 601385) mapped to chromosome 8p22 of MRT7 locus 
(MacGrogan et al., 1996). It encodes a protein that  catalyze the transfer of a 14-sugar 
oligosaccharide from dolichol to nascent protein in N-linked protein glycosylation 
(Molinari et al., 2008; Garshasbi et al., 2008) as well as essential for  regulation of 
Mg
2+
 in cell.   
Molinary et al., (2008) and Garshasbi et al., (2011) reported two different 
homozygous truncation mutation in TUSC3 gene form two unrelated families with 
NS-ARID. Study on patients fibroblasts cell lines revealed decreased level of TUSC3 
mRNA but serum N-glycan synthesis and transfer was normal, suggesting  defect in 
TUSC3 has no effect on glycosylation either as a result of functional compensation or 
TUSC3 is in fact involved in entirely different context.  
Further investigation showed that TUSC3 is essential component of 
magnesium ion (Mg
2+
) transport system in vertebrate plasma membrane (Zhou and 
Clapham 2009). In order to substantiate the role of Mg
2+
 in cognition, Slutsky et al., 
(2010) found that increasing Mg
2+
 levels in the brain improves learning abilities as 
well as both short and long term working memory in rats. On the basis of these 
results, it is predicted that perturbed Mg
2+
 levels due to impairment of TUSC3, rather 
than N-glycosylation defects, are responsible for the ID phenotype observed in the 
patients with NS-ARID (Garshasbi et al., 2011). 
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2.1.6-Trafficking Protein Particle Complex, Subunit 9 (TRAPPC9): 
 TRAPPC9 (OMIM #: 611966), for MRT13, was mapped to chromosome 
8q24.3 (Hu et al., 2005). Since 2009, four different truncating mutations in TRAPPC9 
gene have been identified in affected individuals from six unrelated families of 
Iranian, Israeli Arab, Syrian, Tunisian, Pakistani, and Italian origin with NS-ARID 
(Najamabadi et al., 2007; Mochida et al., 2009; Jamra et al., 2011; Philippe et al., 
2009; Mir et al., 2009;  Marangi et al., 2013).    
 TRAPPC9 encodes the trafficking protein particle complex 9 commonly 
referred as NF-kappa-B-inducing kinase (NIK) or Inhibitor of Kappa Light 
polypeptide gene enhancer in B-cells, kinase beta (IKBK-β) Binding Protein (NIBP). 
It interacts with NIK and IKK-protein and plays important function in neural Nuclear 
Factor (NF-kappa B) signaling pathway (Hu et al., 2005). NF-kappa B is a 
multipotent transcription factor that regulates the expression of numerous genes 
involved in a wide array of biological responses such as inflammation, immunity, 
apoptosis, and synaptic plasticity (Mattson and Camandola, 2001; Kucharczak et al., 
2003; Weih and Caamano, 2003; Shishodia and Agarwal, 2004).  
 Multiple isoforms of NIBP are highly expressed in muscle and kidney and 
lowly expressed in brain, heart and placenta. In brain, only isoform 1 of NIPB is 
expressed in the cell bodies and the processes of neuron.  Inactivation of NIPB result 
in reduced TNFα-induced NF-κB activation that inhibited nerve growth factor-
induced neuronal differentiation and drop off Bcl-xL gene expression in PC12 cells 
(Hu et al., 2005). TRAPPC9 mutations seem to cause moderate to severe ID which is 
inconsistently associated with clinically postnatal microcephaly, speech delay and 
neuroradiological abnormalies of the corpus callosum, cerebellum and cerebral white 
matter hypoplasia and disturb the neural differentiation (Mir at al., 2009; Kakar et al., 
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2012). Direct interaction of NIBP with IKK-β and Mitogen-Activated Protein Kinase 
Kinase Kinase 14 (MAP3K14) in both classical and alternative activation of the NF-
κB signaling pathway has also been reported (Hu et al., 2005). Interestingly, CC2D1A 
gene is also activator of NF-κB signaling pathway disruption of this pathway might 
also be relevant to the etiology of ID.  
2.1.7-Mannosidase, Alpha, Class 1B, Member 1 (MAN1B1): 
MAN1B1 (MIM # 604346) gene located on chromosome 9q34.3 of MRT 15. It 
encodes for endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase 
(ERManI). ERManI belongs to the glycosyl hydrolase family 47 (GH47) and is key 
enzyme in the maturation of N-glycans in the secretory pathway (Gonzalez et al., 
1999; Tremblay and Herscovics 1999). It also determines the timing and removal of 
misfolded glycoproteins through endoplasmic-reticulum-associated degradation 
pathway (Karaveg et al., 2005). ERManI catalysed reactions require Ca
+2
 ions as 
cofactor which acts mediator between enzyme-substrate interactions (Tremblay 
Herscovics 1999).        
 Rafiq et al., (2011) demonstrated three different mutations in MAN1B1 gene 
in three Pakistani families and one Iranian family with non Syndromic autosomal 
mental retardation. Expression studies from patients‟ lymphoblast cell lines 
demonstrated that the expression and secretion of mutated protein was remarkably 
less than wild type protein. But the exact role of MAN1B1 in cognitive impairment is 
unknown. 
2.1.8-Glutamate Receptor, Ionotropic, Kainate 2 (GRIK2): 
GRIK2 (MIM # 606494) gene maps to chromosome 1p34.1 of MRT 12/15 
loci and encodes for GRIK2 receptors which are ionotropic receptor, involve in L-
glutamate mediated excitatory neurotransmission in mammalian nervous system 
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(Dingledine et al., 1999). Ionotropic glutamate receptors belong to three receptor 
families, which have been named after their preferred ligands: N-methyl-D-aspartate 
(NMDA receptors or NMDARs), Alphaamino-3-hydroxy-5-methyl-4-isoxazole 
propionic acid (AMPA receptors or AMPARs), and Kainate (KA receptors or KARs 
(Lerma, 2006). 
Glutamate receptors are integral membrane proteins, transferring information 
at most excitatory synapses in the brain; it is believed that the induction and efficacy 
of sustained neurotransmission is correlated to memory formation (Lerma et al., 
2001). Glutamate plays a vital role during ontogenesis of the nervous system, 
responsible for forming, strengthening and eliminating synapses as well as fine tuning 
of delicately precise patterns of connectivity in several areas of brain (Lerma et al., 
2001). Alterations in glutamatergic neurotransmission lead are associated with 
various neurological conditions like epilepsy, Alzheimer‟s disease and Chorea 
Huntington etc. (Jonas and Monyer, 1999).  
Motazacker et al., (2007) identified a homozygous deletion that removed 
exons 7 and 8 of the GRIK2 gene in an Irannian family with autosomal recessive 
mental retardation. Loss of these exons results in deletion of 84 amino acids from the 
protein. It was predicted that deletions would severely effect ligand-binding  and  
transmembrane domain of GRIK2 and lead to defective and non functional GRIK2 
gene product form the lymphoblast cell lines derived from patients. Further studies 
found that glutamate receptors are present on both the preynaptic (Contractor et al., 
2000; Mulle et al., 2000) and postsynaptic membranes (Bureau et al., 2000). The 
involvement of glutamate repectors in excitory synaptic activity suggests that any 
defect in glutamate receptor may alter local brain circuitry and result in impaired 
cognition. (Motazacker et al., 2007).  
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In order to evaluate the possible involvement of GRIK2 brain function, 
Motazacker et al., 2007 assumed that it might be involved in the maturation of 
microcircuits and network formation in brain areas such as the hippocampus. Further 
investigation on developing mice brain revealed higher expression of GRIK2 mRNA 
in hippocampus but in adults its level declined (Bahn et al., 1994; Ritter et al., 2002). 
Another study in the rodent neonatal hippocampus found that KARs is activated by 
ambient glutamate, indicating that GRIK2 regulates spontaneous network activity and 
functional maturation of hippocampal synapses (Lauri et al., 2005; Lauri et al., 2006). 
2.1.9-ST3 Beta-Galactoside Alpha-2,3-Sialyltransferase 3  (ST3GAL3): 
ST3GAL3 (MIM # 606494), located on chromosome 1p34.1, encodes the b-
galactoside-a2,3-sialyltransferase-III (ST3Gal-III), a golgi resident membrane protein, 
which in humans, predominantly forms the sialyl Lewis a (sLe-a) epitope on 
glycoproteins. These glycoproteins form the glycocalyx, composed of sialic acids that 
act as key determinants of a variety of cellular recognition and communication 
processes (Hu et al., 2011). 
Sialyltransferase have been shown to interact with both type I (GalBeta1-
3GlcNAc) and type II acceptor (GalBeta1-4GlcNAc) structures sequence in N liknked 
glycan chains. (Hu et al., 2011) but the human ST3Gal-III has been demonstrated to 
exhibit a marked preference for type I structures on glycoproteins (Weinstein et al., 
1982; Kono et al.,, 1997) and produce sLe-a that is involved in immune reactions 
(Kannagi, et al., 2009). The number of distinct ST3GAL3 transcript which differ from 
other tissues are being expressed in human fetal neural tissues (Grahn et al., 2002) 
suggesting the role of ST3Gal-III activity in brain function. 
Hu et al., (2011) demonstrated the interplay between ST3Gal-III activity and 
the establishment of higher brain functions.  In two unrelated consanguineous Iranian 
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families with NS-ARID, a mutation in ST3Gal-III resulted in mislocalization of 
mutant protein to endoplasmic reticulum and its catalytic activity was diminished. 
The findings elucidated the link between the glycoprotein complex, sialyltransferase 
activity, and higher cognitive functioning of brain. 
2.1.10-Mediator Complex Subunit 23 (MED23): 
MED23 (MIM # 605042) encodes for a subunit of the mediator complex, a 
multiprotein co-regulator of RNA polymerase II (Pol II) transcription located on 
6q23.2 of the MRT18 locus. The mediator complex is an essential component of the 
RNA polymerase II transcriptional apparatus in metazoans (Bourbon, 2008) and is 
considered as interface between gene specific transcription factors and RNA 
polymerase II (Kornberg et al., 2005). Its function is to regulate gene expression and 
control of cell development, growth and differentiation as well as cellular homeostasis 
(Malik and Roeder, 2010; Conaway and Conaway, 2011). Any disturbance to 
physiologic transcription control by genetic or environmental factor results in a 
diverse range of pathologic conditions like developmental defects and cancer.  
The mediator complex consists of many subunits and each subunit performs a 
specific role in gene regulation. Genetic inactivation of the core mediator subunits 
results in very early embryonic death (Tudor et al., 1999). Thus, peripheral mediator 
subunits confer distinctive defects during organogenesis. For example, defect in 
MED23 leads to autosomal recessive axonal forms (ARCMT2). (Leal et al., 2009) 
and non-syndromic intellectual disability (Hashimoto et al., 2011), Lujan syndrome is 
caused by defect of MED12 (Schwartz et al., 2007). 
Hashimoto et al., (2011) reported a homozygous missense mutation in the 
MED23 gene in a family with non sydrnomic intellectual disability. Gene expression 
analysis by microarray experiments on cultured skin fibroblasts cells from patients 
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and healthy control revealed impaired JUN and FOS response and altered the 
interaction between enhancer-bound transcription factors. Transcriptional 
dysregulation of these genes was also observed in cells derived from patients 
presenting with other neurologic disorders linked to mutations in other Mediator 
subunits or proteins interacting with the Mediator complex. Thus, Hashimoto et al., 
(2011) concluded that their findings highlight the crucial role of the mediator complex 
in brain development and functioning, thereby suggesting that altered immediate-
early gene expression might be a common molecular hallmark of cognitive deficit. 
2.1.11-Trans-2,3-Enoyl-Coa Reductase (TECR): 
TECR (MIM # 610057), also referred to as GPSN2 (synaptic glycoprotein 2), 
is located on 19p13.12 and encodes a synaptic glycoprotein involved in the synthesis 
of very long-chain fatty acids (VLCFA) in a reduction step of the microsomal fatty 
acyl-elongation process (Moon and Horton 2003).  
Parysek et al., (2004) demonstrated that the mouse orthologue of TECR is 
highly expressed in the nervous system and accordingly, disturbances to the normal 
synthesis and degradation of VLCFA cause neurological diseases (e.g. 
adrenoleukodystrophy and Zellweger syndrome). For example, a mutation in FACL4 
gene, a long-chain acyl-CoA synthetase, impairs the degradation of VLCFA and the 
production of key intermediates in the synthesis of complex lipids lead to cause X-
linked NSMR (Piccini et al., 1998; Meloni et al., 2002; Longo et al., 2003).  
The role of TECR in fatty acyl elongation, combined with its high expression 
in the nervous system indicates that this gene may be critical for neuronal function. 
As TECR is synaptic glycoprotein, any perturbation to this gene might result in 
NSMR. Corroborating the fact that TECR influences neuronal communication 
(Martin, 2002) or synaptic plasticity (Smalla et al., 2000; Kleene et al., 2004). 
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Caliskan et al., (2011) reported homozygous pro182-to-leu mutation in the 
TECR gene in all affected members of a large Hutterite family with autosomal 
recessive nonsyndromic mental retardation, and suggested that the Pro182Leu 
mutation might perturb fatty acid elongation pathways and result in NSMR. But the 
overall function and effect of TECR is still unknown (Caliskan et al., 2011).  
2.2-Mirror Movement 
Mirror movements (MRMV) are involuntary and contralateral movements of 
one side of the body that mirror intentional movements on the opposite side. Mild 
MRMV is a normal physiological occurrence in young children and gradually 
disappears within the first decade of life as the motor network matures with age 
(Bonnet et al., 2010). Mirror movements persisting beyond the age 10 in subjects with 
no other clinical feature, however, are referred to as Congenital Mirror Movement. 
MRMV is a rare disorder mainly inherited in an autosomal-dominant fashion, 
although sporadic cases also exist. Using a linkage analysis and candidate gene 
approach two genes so far have been in implicated to MRMV (Depienne et al., 2012).  
2.2.1-Deleted in Colorectal Carcinoma (DCC): 
The DCC (MIM # 120470) gene is located on chromosome 18q21.2, and 
encodes the netrin 1 (NTN1) receptor that binds to diffusible extracellular protein, 
netrin, which promotes axon outgrowth and guides axon in pathfinding across the 
body‟s midline during the development of nervous system (Keino-Masu et al., 1996). 
Accurate neural connections in developing axons are mediated by combined action of 
attractive and repulsive guidance signals of extracellular environment. These signals 
are mediated by diffusible chemoattractants and chemorepellents which include 
netrins and semaphorins, secreted by target and non target cells to generate inclusion 
and exclusion zones for axons during development respectively (Keynes and Cook, 
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1995; Keino-Masu et al., 1996).  Netrins are chemoattractants for commissural axons 
in the vertebral spinal cord. An antibody to DCC selectively blocked the netrin-1-
dependent outgrowth of commissural axons in vitro. DCC is a transmembrane protein 
of the immunoglobulin superfamily (Keino-Masu et al., 1996). It is expressed on 
spinal commissural axons and possesses netrin-1-binding activity. The binding of 
netrin-1 to its ligand is facilitated by the fourth and fifth fibronectin type III repeats of 
DCC (Geisbrecht  et al., 2003).  
To dissected the complex network of intracellular signaling downstream of 
netrin-1. Liu et al., (2004) demonstrated that netrin-1 induced tyrosine 
phosphorylation of Focal Adhesion Kinase (FAK) and Tyrosine Protein Kinase FYN 
in cultured neuronal cells from rat cerebral cortex. Coimmunoprecipitation studies 
showed that FAK and FYN interacts directly with DCC and inhibition of FYN 
impaired the phosphyraltion of FAK; and mutation in FYN prevented the attractive 
turning responses to netrin. Neurons lacking the FAK gene showed reduced axonal 
outgrowth and attractive turning responses to netrin. Additional studies by Li et al., 
(2004) on cultured mouse and chick neuronal cells established that netrin increases 
tyrosine phosphorylation of DCC and FAK. Coimmunoprecipitation studies 
confirmed the direct interaction of DCC with FAK and SRC proto-oncogene by 
demonstrating that the FAK and SRC complex cooperate to stimulate DCC 
phosphorylation. Li et al., (2004) suggested that phosphorylated DCC acts as a 
kinase-coupled receptor and that FAK and SRC act downstream of DCC in netrin 
signaling pathway. Ren et al., (2004) showed that inhibition of FAK phosphorylation 
inhibited netrin-1-induced axonal outgrowth and guidance. The authors suggested that 
FAK may also function as a scaffolding protein and play a role in cytoskeletal 
reorganization that is necessary for neurite outgrowth and turning. 
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Mouse studies showed that homozygous null mutations in DCC impaired 
commissural development in the brain and spinal cord, which are characterized by an 
absent corpus callosum, and misrouting of commissural axons, respectively (Fazeli et 
al., 1997). Deletion of DCC exon 29 in “Kanga” mice displayed mirror-type 
movements with distinctive hopping gait (Jacqueline et al., 2002) defects in the 
crossing of corticospinal tracts and persistence of ipsilateral corticospinal tracts in 
hindbrain and spinal cord. These result are consistent with neurophysiological studies 
on human in which unilateral stimulation of the motor cortex in patients with MRMV 
evokes a bilateral response (Farmer et al., 1990) indicating a misdirected ipsilateral 
corticospinal connection in contrast to normal participants.  
Srour et al., (2010) reported mutation DCC gene from French Canadian 
Family segregating autosomal dominant congenital mirror movements with 
incomplete penetrance. This mutation skips exon 6 and introduces a frameshift after 
amino acid 329, resulting in a stop codon 15 amino acids downstream of the new 
reading frame.  Srour et al., (2010) proposed that DCC mutations in individuals with 
MRMV cause a reduction in gene dosage and less robust midline guidance, which 
may lead to a partial failure of axonal fiber crossing and development of an abnormal 
ipsilateral connection. The authors also concluded that DCC has a central role in the 
development of human nervous system lateralization. Depienne et al., 
(2011) identified a truncating mutation in the DCC gene in an Italian family with 4 
affected members. 
2.2.1-RAD51: 
RAD51 (MIM # 179617), located on chromosome 15q15.1,  involved in 
maintenaning genomic integrity by mediating homologous pairing and recombination, 
as well as repairing double strand DNA breaks (Park et al., 2008). The RAD51 protein 
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interacts with BRCA1 and BRCA2 (Jensen et al., 2010; Carreira et al., 2009; 
Pellegrini et al., 2002) and mutations in RAD51 may contribute to genomic 
instability, thus increasing the risk for cancer (Thacker et al., 2005) by modulating the 
tumor response or influencing resistance to chemotherapy (Klein et al., 2008; 
Slupianek et al., 2001). However, mutation in RAD51 in MRMV subjects revealed the 
role of RAD51 in neurodevelopment suggesting RAD51 is not a major cancer 
predisposition gene (Kato et al., 2000).  
In order to elucidate possible relationship between RAD51 and MRMV, 
expression of the RAD51 genes was analyzed in the developing mouse brain. The 
higher expression of RAD51 was observed in day 12 in cortex of the brain thereafter 
its level declined. Further investigation revealed that RAD51 is specifically distributed 
in the cortical ventricular zone (proliferative zone).  RAD51 was detected in a 
subpopulation of corticospinal axons at the pyramidal decussation in 2 day old mice, 
suggesting that deficiency of RAD51 could specifically changes the decussation 
process. Therefore the presence of RAD51 in the developing mouse cortex at stages 
that are critical for the establishment of the corticospinal tract (Depienne et al., 2012).  
The precise mechanisms underlying RAD51 deficiency to MRMV are blurred, 
and the possible involvement of the DNA repair function in MRMV pathogenesis 
remains to be elucidated. Insufficient RAD51-related DNA repair during early 
corticogenesis might lead to excessive apoptosis and altered central nervous system 
development (Deans et al., 2000; Francis et al., 2006). It is supposed that RAD51 
might have direct or indirect role in axonal guidance and high level of RAD51 levels 
during brain development are associated with increased expression of genes involved 
in actin remodeling in non-neuronal cells. 
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Depienne et al., (2012) reported a heterozygous truncating mutation in the 
RAD51 gene in a large French family with mirror movements. The mutation was 
found in eight affected individuals and in eight unaffected individuals, suggesting 
incomplete penetrance of disease gene. A second truncating mutation in the 
RAD51 gene was identified in a German family with the MRMV. The authors 
concluded that haploinsufficiency was the pathogenic mechanism, yet the mechanism 
linking RAD51 deficiency to the disorder remains unclear. Indeed, while insufficient 
RAD51-related DNA repairs during early corticogenesis may lead to excessive 
apoptosis and altered CNS development. The precise role of RAD51 in axonal 
guidance is currently unknown. As such, further investigations regarding the negative 
effects of RAD51 mutations on neurobiological pathways will lead to a greater 
understanding of mirror movements in humans (Depienne et al., 2012). 
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       Chapter 3 
3-MATERIALS AND METHODS 
3.1-Families studied:        
 Three Families, affected by mental retardation (MR) or Intellectual disability 
(ID) and one Family of Mirror Movement (MRMV) participated in this study. 
Families belonged to areas of Sindh, Balochistan and Azad Kashmir of Pakistan 
(Figure 3.1). The study was approved by Institutional Review Board and Ethical 
Committee of National University of Sciences and Technology, Islamabad.  Families 
were visited at their homes and were informed about the study. Written informed 
consent was obtained from the parents/guardian of each family for their participation 
in this study and for photography. Families were assigned laboratory names as A, B, 
C for Intellectual Disability and D for Mirror Movement. 
3.2- Clinical and Physical Examination:     
 The Intelligence Quotient (IQ) levels of all affected individuals from each 
family (A-C) were evaluated with the help of standard questionnaires (Appendix II) 
and severity of disease was determined. Multieco and multiplaner imaging MRI 
(Magnetic Resonance Imaging) was performed on V:3 individual of Family A (Figure 
4.1) and post-contrast images were obtained. Head circumference and height of 
affected individuals were measured. Clinical evaluation was performed in local 
hospital. Photographs of affected and normal individuals were taken with digital 
camera (Sony Cypbershot, China). Parents were interviewed about the prenatal and 
neonatal medical history of the probands and mother during pregnancy. Pedigrees of 
each family were drawn. Where in squares represented males and circles were used 
for females. 
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Filled squares and circles showed affected individuals whereas unfilled squares and 
circles designated for normal individuals. The circles and squares with dot represents 
carrier individuals. A crossed line over square and circle showed deceased 
individuals. Each generation was shown with roman numerical and individuals within 
a generation were symbolized by numbers. Consanguinity was represented by double 
marriage line.   
 
 
The diagnosis of Family D was carried out according to the guidelines 
provided by Erlenmeyer (Cohen et al., 1991). The age of patients ranged from four to 
thirty nine years. MM was recorded in hands and feet. The differences in MM were 
also examined with distal extremity movement (First dorsal interossei and flexor 
digitorum communis) and proximal extremity as well as right and left side. The 
amplitude of mirroring was also taken in account. The position of major organs in the 
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        Family C 
        Family D 
 
Figure 3.1: Map of Pakistan marked with circles showing the locations of families included in this 
study.  
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abdomen and thorax was confirmed with ultrasound for individuals VI:8, VI:4 and 
VI:2 (Figure 4.31) at a commercial diagnostic ultrasound facility in Sukkur, Sindh 
Province.  
3.3-Blood Sampling:        
 Five millilitre (5mL) of peripheral blood sample were taken from available 
affected and unaffected members of each family with syringe (BD, USA) and blood 
was collected into 10mL vacutainer tubes (K2 EDTA 18mg- BD, USA) for DNA 
extraction.   
3.4-DNA Extraction from Whole Blood     
 Firstly, DNA extraction was performed with DNA extraction kit 
(MACHEREY-NAGEL Ref No. 740951.250) but the required quantity of DNA was 
not being harvested therefore DNA extraction method was switched to Non 
Enzymatic Method. 
3.4.1- Nucleospin DNA Extraction Kit:     
 DNA from affected and unaffected individuals was extracted by NucleoSpin 
Blood Extraction Kit. Before proceeding for DNA extraction buffers were prepared 
according to the instruction provided by manufacturer. Lysis Buffer B3 was prepared 
by transferring total content of Buffer B1 to Buffer B2 and mixed well and bottled 
was labeled as B3. 80mL of Ethanol (96-100%) was added to Wash Buffer B5. 
Proteinase K was prepared by adding 3.5mL of Proteinase Buffer PB to lyophilized 
Proteinase K. 
3.4.1.1-Lysis of Blood Cells:       
 The 25μL Proteinase K and up to 200μL blood (equilibrated to room 
temperature for 10 minutes) were pippetted into 1.5mL microcentrifuge tubes.  Buffer 
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B3 was added to each blood samples and vortexed vigorously for 30 seconds. 
Samples were incubated at 70°C for 45 minutes in incubator, during incubation 
samples were vortexed twice. 
3.4.1.2-DNA Binding:       
 Each lysate sample was mixed with 210μL ethanol (96–100 %) and vortexed 
for 15 seconds. Samples were transferred to column, placed in a 2mL collection tube 
and centrifuged for 1 minute at 11,000 rpm in microcentrifuge (Spectrafuge, Labnet 
Inc.).            
3.4.1.3-Washing and Drying of Silica Membrane: 1st wash  
 The 500μL Wash Buffer (BW) were added to column tubes and centrifuged 
for 1 min at 11,000 rpm. Collection tubes with flow-through were discarded.  
Columns were placed into a new collection tubes and 600μL of Buffer B5 was added 
in each sample and centrifuged for one minute at 11,000 rpm. Samples were again 
centrifugated to remove residual ethanol from silica membrane. 
3.4.1.4-DNA Elution:       
 Columns were placed in a 1.5mL microtubes and 100μL of preheated Buffer 
BE (70˚C) was dispensed directly onto the silica membrane and incubated at room 
temperature for one minute. DNA samples were finally eluted by centrifugation at 
11000 rpm for one minute. The concentration of DNA was measured with nanodrop 
spectrophotometer (Thermo Scientific Ltd., USA). DNA samples, with <20ng/μL, 
were concentrated with DNA Vacuum Concentrator (DNA 110 Speed Vac, Thermo 
Savent). Finally, DNA was stored at 4˚C. 
3.4.2-Non-Enzymatic Genomic DNA extraction from Blood:   
 Non-Enzymatic Genomic DNA extraction from blood was performed 
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according to method described by Lahiri et al., (1991) with modification. The 
composition of buffers and solutions required are given in table 3.1. Blood samples 
from affected and unaffected individual of each family were poured into labelled 
15mL falcon tube. 1 volume of TKM1 and 2% Tritron X-100 (1mL of Tritron X-100 
and 49mL of TKM1) was added (for example in 5mL of blood, 5mL of TKM1 was 
added). Samples were mixed well by inverting the tubes and centrifuged at 2600 rpm 
for 15 minutes (Allegra X15R, Beckman Coulter). Supernatant was poured off and 
TKM1 was again added to the original volume of samples and pellets were 
resuspended by pippeting.  Samples were centrifuged at 1600 rpm for 10 minutes and 
supernatant was discarded. TKM2 was added to re-suspend the pellet in the ratio 
given in table 3.2.  
Table 3.1: Composition of Buffers and Solutions for DNA Extraction 
S.No. Buffer Name Composition 
01. TE (Tris-EDTA) 10mM Tris-HCl, 1mM EDTA, pH 8.0 
02. 
TKM 1 
(Tris-KCl-
MgCl2) 
20mL of 1M Tris-HCL pH 7.6, 20mL KCl (1M), 20mL MgCl2 
(1M),  16mL of  EDTA (0.5M, pH 8.0). Volume was brought to 
2L with dH2O. 
03. 
TKM 2 
(Tris-KCl-
MgCl2) 
5mL of 1M Tris-HCL pH 7.6, 5 mL KCl (1M), 5mL MgCl2 (1M),  
4mL of  EDTA (0.5M, pH 8.0); 40mL Saturated NaCl (5M) 
Volume was brought to 500mL with dH2O. 
04. 
TKMI and 2% 
Tritron X-100 
1mL of Tritron X-100 and 49mL of TKM1 
05. TRIS (1M) 60.57g of Tris and 500mL of dH2O 
06. MgCl2 (1M) 101.65g of MgCl2 and 500mL of dH2O 
07. KCl (1M) 37.28g of KCl and 500mL of dH2O 
08. 
Tris-HCl (1M, 
pH 7.6) 
60.57g of Tris ~30mL of HCl adjust the pH and add 500mL of 
dH2O 
09. 
NaCl saturated 
(~5M) 
Fill ¼ of 500mL bottle with salt, add500mL of dH2O and shake 
well. 
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Then, 10% of SDS was added in each sample with ratio given in table 3.3. 
Samples were mixed well and incubated at 55˚C for 10 minutes. 300µL of Saturated 
NaCl was added in each sample in ratio given in table 3.4. After addition of saturated 
NaCl, samples were shaked well and centrifuged at 13,000 rpm for 15 minute. 
Supernatant was poured into a clean falcon tube and pellet was discarded. Two 
volumes of absolute ethanol were added to the original volume of blood (10mL of 
absolute ethanol to 5mL of Blood) and tubes were inverted several times until DNA 
precipitated. DNA was spooled out with sterile loop and soaked in 70% ethanol for 10 
minutes. Each DNA sample was allowed to air dried and dissolved in 500µL of TE 
buffer incubating at 55˚C in water bath (VWR Inc.). The dissolved DNA was stored 
at 4˚C. 
Table 3.2: Amount of TKM2 required per volume of blood samples. 
S. No. Volume of Blood (mL) Volume of TKM2 (mL) 
01. 20 or 20+ 4 
02. 15 2.4 
03. 10 1.6 
 
 
 
Table: 3.3: The ratio of 10% SDS required for blood sample 
S.No. Volume of Blood (mL) Volume of 10%SDS (µL) 
01. 20 or 20+ 250 
02. 15 150 
03. 10 100 
04. 05 50 
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Table 3.4: The ratio of NaCl required per volume of blood sample. 
S.No. Volume of Blood (ml) Volume of Saturated NaCl (mL) 
01. 20 or 20+ 1.5 
02. 15 or <15 0.9 
 
3.5-Genetic Mapping of Genes Associated with Mental Retardation 
3.5.1-Exclusion Mapping:        
 To exclude the association of FMR1 gene, all the affected individuals of ID and their 
respective mothers were analysed with the following sets of primers given in table 3.5. These 
primers were designed to determine either deletion or expansion of CGG trinucleotide repeats 
in promoter regions of FMR1 gene.  
PCR reaction cocktail was prepared by adding 6µL of Q solution (Invitrogen), 
2µL of each forward and reverse primer, 2µL of DNA and 12µL 2xKappa (Kappa 
Biosystem SA). Thermal Cycle was set at 10 minutes at 95˚C for initial denaturation 
of template DNA followed with 40 cycles consisted of 3 steps: (i) denaturation at 
96
˚C for 1 minutes; (ii) primer annealing for 1 minute at 60˚C, (iii) polymerization or 
extension for 1 minute at 68
0C. Final extension was set at 72˚C for 3 minutes.  
Table 3.5: The sequence of FMR1 gene primers and product size. 
S.No. Sequence 
Anneling  
Temperature 
(Tm) 
Product 
Size 
(bps) 
01. 
  FMR1-F: 5ˋTCAGGCGCTCAGCTCCGTTTCGGTTT3ˋ 
FM1-R:  5ˋAAGCGCCATTGGAGCCCCGCACTTC3ˋ 
60˚C 299 
02. 
XE1-F  5ˋCCCTGTGAGTGTGTAAGTGTGTGATG3ˋ 
XE1-R  5ˋGGCGGGCGGCCCAGCCCGCCTGAGCC3ˋ 
60˚C 218 
03. 
EX1-F  5ˋCCCTGTGAGTGTGTAAGTGTGTGATG3ˋ 
XE2-R  5ˋGCCCTCCCGCCCAGCTAAAAGTGTCCGGG3ˋ 
 
60˚C 
 
415 
Chapter No. 03                                                                                                       Materials and Methods 
    
 
Mapping of Genes Involved in Neurological Disorders in Pakistani Families                                      42 
 
3.5.2- Whole Genome Homozygosity-by-Descent Mapping   
 Genome wide homozygosity mapping of all affected and one normal 
individual of each family was performed with Gene chip Mapping 250K array NspI 
chip (Affymetrix-USA) at Centre for Addiction and Mental Health, University of 
Toronto, Ontario-Canada. This technique is capable of genotyping 250000 SNPs and 
have 237321 probes for copy number variation (CNV). Experiment was performed in 
96 well plates which consisted of following steps: 
3.5.2.1-DNA Sample Preparation:      
 DNA samples were dissolved in TE buffer and concentration of DNA was 
measured with nanodrop spectrophotometer (NanoDrop 1000, ThermoScientific, 
USA). 50ng/µL DNA sample were used for this analysis and 5µL of DNA was 
aliquated in each well of 96 well plates. 
3.5.2.2-Restriction Enzyme Digestion:     
 The genomic DNAs were digested with Nsp I restriction enzyme with Nsp I 
digestion master mix. The thermal cycler was set on 250K digestion program 
(GeneChip® Mapping 250K Assay Manual). Both positive and negative controls 
were used to ensure the experimental success rate. 
3.5.2.3-Ligation, PCR based Amplification and Purification:  
 Fragments generated from restriction enzymes were ligated with Nsp I 
adaptors using T4 DNA ligase and amplified with adaptor specific primers and 
TITANIUMTM Taq DNA polymerase (Affymetrix-USA). Finally, the PCR products 
were fragmented by DNAse I as a fragmentation reagent.           
3.5.2.4-End Labeling and Hybridization:      
 The 3ˋ end of the fragmented PCR products were labeled by Terminal 
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deoxynucleotidyl transferase (TdT) which were then hybridized with GeneChip 
Human Mapping 250K Nsp I array (Affymetrix, USA). Chips were washed, stained 
and finally scanned in Genechip canner 3000 7G (Affymetrix, USA). 
3.5.2.5-Microarray Data Analysis: 
The data generated through microarray was analyzed with dChip software 
(http://biosun1.harvard.edu/complab/dchip). This software performed LOH (Loss of 
Heterozygosity) (Lin, et al., 2004) for investigation of common homozygous regions 
among affected individuals. Copy Number Variation (CNV) (Zhao et al., 2004) for 
selected set of samples from each family was also assessed. SNP genotype data was 
further analyzed with homozygosity mapper, an online tool for SNP data analysis to 
identify homozygous intervals in the whole genome 
(http://www.homozygositymapper.org) (Seelow et al., 2009). 
3.6-Whole Exome Sequencing (WES) 
Whole Exome Sequencing was performed with solid 4 system (Applied 
Biosystem). Genomic DNA of one affected individual from each family with 
concentration of 5µg/µL was used for WES which consisted of following steps: 
3.6.1-Library preparation: 
Library preparation consisted of following steps:          
3.6.1.1-Shearing of Genomic DNA:      
 This step required 5µg of genomic DNA in total volume of 100µL of 
Genomic DNA. Covaris™ S2 System was used to sonicate input DNA into small 
fragments with a mean fragment size of 165bp and a fragment size range of 150 to 
180bp.  
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3.6.1.2-End-Repair the DNA:      
 The ends of DNA fragments during shearing process were either damaged or 
have incompatible 5ˋ or 3ˋ protruding ends were converted into blunt end with End 
Polishing Enzyme 2. The 5ˋ end of DNA was subsequently phosphorylated by End 
polishing Enzyme 1 and ATP which was essential for ligation reaction.  
For the end repairing of the DNA, reaction was performed in total volume of 
200µl. In which 100µL of sheared DNA was mixed with 40µl of 5X End-Polishing 
Buffer, 8µL of 10mM dNTP mix, 4µL (10 U/µL) of  End Polishing Enzyme 1 and 
16µl (5U/µL) of End Polishing Enzyme 2, 32µL of Nuclease free water. The mixture 
was incubated for 30 minutes at room temperature. 
3.6.1.3-DNA Purification        
 Four volumes of Binding Buffer (B2-S) was added with 55% isopropanol to 
the end repaired DNA and loaded into PureLink columns and incubated for 2 minutes 
at room temperature. The columns were centrifuged at 13000rmp for 1 minute and 
flow through was discarded. 650μL of Wash Buffer (W1) was added to wash the 
columns and centrifuged at 10,000 x g for 2 minutes. Flow through was discarded and 
columns were air dried. 50μL of Elution Buffer (E1) was added to the columns and 
incubated for two minutes. Columns were centrifuged at 10,000 x g for 1 minute. The 
concentration of eluted DNA was measured in nanodrop spectrophotometer 
3.6.1.4-Ligation of P1 and P2 Adaptors to the DNA:    
 The ligation reaction of P1 and P2 adaptors was performed in total volume of 
200µL. The reaction mixture included 5.5μL (50 pmol/μL) of each P1 and P2 
Adaptor, 5✕ T4 Ligase Buffer 40µL, DNA T4 Ligase (5 U/μL) 10µL and 89µL 
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Nuclease-free Water. The reaction mixture was incubated at room temperature for 15 
minutes and purified as mentioned in section 3.6.1.3. 
3.6.1.5-Size-selected selection of the DNA:     
 The ligated and purified DNA was run on a SOLiD™ Library Size Selection 
gel. The correct sized ligation products (200 to 230bp) were electrophoresed to the 
collection wells of the Size Selection Gel. The eluted products in each collection well 
were transferred directly for the nick translation reaction. 
3.6.1.6-Nick-Translation and Amplification of the Library:   
 The products from the SOLiD Library Size Selection gel underwent nick 
translation and subsequently amplification using Library PCR Primers 1, 2 and 
Platinum® PCR Amplification Mix. PCR conditions were set as: nick translation at 
72˚C for 20 minutes, initial denaturation at 95˚C 5 minutes followed 10 cycles by 
denaturation for 15 seconds at 95˚C, annealing at 62˚C for 15 seconds; extension at 
70˚C for one minute and final extension for 05 minutes at 72˚C. 
PCR samples were purified with the SOLiD™ Library Column Purification 
method as described in previous section 3.6.1.3 except 4 volumes of Binding Buffer 
(B2-L) with 40% isopropanol was added to the PCR samples prior to purification. 
Quantitative PCR (qPCR) was performed to determine the amount of template in a 
SOLiD™ library.  
3.6.2-Templated Bead Preparation:     
 Templated beads were prepared by emulsion PCR (ePCR) (SOLiD EZ Bead 
Amplifier, Applied Biosystems) in which each library template was clonally 
amplified onto SOLiD™ P1 Beads. The beads enriched with template (SOLiD EZ 
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Bead Enricher, Appplied Biosystems) and deposited onto slide for sequencing on 
SOLiD™ 4 System. 
3.6.3-Instrument Operation:       
 The instrument operation consisted of following steps: 
3.6.3.1-Washing of Beads:       
 Beads were sonicated using the Covalent Declump 1 program on the 
Covaris® S2 System and were given a short spin.  Beads were quantified with 
NanoDrop® ND-1000 Spectrophotometer and the volume of beads was adjusted in 
1xTEX Buffer as per instruction of manufacturer. Fifteen million beads were 
transferred to a 1.5mL DNA Eppendorf LoBind® Tube and remaining beads were 
stored at 4˚C.   
Tubes containing beads were placed on in a magnetic rack for at least one 
minute. The supernatant was discarded and beads were resuspended in 400μL of 
SOLiD® XD Slide Deposition Buffer v2.  Beads were subjected to pulse-spin 
centrifugation and again placed in magnetic rack for at least one minute and 
supernatant was discarded. This process was repeated twice. Finally beads were re-
suspended in the volume of SOLiD® XD Slide Deposition Buffer v2. 
3.6.3.2-Beads Deposition:       
 Fresh slides were inserted into the SOLiD® 4 or Opti Slide and slide carrier 
assembly was placed into the single Well SOLiD® Deposition Chamber. Beads were 
sonicated with Covalent Declump 3 program on the Covaris S2 System twice 
followed by short spin. Templated beads were immediately transferred into one of the 
four wells in the SOLiD® Deposition Chamber. Three milimeter adhesive disks were 
placed over all the chambers and centrifuged at 167 × g for 10 minutes. SOLiD® 
Chapter No. 03                                                                                                       Materials and Methods 
    
 
Mapping of Genes Involved in Neurological Disorders in Pakistani Families                                      47 
 
Deposition Chamber was incubated at 37˚C for one hour and again centrifuged at   
167 × g for 10 minutes. 
3.6.3.3-Installment of Reagents on Instrument:    
 Instrument was set on Chiller to attain temperature <10˚C by using SOLiD® 
Instrument Control Software. 1x Instrument Buffer, 1x T4 Ligase Buffer, Universal 
Buffer and Imaging Buffer were used provided by manufacturer (Applied Biosystems 
SOLiD® 4 System Instrument). 
3.6.3.4-Installation of Slides on the Instrument and Analysis:   
 Three millimetre adhesive disks were removed and enough SOLiD® XD Slide 
Deposition Buffer v2 was poured to cover the top of the SOLiD® Deposition 
Chamber. Deposition Buffer from the SOLiD® Deposition Chamber was aspirated 
using different pipette tip for each well. SOLiD® Deposition Chamber was carefully 
removed from the slide carrier assembly and placed on the instrument.  
The raw reads were aligned using SHRiMP2 (David et al., 2011). Duplicated 
reads were removed with the MarkDuplicate subroutine of PICARD 
(http://picard.sourceforge.net). To improve the consensus base resolution, a re-
alignment was performed using the SRMA program (Homer & Nelson, 2010). 
Genome Analysis Tool Kit Package (GATK; McKenna et al., 2010) was used for Q 
score recalibration. The resulting BAM files then annotated using DNASTAR 
software. Seqman NGen ver 3.0.4 against the human reference genome, build hg19. 
3.6.3.5-Whole Genome Exome Sequences (WES) Data Analysis: 
 WES results were analysed on Integrated Genome Viewer 2.2.0 (IGV) 
supported by Java (TM) web starter (Robinson et al., 2011 and Thorvaldsdóttir et al., 
2012) 
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3.7-Confirmation of Candidate Genes/Variants 
3.7.1-Primer Designing:        
 In order to validate the information given by SNP genotyping and WES, each 
exon, UTRs and exon-intron junctions were amplified with gene specific primer. 
Primers were designed by ExonPrimer (www.genome.ucsc.edu) and manually with 
onlinetools: Oligocalulator (http://www.basic.northwestern.edu/biotools/OligoCalc.html) 
and (http://www.bioinformatics.org/sms/rev_comp.html) which were further analysed 
through in silico PCR (http://genome.ucsc.edu/cgi-bin/hgPcr?command=start).  
3.7.2-Polymerase Chain Reaction (PCR):    
 Polymerization Chain Reaction was performed in strip PCR tubes 100µL 
(Invitrogen-USA). PCR reaction volume was 11 µL containing: 2µL of H2O, 1µL of 
each forward and reverse primer, 1µL of DNA and 6µL KAPA2G Fast HotStart 
ReadyMix (Kapa Biosystem). PCR was performed in Thermal Cycle (Applied 
Biosystem) set at: 1 minutes at 95˚C for initial denaturation of template DNA 
followed by 30 cycles consisted of 3 steps: (i) Denaturation at 95˚C for 10 seconds 
(ii) Primer annealing for 10 seconds at 59˚C (iii) Polymerization or extension for 1 
second at 72˚C.          
3.7.3-Horizontal Gel Electrophoresis:      
 PCR product were analysed on 2% agarose (Invitrogen) prepared by adding 
1g of agarose in 50mL of 1xTBE.  The suspension was heated in loosely stopper 
bottle to dissolve the agarose in microwave oven and 3µL (10mg/mL) Ethidium 
Bromide was added. The solution was poured in casting platform of horizontal gel 
electrophoresis apparatus (VWR Inc.) and comb was placed at one end. 4µL of each 
PCR product and 4µL of loading dyes (10mM Tris-HCl pH7.6, 0.03% bromophenol 
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blue (salt), 60mM EDTA, 60% glycerol) was loaded into each well with micropipette 
(VWR Inc). Electrophoresis was performed at 100 volts for half an hour in horizontal 
gel electrophoresis apparatus. PCR amplified products were visualized by placing the 
gel on UV Transilluminator (VWR Inc).              
3.7.4-Sequencing of Genes:       
 Amplified PCR products of affected and unaffected individual were submitted 
for Sanger Sequencing facility available at The Center of Applied Genomics (TCAG), 
Toronto-Ontario, Canada.  Samples for sequencing were prepared in total volume of 
14µL: 0.6µL of PCR product, 1.4µL of forward primer or reverse primer, 12µL of 
H2O.         
 Chromatograms of sequences were visualized and analysed on FinchTV (1.4.0 
Version) software (http://www.geospiza.com/Products/finchtv.shtml). University of 
California, Santa Cuse (UCSC) Genome Browser was used to BLAT (Blast Like 
Alignment Tool) the sequence results to map the position of mutation in gene 
(http://genome.ucsc.edu/cgi-bin/hgBlat?command=start). 
3.8-Establishment of Lymphoblast Cell Lines and RNA Extraction:  
 A total of five ml blood was drawn from affected individuals of Family A and 
D, with 5ml syringes (BD-USA). Three mL of that blood was collected in Tempus 
Blood RNA Tubes which were then mixed for 10 seconds so that blood may 
uniformly make contact with the RNA stabilizing reagent. Remaining 2mL of blood 
was collected into BD Vacutainer tubes containing ACD (BD-USA), for lymphoblast 
cell line establishment which allowed preservation of whole cells.   
3.8.1-Epstein Bar Virus (EBV) Transformation of Lymphocytes:                               
 Roswell Park Memorial Institute (RPMI) medium (without serum and 
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antibody), supplemented with 50% Fetal Bovine Serum (without antibiotic) and 
Accuspin tubes were kept at room temperature. EBV suspension was also thawed at 
room temperature.   
Blood were gently mixed in tempus blood RNA tube and was diluted with 1:1 
with RPMI medium (without serum and antibiotic). 4mL of diluted blood was 
carefully layered onto histopaque in Accuspin tube (A6929, Sigma) and centrifuged at 
2,000rpm for 30 minutes with low deceleration.  About 0.5-1cm of layered plasma of 
white blood cells was aspirated with serological pipette. White blood cells layer was 
transferred to 15ml tube containing 10ml RPMI medium. Tubes were centrifuged at 
1000 rpm for 10 minutes. Medium was discarded. Cells were re-suspended in 15mL 
RPMI medium and again centrifuged at 1000 rpm for 10 minutes. Medium was 
discarded and pellet was resuspended in 0.3-0.5mL of EBV. Suspension was 
transferred to 5mL tube containing 1mL 50% RPMI medium with 3µL of 
cyclosporine (round bottom snap cap tube). Samples were incubated for a week at 
37˚C and cells were transferred to T-25 flask. One milliliter of 15% RPMI medium 
containing penicillin and streptomycin was added and again incubated at 37˚C.  As 
medium gets yellow volume was doubled by adding 15% RPMI medium. When 
volume reaches 10mL, culture was split into 2 flasks.  More 15% RPMI was added to 
each culture flask to make volume of 20mL. Cultures were again incubated, when 
medium turned yellow, cells were frozen at -80˚C.  
3.8.2-RNA Extraction:        
 RNA extraction from blood as well from lymphoblast cell lines was 
performed with Tempus Spin RNA isolation kit (Applied Biosystem) and RNeasy 
Mini kit (Qiagen) respectively. Blood from tempus tube was poured into 15ml falcon 
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tube and was labelled for RNA extraction. In the same way, 3mL of lymphoblast cell 
lines were poured into 15mL of falcon tube. 3mL of 1xPBS (Ca
2+
/Mg
2+ 
free) was 
added into the tube to make the volume up to total volume of 12mL. Diluted Samples 
were vortex for 30 second and centrifuged (Beckman Coulter) at 3,000 rpm for 30 
minutes at 4˚C. Supernatant was discarded and tubes were carefully left inverted on 
absorbent paper for 1 to 2 minutes.  Four hundred microlitre of RNA purification re-
suspension solution was added in the tube. The samples were vortex briefly to re-
suspend the RNA pellet.  
3.8.3-RNA Purification: 
RNA purification filter was labelled and placed into waste collection tube. The 
filter was pre-wetted with Wash Solution 1.  Re-suspended RNA was transferred into 
the purification filter then centrifuged at 13000 rpm for 30 second. Flow through 
(waste) was discarded and Purification Filter was again placed into waste tube.   
3.8.4-Washing of RNA: 
RNA Purification Wash Solution 1 (500µL) was added into the purification 
filter and centrifuged for 30 seconds at 13,000 rpm. Flow through collected into waste 
tube was discarded and waste tube was re utilized for further washing with Wash 
Solution 2. Five hundred microlitres RNA Purification Wash Solution 2 was pipette 
onto the purification filter, then centrifuged at 13,000 rpm for 30 seconds. Purification 
filter was removed and liquid waste collected in waste collection tube was discarded. 
Purification filter was again inserted into the waste tube and 500µL Wash Solution 2 
was pipette onto the purification filter and incubated for 5 minutes; and centrifuged 
for 30 seconds at 13,000 rpm. Liquid waste collected in the waste tube were 
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discarded, purification filter was re-inserted into the waste tube and again centrifuged 
at 12,000 rpm for 30 seconds in order to remove residual ethanol and make filter dry. 
3.8.5-Elution of RNA: 
Purification filter was placed on fresh labelled micro tube. 100µL elution 
solution was pipette into the purification filter and incubated for 2 minutes at 70˚C. 
RNA was eluted with centrifugation for 30 seconds at 12,000 rpm. RNA collected 
into the purification filter was pipette back into the purification filter and again 
centrifuged at 12,000 rpm for 30 seconds without incubation. Purification filter was 
finally discarded and approximately 90µL of the RNA elude was transferred to new 
labelled collection tube. Concentration of RNA was measured in spectrometer 
(Nanodrop 1000 sepctrometer- Thermo scientific-USA) and was stored at ̵ 80˚C. 
3.9-Reverse Transcription and Polymerase Chain Reaction (RT-PCR)  
3.9.1-Reverse Transcription (RT): 
Reverse Transcription was performed with SuperScript III Reverse 
Transcriptase (18080044, Invitrogen). 2µg of RNA was diluted in 11µL water and 
then 1µL of each Random Hexamer (Fermentas, SO142) and 10mM dNTPS was 
added.  Total volume of reaction mixture was 13µL in each tube. Reaction mixture 
were incubated at 65˚C for 5 minutes in thermal cycler and chilled immediately on ice 
for 01 minute. Then, 7L of RT reaction mixture containing 5X RT buffer 4L; DTT 
1L; RNAase OUT 1L and 1L (50 units) of SuperScript III RT was added to each 
RNA and Primer mixture. Reaction mixture was incubated for 5 minute at room 
temperature and RT was performed in total volume of 20L in thermal cycler set at: 
50˚C for 60 minutes and 72˚C for 10 minutes.  cDNA was stored at -20˚C. 
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3.9.2-RT-PCR:        
 PCR reaction mixture (total volume of 26µL) consisted of: Q solution 10µL, 
forward primer 2µL (4.7nmol), reverse primer 2µL (4.2nmol)  (Table 3.6), cDNA 
2µL and 2x Kappa Mix 10µL. Thermal Cycler was set at initial denaturation 95˚C for 
10 minute followed by 40 cycles of 95˚C for 15 seconds (denaturation), 57˚C for 20 
seconds (annealing), 72˚C for 04 minute (polymerization) and final extension was 
given at 72˚C for 03 minutes. 
Table: 3.6: Primer sequence of whole transcript of DCPS gene. 
S.No. 
Primer 
name 
Sequence 
Annealing 
Temp: (
0
C) 
Product 
size 
(bp) 
01. DcpS_F 5ˋACCACAACGGGGCCAAAGGCAGTAAC3ˋ 
60 1267 02. DcpS_R 5ˋACTCCTCCCCCAATCCCACACATCTG3ˋ 
 
3.9.3-Gel Electrophoresis:       
 PCR product was run on 2% agarose gel with 1kb plus ladder (Fermentas). 
For positive control GAPDH (a house keeping gene) and negative control without 
template (cDNA) was used in parallel to above reaction. The PCR Product was 
visualized with gel documentation system (Bio RAD).     
3.9.4-Gel Elution        
 PCR products were eluted from gel with QIAquick Gel Extraction Kit 
(Qiagne). Before starting the pH of buffer QG was checked (< 7.5). 40mL of ethanol 
(96–100%) was added to Buffer PE. Water bath was set at 50˚C. Centrifugation was 
performed at 13,000 rpm in microcentrifuge throughout gel elution process. 
3.9.4.1-Gel Excision and Dissolving: 
DNA fragments from the agarose gel were excised with a clean, sharp scalpel 
and gel slice was weighed on balance in colorless tube.  Three volumes Buffer QG 
was added to one volume of gel (100mg ~300μL) and incubated at 50˚C for 10 
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minutes (or until the gel slice was completely dissolved). Tubes containing samples 
were vortexed two to three times during incubation. Isopropanol was added per 
volume of gel (e.g in 150mg of gel slice 150μL of Isopropanol) and mixed.  
3.9.4.2-Binding of DNA to Column:      
 Samples were transferred to QIAquick spin column provided with 2mL 
collection tube and centrifuged for 1.30 minutes at 13,000 rpm. Flow through was 
discarded and collection tube was reused. Five hundred microlitre of buffer QG was 
added and again centrifuged for one and half minutes and flow through was 
discarded.  
3.9.4.3-DNA Washing:        
  In each sample, 750μL of buffer PE was added and centrifuged for 1.30 
minutes. The flow through was discarded, columns were placed again into collection 
tube and centrifuged for 1.30 minutes at 13,000 rpm to remove the residual alcohol 
from the columns. Columns were placed into fresh 1.5mL microcentrifuge tube and 
were incubated for 05 minutes at room temperature in order to evaporate the ethanol. 
3.9.4.4-DNA Elution:       
 DNA was eluted by adding 20μL Buffer EB (10 mM Tris·Cl, pH 8.5) on 
column membrane and column was incubated for 02 minutes at room temperature. 
Finally, column was centrifuged at 13,000 rpm for 1.30 minutes and eluted DNA in 
microcentrifuge tube was quantified on Nano Drop spectrometer.  
3.9.4.5-Sequencing of cDNA:       
 To sequence gene, cDNA was amplified using forward and reverse primers 
given in Table 3.6.  The 14µL of reaction volume contained: 0.6µL of PCR product, 
1.2µL forward or reverse primer and 12µL of H2O. 
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3.9.4.6-Multiple Sequence Alignment:     
 Sequences of normal and affected individuals were aligned by ClustalW2, an 
online tool (http://www.ebi.ac.uk/Tools/msa/clustalw2). 
3.10-Cloning of DCPS Gene        
 In order to study the in vitro enzymatic activity, DCPS gene was cloned in TA 
vector and subcloned in pET32a expression vector. TA Cloning was performed by 
using TA cloning kit  (Qiagen).  
3.10.1-pDrive Vector:       
 Cloning of gene was performed with pDrive vector (Figure 3.2) where P lac: 
Promoter of Lac Z gene. Lac Z: The lac Z encodes for β-galactosidase. In the presence 
of IPTG it metabolizes X-gal to produce blue colour. The inserted fragment will cause 
insertion inactivation of lac Z gene and transformed Cells will not metablize X-gal 
and thus produce white colonies. In addition, it contains Ampicillin and Kenamycin 
antibiotic resistance gene that will make sure the growth of those bacterial colonies 
that contain pDrive.                
3.10.2-Ligation:        
 pDrive Cloning Vector, 2x Ligation Master Mix and distilled water were 
thawed and placed on ice. To avoid localized concentration of salts, the 2x ligation 
mixture was mixed. A ligation-reaction mixture was prepared according scheme 
given in table 3.7.  
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Figure: 3.3: Diagrammatic representation of p-Drive Vector.  
Table 3.7:  The chemical preparation of ligation mixture 
S. No. Component Volume/Reaction 
01 pDrive Cloning Vector (50 ng/μl) 1 μL 
02 PCR product 1–4 μL* 
03 Distilled water Variable 
04 Ligation Master Mix, 2x 5 μL 
Total volume 10 μL 
*PCR product was added in 7.5 molar ratio in ligation reaction mixture. It was 
calculated using following equation: 
ng of PCR product required = 
 
 
Ligation reaction mixture was mixed briefly by pipetting and then incubated for one 
hour at 4˚C in refrigerator and stored at -20°C. 
 50 ng (pDrive Cloning Vector) x PCR product size (bp) x molar ratio 
3851 
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3.10.3-Preparation of LB/Agar Plates: 
LB agar plates were prepared for bacterial cell culture by adding 5g LB, 3g 
Agar and 200mL of Water. The mixture was autoclaved and put in water bath to set 
temperature to 55˚C.  Ampicillin (100 mg/mL), 100µL IPTG (100mM), 400µL X-gal 
(40 mg/mL) was added in LB agar solution and poured in culture plates to solidify.  
3.10.4-Transformation and White Blue Colony Selection: 
Transformation was performed with QIAGEN EZ Competent Cells which 
were stored at -80
0
C.  The cells were thawed on ice and mixed with gentle flicking.  
Three microlitre ligation-reaction mixture was added in QIAGEN EZ Competent 
Cells tube and mixed by flicking for few times; and incubated on ice for 5 minutes. 
Heat shock was given to the cells in water bath already set at 42˚C for 30s without 
shaking. The cells were transferred immediately to ice and incubated for 2 minutes. 
Two hundred fifty microlitre of SOC medium (already set at room temperature) was 
added in cells and 140μL of transformation mixture was directly plated onto LB agar 
plates. Cells were incubated at 37˚C in incubator for 14-16 hours. Two types of 
bacterial colonies appeared on LB Agar plates, white and blue.   
3.10.5-Colony PCR:        
 Randomly 10 white colonies from each plate marked and were picked for 
colony PCR with plasmid specific primers given in table 3.8. Reaction mixture was 
prepared as given in table 3.9. Thermal Cycle was set as: 95˚C for 5minutes as initial 
denaturation followed by 30 cycles with 95˚C denaturation for 15 seconds; annealing 
at 60˚C for 30 seconds; extension 72˚C for 2 minutes and final extension was set at 
72˚C for 5 minutes. The PCR products were resolved on 1.5% agarose gel and 
visualized in Gel Doc System. 
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Table 3.8: Sequence of the plasmid specific primers and product size 
S.No. 
Primer 
Name 
Sequence 
Annealing 
Temp: 
(˚C) 
Product Size 
(bps) 
01. SP6 5ˋCATTTAGGTGACACTATAG3ˋ 
57 179 
02. T7 5ˋGTAATACGACTCACTATAG3ˋ 
 
Table: 3.9: The composition of PCR reaction mixture. 
S.No. Ingredients Volume 
01. H2O 4µL 
02. T6 1µL 
03. SP6 1µL 
04. 2xKAPPA 5µL 
05. Colony Single/half 
 
3.10.6-Propagation of Transformed Cells:      
 The transformed cells were propagated in 5mL of LB medium containing 
ampicillin in 15mL cell culture tube (Sarstedt-Germany).  White colonies from LB 
agar plates were transferred to LB medium and incubated for 12-14 hours in shaking 
incubator at 37˚C. Five hundred microlitre of each glycerol and cell culture were 
mixed in 2mL cryovial tube (Sarstedt-Germany) and stored at -80˚C. 
3.10.7-Plasmid Extraction and Purification:    
 Plasmid from transformed cells were extracted and purified by GenElute™ 
Plasmid Miniprep Kit (Sigma-Aldrich) according to manufacturer instruction. 
3.10.8-Cell Culture Resuspension:      
 The recombinant E.coli cells were cultured for overnight at 37˚C. 4.5mL of 
cultured cells were centrifuged at 4,000 rpm for 10 minutes.  Supernatant were 
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discarded and cell pellets were resuspended in 200µL of resuspension solution 
provided with kit. The resuspended solution was transferred to 1.5mL microcentrifuge 
tube.   
3.10.9-Cell Lysis:        
 The resuspended cells were lysed with 200µL of the Lysis Solution. The 
contents were immediately mixed by gentle inversion (6–8 times) until the mixture 
became clear and viscous. Cell debris was precipitated by adding 350µL of the 
Neutralization/Binding Solution. Tubes were gently inverted for 4–6 times and 
centrifuged at 13,000rmp for 10 minutes. Supernatant containing plasmids were 
transferred to fresh tubes and pellet was discarded.  
3.10.10-Column Preparation: 
Columns were placed in collection tube and 500µL of column preparation 
solution was poured into columns and were centrifuged at 13000 rpm for one minute. 
The flow through was discarded.       
3.10.11-Washing of Plasmid:       
The 750µL of wash solution was added in each column and centrifuged at 
13,000 rpm for 1.30 minutes. Flow through fluid was discarded and collection tube 
was re-used. The columns were again centrifuged at 14,000rmp for one and half 
minutes in order to remove residual ethanol of wash solution.  
3.10.12-Plasmid Elution:       
 Fifty microlitres of Dnas and Rnas free water was poured directly on column 
membrane and incubated for two minutes at room temperature. Samples were 
centrifuged at 13,000 rpm for one and half minutes. Concentration of eluted plasmid 
was measured by nanodrop spectrophotometer. 
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3.10.13-Plasmid PCR:        
 To confirm the insert in the vector, PCR was performed using plasmid specific 
primers given in table 3.8. Polymerize Chain reaction master mix was prepared 
according to table 3.10. Thermal cycle was set as 95˚C for 5 minutes as initial 
denaturation followed by 30 cycles with 95˚C denaturation for 15 seconds; annealing 
60˚C; extension 72˚C for 02 minutes and final extension was set at 72˚C for 05 
minutes. 
3.10.14-Horizontal Gel Electrophoresis:     
 PCR products were analysed on 1.5% agarose gel. Appropriate ladder was run 
to see the product size. 
3.10.15-Sequencing of Recombinant DNA or Plasmid: 
Recombinant plasmids were sequenced for correct orientation and proof 
reading of sequences of insert. Recombinant DNA or Plasmids were submitted for 
sequencing. The sequencing reaction was prepared as: 250ng/µl of plasmid in 7µL 
reaction mixture, 0.7µL of plasmid specific primer either T7 or SP6 and volume was 
adjusted with H2O. 
 
Table 3.10:  Master mixture for colony PCR 
S. No. Ingredients Volume 
01. H2O 3.5µL 
02. T6 1µL 
03. SP6 1µL 
04. 2Xkappa 5µL 
05. Plasmid 0.5µL 
 
Chapter No. 03                                                                                                       Materials and Methods 
    
 
Mapping of Genes Involved in Neurological Disorders in Pakistani Families                                      61 
 
3.11-Expression and Purification of DCPS protein 
3.11.1- cDNA Isolation from pDrive Vector:    
 The pDrive vector carrying cDNAs of DCPS mutants and wild type in E.coli 
cells were propagated in LB medium containing ampicillin and plasmids (pDrive 
Vector) were isolated from cells (see section 3.10.6 and 3.10.7). cDNAs encoding the 
various DCPS proteins were amplified from pDrive plasmids containing full length 
wild type DCPS, the T316M mutation and the 15 amino acid insertion, with primers 
(Table 3.11) containing BamH1 and Xho1 restriction endonculeases sites respectively. 
The protocol for plasmid PCR is given in section 3.10.13. The PCR products were 
eluted from gel previously described in section 3.9.4.   
 The purified PCR products were subjected for restriction endonculeases 
(BamH1 and Xho1). The composition of reaction mixtures is given in table 3.12. 
Reaction mixture was incubated at temperature 37˚C for 04 hour. Three microlitre of 
sample together with DNA marker was run on 01% agarose gel. After complete 
digestion, calf intestinal alkaline phosphatase was directly added to digested product. 
The samples were loaded into a large well (0.5-1.0cm) on 1% agarose gel containing 
0.5µg/mL ethidium bromide. Gel was run enough to separate the linear plasmid from 
nicked and supercoild vectors. Undigested vector DNA was also run as a control to 
distinguish undigested from linearized plasmid DNA. Band was visualized on UV 
light source. The DNA fragments from gel were excised by using clean razor blade 
and recovered from gel slice by method described previously in 3.9.4. The DNA was 
quantified by nanodrop spectorphotometer. Samples were stored at -20˚C. 
3.11.2-Sub-cloning of DCPS Gene in pET32a Vector: 
Ligation of purified digested gene with pET32a vector was performed in 
1.5mL tube with DNA ligation Kit (Novagen) according to manufacturer instruction. 
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The ligation premix was prepared as given table 3.13. The ligase enzyme was added 
at the last and gently mixed by stirring with a pipet tip. Samples were incubated at 
16˚C for 6 hour. A control reaction was prepared without insert to see non-
recombinant background.  
3.11.3-Transformation: 
E.coli BL21 (DE3) Competent Cells were stored at -80 were thawed on ice 
and were mixed by flicking the tubes 1–3 times.  20µL of cells were transferred to 
pre-chilled 1.5mL in microcentrifuge tubes. 1μL of a ligation reaction was directly 
added to the cells and samples were mixed gently by flicking the tubes and incubated 
on ice for 5 minutes. Tubes were placed in water bath set at 42˚C for 30 seconds and 
again tubes were placed on ice for 02 minutes. The 80μL of SOC medium (set at 
room temperature) was added in each tube.  50 μL of each transformed cells were 
spread on LB agar plates containing the amplicillin and incubated at 37˚C for 15 
hours. Colony PCR was performed described previously 3.10.5. The insert was 
confirmed by sequencing. 
3.11.4-Preparation for Induction and Cell Lysis:     
 A single colony from freshly streaked plates was picked up and inoculated in 
50mL LB containing the ampicillin in 250mL Erlenmeyer flask and incubated with 
shaking at 37˚C until the OD 600 reaches 0.6–1.0. Culture was centrifuged at 13,000 
rpm for 30 seconds. Supernatant were removed and pellet was re-suspend in 50mL 
fresh medium containing ampicillin. Cultures were again incubated with shaking at 
37˚C until OD-600 reaches 0.8. Then, 100 mM IPTG was added to a final 
concentration of 0.4 mM and incubation was continued for 2 hour.  Flasks were 
placed on ice for 05 minutes and cells were harvested by centrifugation at 4,000 rpm 
for 20 minutes at 4˚C. Supernatant was discarded and pellet was washed once with 
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cold PBS. The resulting pellet was resuspended in 1X binding buffer (5mM 
imidazole, 0.5 M NaCl, 20 mM Tris-HCl, pH 7.9) with 1M urea, 0.5% TritonX-100 
and protease inhibitors, lysed by sonication and the cell lysate isolated by 
centrifugation at 14,000 rpm for 20 minutes at 4˚C.   
3.11.5- Purification of Protein:     
 Purification of the recombinant protein was carried out with charged nickel 
column according to the manufacturer (Novagen) protocol, except that 300mM urea 
and 0.5% TritonX-100 was included in the binding buffer. The clarified supernatants 
were loaded into a nickel column at a loading speed of 0.5 mL/min. Then nickel 
column was washed twice with wash buffer (60 mM imidazole, 0.5 M NaCl, 20 mM 
Tris-HCl, pH 7.9) containing 800 mM urea and 0.5% TritonX-100. Washing was 
preformed again by wash buffer but without urea and Triton X-100. Protein eluted 
from the nickel column was dialyzed against PBS (0.14 M NaCl, 2.7 mM KCl, 1.5 
mM KH2PO4, 8.1 mM Na2HPO4, pH 7.4) and concentrated by Centricon centrifugal 
filter columns (Amicon) and stored at -80˚C in 10% glycerol. Protein concentrations 
were determined by Bradford assay. 
3.11.6-Bradford assay:       
 The Bradford reagent was diluted in fivefold dH2O (1 part Bradford: 4 parts 
dH2O). The diluted reagent was filtered through Whatman 540 paper.  10-20 μL of 
the protein extract was added to 1 mL of the diluted reagent and were mixed. The 
blue color formed was measured at the wavelength 595nm with spectrophotometer 
(Bio-Rad). 
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Table 3.11: Primer Sequence for Full Length DcpS gene with BamH1 and Xho1 
restriction endonculeases sites. 
S.No. 
Primer 
Name 
Sequence 
Annealing 
Temp: 
(
o
C) 
Product 
Size 
(bp) 
01. DcpS-F 5̍GAATTCGGATCCATGGCGGACGCAGCTCCTC3̍ 
68 
 
1038 
 02. DcpS-R 5̍AAGCTTCTCGAGTCAGCTTTGCTGAGCCTCCTGC3̍ 
 
 
Table 3.12: The composition reaction mixture for restriction endonculeases activity 
S. No. Reagents  Volume 
01. pET vector  3 μg 
02. 10X restriction enzyme buffer  3mL 
03. Each restriction enzyme Xho1 and BamH1 (15 U/µl)  5+5 μL 
04. 1 mg/ml acetylated BSA (optional)  3 μL 
05. Nuclease-free water brought to volume  11 μL 
 Total volume  30 μL 
 
 
 
 
Table 3.13:  The composition of ligation mixture and volume required for reaction 
S. No. Composition Volume 
01. 
10X Ligase Buffer (200 mM Tris-HCl pH 7.6, 100mM MgCl2, 
250μg/mL acetylated BSA) 
2μL 
02. 100 mM DTT 2μL 
03. 10 mM ATP 1μL 
04. 50 ng/μL prepared pET vector 2μL 
05. 
T4 DNA ligase, diluted (with ligase dilution buffer) 0.2–0.4 Weiss 
units/Μl 
1μL 
06. Prepared target gene insert (0.4 pmol or 150ng of DNA fragment) 6μL 
07. Nuclease-free water to volume 6μL 
Total volume 20μL 
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3.11.7-Generation of labeled RNA and cap structures 
Unlabeled, uncapped RNA corresponding to the pcDNA3 polylinker spanning 
from the SP6 promoter to the T7 promoter (pcP) with 16 guanosine at the 3ˋ end was 
transcribed by SP6 RNA polymerase from a PCR-generated template using the 
primers given in table 3.14. Cap labeled oligonucleotide RNA was generated with the 
vaccinia virus capping enzyme utilizing-32P GTP and S-adenosyl-methionine (SAM) 
to label the first phosphate within the cap relative to the methylated guanosine  
(m7G*pppG-) and the RNA gel-purified as described (Wang et al., 1999). Labeled 
cap structure without the RNA body was generated by treating the cap-labeled RNA 
with 1 unit Nuclease P1 (Roche) for 1.5 hour at 37˚C to hydrolyze the RNA body 
leaving the intact cap structure as described (Wang and Kiledjian, 2001). Uniformly 
labeled uncapped RNA was generated with SP6 RNA polymerase using-32P UTP 
according to the manufacturer (Promega) (Liu et al., 2008). 
3.11.8-In vitro Decapping Assays:  
Decapping assays were carried out with 10, 20, 40ng of recombinant protein 
or 5µg total cell extract derived from patient lymphoblasts. Proteins or extract were 
incubated with the indicated labeled cap structures in decapping buffer (10 mM Tris-
HCl at pH 7.5, 100 mM KCl, 2mM MgCl2, 2mM DTT, 0.5mM MnCl2). Decapping 
reaction was carried out for 05 minutes (for recombinant proteins) or 10, 20, 30 min 
(for cell extract) at 37˚C and stopped by extracting once with phenol:chloroform 
(1:1). Decapping products were resolved by polyethyleneimine-cellulose TLC plates 
(Sigma-Aldrich) and developed with 0.45M (NH4)2SO4 in a TLC chamber at room 
temperature. The TLC plates were air-dried and exposed to PhosphorImager for 
quantitation (Liu et al., 2008).  
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Table 3.14: Sequence of primers for generation of labeled RNA   
S. 
No. 
Primer 
Name 
Sequence 
Annealing 
Temp: (˚C) 
01. Forward 5ˋCGATTTAGGTGACACTATAG3ˋ 
57 
02. Reverse 5ˋCGTAATACGACTCACTATAGGG3ˋ 
 
3.11.9-Western Blot:        
 Western blot analysis was carried out with 120µg cell extract resolved on 
12.5% SDS-PAGE. The DCPS proteins were detected with affinity purified rabbit 
antibodies directed to DCPS (1:200) (Liu et al., 2004) and visualized with secondary 
antibodies coupled to horseradish peroxidase (Jackson Immuno Research, West 
Grove, PA, USA) and ECL chemiluminescence (GE Healthcare Life Science, NJ, 
USA).  
3.12-Quantitification of Amino Acids:     
 Amino Acid quantification was performed from blood plasma of affected 
individuals. Five millilitre of whole blood was submitted to Agha Khan University 
Hospital Laboratory-Karachi, Pakistan.  
2.13-Whole Genome Homozygosity-by-Descent Mapping of MRMV (Family D)
 DNA was isolated from the blood samples of affected and unaffected 
individuals by method described previously by Lahiri et al., (1991) with little 
modification. The family was excluded for mutation in the DCC and RAD51 genes by 
Sanger Sequencing (list of Primers shown in Appendix III).    
 Genome wide homozygosity mapping of five affected individuals (IV-6, 1V-
7, 1V-8, V-4 and V-13) and one unaffected family member (1V-9) was performed 
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with Gene chip Mapping CytoScan HD array (Affymetrix, CA, USA) at The Centre 
for Applied Genomics (TCAG), Toronto-Ontario. Genotypes were analyzed for HBD 
regions using Chromosome Analysis Suite (ChAS; Affymetrix) and 
HomozygosityMapper (http://www.homozygositymapper.org) (Seelow et al., 2009).  
3.13.1-Linkage Analysis: 
Microsatellite markers were used to corroborate autozygosity, and the markers 
D22S280, D22S283, D22S423 and were genotyped for DNAs from all available 
family members. Genotyping was performed at TCAG. Linkage analysis was 
performed using SimWalk2 (version 2.91) (Sobel and Lange 1996; Sobel et al., 2001; 
Sobel et al., 2002). 
2.13.2-Whole Exome Sequencing: 
Whole Exome Sequencing of one affected individual (1V-7) was carried out 
with the SOLiD 5500 (Life Technologies) platform (upgraded version of Solid4 
system with better Coverage Bias and Sensitivity of Variant Calling)  and TargetSeq 
exome (Life Technologies) capture array, according to the manufacturers’ 
recommended protocols. The raw reads were aligned using SHRiMP2 (David et al., 
2011). Duplicated reads were removed with the MarkDuplicate subroutine of 
PICARD (http://picard.sourceforge.net). To improve the consensus base resolution, a 
re-alignment was performed using the SRMA program (Homer & Nelson, 2010). 
Genome Analysis Tool Kit Package (GATK) (McKenna et al., 2010) was used for Q 
score recalibration. The resulting BAM files then annotated using DNASTAR 
software. Seqman NGen ver 3.0.4 against the human reference genome, build hg19. 
Sanger sequencing was used to confirm a homozygous variant. RT-PCR of 
lymphoblast mRNA followed by Sanger sequencing was used to examine the effects 
of the variant on mRNA splicing. Control individuals were screened by PCR followed 
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by restriction digestion with the enzyme BsrDI (New England Biolabs). BsrDI is 
predicted to cut at the site generated by the allele variant. 
2.14-Bioinformatics Tools: 
Swiss Model Workplace (http://swissmodel.expasy.org/interactivewas) was 
used for protein modeling and protein structure was visualized with Pymol 
(http://www.pymol.org/).   
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Chapter 4 
4-RESULTS 
4.1:-Family A 
4.1.1-Human Subjects and Clinical Findings: 
The Family „„A‟‟ presented in this study belonged to Azad Jamu and Kashmir. 
It consisted of four loops; three of them were living in Tehsil Sehnsa, District Kotli of 
Azad Kashmir and one was living in Islamabad, Pakistan. The pedigree was 
constructed after careful investigations and information collected from the family 
elders. The family members marry within their own community because of strict 
social customs traditionally resulting in high rate of consanguineous marriages. This 
five generations pedigree (Figure 4.1) consisting of four affected individuals (III:2, 
III:8, V:3 and V:7) including three females (III:8, V:3 and V:7) and one male (III:2). 
The individual II:7 and II:8 have remote consanguinity. All the affected individuals 
were born from normal parents and the mode of inheritance is therefore autosomal 
recessive. The affected individuals had severe form of Intellectual Disability (ID) (IQ 
level ranges 25-35), diagnosed by Psychiatrist and Neurologist. The characteristics of 
patients like ages, height and head circumstance are mentioned in table 4.1. There was 
no previous history of ID in this family. Blood samples were collected from sixteen 
individuals including twelve normal (II:1, II:2, II:7, II:8, III:3, III:9,  IV:1 IV:2, IV:5, 
IV:6, V:2 and V:8) and four affected individuals (III:2, III:8, V:3 and V:7). Blood was 
processed for DNA extraction. Parents of affected individuals were normal and have 
no neurological symptoms associated with ID. 
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Table 4.1: The sex, ages and head circumference of affected individuals of Family A. 
S. No. 
Affected 
individuals 
Sex 
Age 
(Year
s) 
Head 
circumference 
(Centimetres) 
Height 
(Inches) 
01. III:2 Male 21 57.15 60 
02. III:8 Female 12 52.07 37 
03. V:3 Female 17 55.37 58 
04. V:7 Female 10 55.12 45 
The range of normal head circumference is 55cm and 58cm for female and male respectively 
The clinical analysis of affected individual showed delayed ambulation and 
their facial features and cranium size were normal. Behavioural and physical 
examination showed a slight shyness in their demeanour. Dysarthria was observed in 
one individual (V:7). The shape and size of fingers as well as joint of limbs was 
normal. No symptom of pes cavus was observed and Achilles was tightly bilateral. 
One affected individual V:3 was somehow aggressive in nature but over all she 
shared similar phenotypic features with other two affected individuals (III:2 and V:7). 
The III:8 individual was quite different both physically and clinically from other 
affected individuals of this family. She was non cooperative and had aggressive 
behaviour. She could not walk and speak, but was able to crawl. She had significant 
growth retardation, and at the age of 12 years and was comparable 4 to 5 year old 
child. Her skin was heavily pigmented and hair was normal (Figure 4.2) and declared 
as syndromic form of ID. The individual III:2 and V:7 were very cooperative and 
friendly in nature. All the affected individuals associated socially with the other 
children. There was no evidence of hearing impairment. All were non verbal except 
III:2 who could speak only one word. They could recognize their parents and their 
homes. No joint laxity and spine curvature problem was noticed. Ear shape and size 
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was normal. The rotation of ear was at normal parameters. The position of pinae was 
above the outer canthus of eye except III:2 whose pinae was parallel to outer canthus 
of eye. There was no skin and hair defect in all affected individuals except III:8 
individual.  
Neurological investigation showed normal cranial nerves. Ophthalmic 
examination with Fundoscopy revealed no symptoms of strabismus in all effected 
individuals and their vision was normal. Papillary response to light as well as eye 
movement was normal. No history of other brain issue or epilepsy was reported by 
their parents. Coordination and sensory examination was also normal.  
 Magnetic Resonance Imaging (MRI) report of brain of affected individual 
V:3 showed no evidence of intra and extra axial mass or haemorrhage or infarct in the 
brain. Ventricular system was normal and no abnormal enhancement was observed on 
post-gadolinium images. Basal ganglia, thalamus, brainstem and both cerebral 
hemispheres appeared normal. No abnormality was found in Grey and white matter 
distribution. No abnormality was identified in cervico-medullary. Pituitary gland and 
optic chiasm as well as 7
th
 and 8
th
 nerve complexes were normal and were 
symmetrical bilateral. Basilar cisterns and skull base appeared normal. Major intra-
cranial vessels showed normal flow void. No evidence of nasosinus inflammation was 
observed (Figure 4.3).  
4.1.2-Genetic Mapping 
4.1.2.1-Exclusion of Mapping FMR1Gene: 
All the affected individuals of ID and with their respective mothers were 
analysed for Fragile X syndrome (FMR1 gene). FMR1 gene specific primers were 
designed against promoter region and PCR was performed. The results showed no 
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mutation or pathogenic variation in FMR1 gene and no CGG trinucleotide 
(Guanosine and Cytosine) expansion was observed in PCR products.  
4.1.2.2-SNP Genotyping and Mutation Analysis: 
In Family “A”, two affected (III:2 and V:3) and one normal individual (III:3) 
were selected for 250K SNP (NspI) genotyping. The analysis of SNP genotyping data 
with homozygosity mapper (Seelow et al., 2009) (Figure 4.4) and dChip software 
(Lin et al., 2004) identified Homozygosity by Descent (HBD) on chromosome 01, 03, 
11, 14, 16 and 17 (Figure 4.5) which were flanked between SNPs markers given in 
table 4.2. The coordinates of each locus were obtained from UCSC Genome Browser 
{Feb.2009 (GRCh37/hg19)} and all genes pertaining in each locus were screened 
with Whole Exome Sequence (WES) data generated from the DNA of individual 
(III:2). The variations identified by WES were further analysed with Sanger 
Sequencing. The HBD loci on chromosome 01, 03, 14, 16 and 17 and their respective 
genes were excluded because either normal individuals were also homozygous for 
same allele or were reported dbSNP.   
Table 4.2:  Homozygous regions flanking between SNPs in Family A 
S.No. Chromosome Region Start End Size (Mb)* 
01. 01 1q32.2-q41 rs2491395 rs6657854 14.32 
02. 03 3q24 rs9862119 rs12163649 5.63 
03. 03 3q26.31 rs16828950 rs6445149 0.54 
04. 11 11q25.1-q25 rs10892975 rs10894834 11.34 
05. 14 14q11.2 rs2771331 rs4982731 2.14 
06. 15 15q26.2 rs12148552 rs12912857 0.93 
07. 17 17q24.2-q24.3 rs10512514 rs11652864 5.08 
*Mb=Megabase 
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A single HBD region of ~11.34Mb (flanked by rs10892975 and rs10894834 
markers) was being shared between affected individual III:2 and V:3  with a 
contiguous run of 1269 homozygous SNPs on chromosome 11q25.1-q25 between 
123,032,803bp to 134,376325bp. UCSC Genome Browser (http://genome.ucsc.edu) 
identified approximately 162 genes in this locus (Figure 4.6).  
Mutation analysis of the genes of 11q25.1-q25 locus with WES data identified 
a homozygous variant in the Decapping Scavenger gene, DCPS. The variant 
chr11:126208295 G>A; NM_014026.3:c.636+1G>A occurs at the splice donor +1 
site after exon 4, changing the canonical GT dinucleotide to AT (Figure 4.7) and is 
predicted to prevent correct splicing at this site. Subsequent Sanger Sequencing 
confirmed c.636+1G>A transition in affected III:2 and V:3 individuals whereas 
unaffected individual (II:1, II:2, III:3,  IV:1 IV:2, IV:5, V:2 and V:8) were carrier 
(Figure 4.8).  
This variant segregated in the left loop of the pedigree (Figure 4.1), with the 
homozygous variant just in affected individuals III:2 and V:3. The right loop of 
pedigree the affected individual V:7 was heterozygous for this change, but was 
subsequently identified as being heterozygous for a second mutation in DCPS, chr11: 
126215441C>T; c.947C>T; p.Thr316Met (Figure 4.9). This variant was not in any 
SNP databases nor present in 1000 Genomes or NHLBI EVS datasets and is predicted 
by PolyPhen2 and SIFT to be deleterious. The Thr316 residue is mostly conserved in 
vertebrate and non-vertebrate species including all mammals, also fruitfly and 
nematode, but with some exceptions such as chicken and zebra fish. Neither mutation 
was present in 200 Pakistani control individuals 
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The individual III:8 from the right hand loop of pedigree, which showed a 
very distinct phenotype to the other three (short stature, dysmorphic features), was 
homozygous wild type for both variants. 
In order to assess the effect of splice site c.636+1G>A mutation  and the 
presence of c.947C>T transition in final transcript, the lymphoblast cell lines 
established from lymphocytes of patients and normal individuals;  and were grown in 
Roswell Park Memorial Institute (RPMI) medium. The total RNAs were extracted 
and converted into cDNA. Gene specific primers were used to amplify the full DCPS 
transcript. Sanger Sequencing also validated the presence of splice site c.636+1G>A 
mutation in the cDNA of the individual III:2 and V:3 (Figure 4.10) which showed the 
shift to a cryptic splice site 45bp downstream (Figure 4.11), with correct splicing to 
exon 5, maintaining the reading frame. Multiple Sequence alignment of transcript 
with 636+1G>A mutation and with normal sequence showed addition of 45 
nucleotides in final transcript of mutant DCPS gene (Figure 4.12).  In silico 
translation of mRNA (cDNA) and subsequently multiple sequence alignment with 
ClustalW2 revealed the incorporation of 15 amino acids between 212-227 
(IKVSGWHVLISGHPA) to the C-terminus of exon 4 of DCPS protein (Figure 4.13). 
In silico analysis predicts a significant effect on the protein folding and protein-
substrate interaction (Figure 4.14). The sequencing of transcript (cDNA) of individual 
(V:7) confirmed the presence of  c.947C>T (Figure 4.15) that leads to Thr316Met 
change in silico translation. Both mutants and normal genes were finally cloned in TA 
vector for subsequent expression studies. 
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4.1.3-Assessment of DCPS Enzymatic Activity 
4.1.3.1-Decapping Activity of DCPS: 
DCPS genes, mutants and normal, were amplified using gene specific primers 
from TA clones and were sub cloned in expression vector PET-28a and expressed in 
bacterial BL21(DE3) cells. Enzymatic activity of both mutants and wild type purified 
DCPS protein was analyzed. DCPS mutant (15 amino acid insertion and Thr316Met) 
and wild type, at the concentration of 10, 20 and 40ng, were incubated with 10 fmol 
of 32-p labelled methylated cap RNA (32-P m7Gp
*
ppG) substrate (3000 
cpm/reaction) at 37
0
C for five minutes. The reaction products were separated on 
polyethylenimine (PEI) cellulose thin-layer chromatography (TLC) and developed 
with 0.45 M (NH4)2SO4. This buffer condition separated the input cap structure from 
the resulting m7GMP generated by the DCPS decapping activity. Significantly 
reduced activity was shown by both mutants (the 15 amino acid insertion and 
Thr316Met) compared to wild type DCPS. The wild type hydrolyzed almost all of 32-
P m7Gp
*
ppG methylated cap structure to methylated guanosine monophosphate 
(m
7
Gp) at the lowest concentration (10ng) within the 5 minutes time period. The 
mutant with 15 amino acid insertion hydrolyzed only 3% at the highest concentration 
(40ng), whereas, 15% activity was shown by T316M mutant at its highest 
concentration (ng) (Figure 4.16). 
4.1.3.2-DCPS Activity in Total Lymphoblast Cell Extract: 
DCPS activity was further investigated in whole cell extract obtained from 
lymphoblast cell lines of patients and normal individuals. Epstein–Barr virus (EBV) 
transformed lymphocytes cells now referred as Lymphoblast cell lines were grown in 
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RPMI medium and whole cell extract was prepared for assay. 5µg of cell extract was 
incubated at 37˚C with 10 fmol of [32P] cap-labelled RNA (32-P m7Gp*ppG) 
substrate (3000 cpm/reaction) at the time intervals of 10, 20 and 30 minutes, 
respectively. Reaction was terminated by incubating reaction mixture tubes on ice. 
The reaction products were separated on polyethylenimine (PEI) cellulose thin-layer 
chromatography (TLC) and developed with 0.45 M (NH4)2SO4. DCPS enzyme of 
patients with 15 amino acid insertion mutation (III:2 and V:3) significantly reduced 
enzymatic activity compared to heterozygous carrier (III:3 and IV:2) and normal 
control (rDCPS).  The mutant DCPS hydrolyzed 6-9% of 32-P m7Gp
*
ppG methylated 
cap structure to m
7
Gp in 30 minutes; whereas, DCPS of heterozygous carrier (III:3 
and IV:2) and normal displayed 82-87% activity (Figure 4.17). 
4.1.3.3-Western Blotting 
The expression level of DCPS gene was analysed in lymphoblast cell lines of 
both affected and unaffected individuals through western blotting. The western blot 
results demonstrated decreased level of expression of DCPS in patients with 
homozygous 15 amino acid insertions as compare to normal homozygous normal 
DCPS. The heterozygous carrier with 15 amino acid insertion showed two molecular 
sized bands. The mutant allele of DcpS was observed with lower level of expression 
whereas the wild type allele of DcpS showed normal expression level (Figure 4.18).  
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Figure 4.1: Pedigree of Family A. Individuals indicated with black shaded symbols 
are affected with apparent NS-ARID, whereas individual III:8 is shaded grey, 
indicating a syndromic form of ID.  Unfilled squares and circles are unaffected. The 
dotted squares and circles represent carrier individuals. Double lines show the 
consanguinity and single lines for non cousin marriages. Crossed lines show deceased 
ones. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
I:1 I:2 I:3 I:4 
II:1 II:4 II:2 II:3 II:6 II:5 II:7 II:8 
III:1 III:3 III:2 III:5 III:4 III:6 III:7 III:8 III:9 
IV:1 IV:2 IV:3 IV:4 IV:5 
V:1 
IV:6 
V:2 V:3 V:6 V:7 V:8 V:4 V:5 
I 
II 
III 
IV 
V 
Chapter No. 04                                                                                                                                 Results 
 
 
Mapping of Genes Involved in Neurological Disorders in Pakistani Family                                       78 
 
 
 
 
Figure 4.2: Facial images, with front and side pose of patients of Family A. The 
facial photographs of affected individuals do not show any facial dysmorphism. The 
affected individual (III:8) individual of this family was phenotypically quite different 
from others. 
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Figure 4.3: MRI images of affected individual V:3 of Family A showing lateral top 
and dorso- lateral of view of brain. Overall structure of brain appears normal.  
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Figure 4.4: Whole Exome Homozygosity (WES) pictures of Family A obtained from 
homozygositymapper. Significant homozygous peaks are shown (indicated by red 
lines) at 01, 03, 11, 14 and 17. The heterozygous peaks represented in black lines. 
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Figure: 4.5: (A) The dChip analysed SNP data on chromosome  03, (B) Chromosome 
05, (C) Chromosome 11, (D) Chromosome 14, (E) Chromosome 16 and (F)  
chromosome 17. Each individual was represented in columns (III:2 and V:3 are 
affected and III:3 is normal). Blue colour depicts homozygous region and yellow 
colour shows heterozygous region.  
   III:2             V:3               III:3  III:2                   V:3             III:3 
   III:2           V:3                 III:3    III:2                 V:3              III:3 
III:2              V:3                 III:3    III:2            V:3            III:3 
(A) (B) 
(C) (D) 
(E) (F) 
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Figure 4.6: UCSC genome browser view of the 11q25.1-q25 locus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: The whole exome sequencing of Family A showing the G> A transition.  
The snapshot was obtained from IGV tool. 
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Figure 4.8: The DNA sequence chromatogram of DCPS gene of Family A.  A) The sequence 
showing the G>A mutation in affected individuals (III:2 and V:3). B) The sequence shows the 
heterozygous/carrier individuals of Family A. C). The sequence of normal individual.  The Green 
colour = Adenine, Red colour = Thymine, Blue colour = Cytosine, Black colour = 
Guanine. 
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Figure 4.9: A) The sequence analysis of individual V:7 of Family A. The affected 
individual (V:7) carries a heterozygous mutation on exon 6 of DcpS gene where C>T.  
B) The mutant allele was sequenced from the cDNA of V:7 showing the presence of 
C>T change. C)  The chromatogram shows the individual (IV-6) is heterozygous and 
carrier. D) The individual IV:5 was normal Green colour = Adenine, Red colour = 
Thymine, Blue colour = Cytosine, Black colour = Guanine. 
B) 
C) 
A) 
C) 
Chapter No. 04                                                                                                                                 Results 
 
 
Mapping of Genes Involved in Neurological Disorders in Pakistani Family                                       85 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10: The sequence of full transcript (cDNA) of DCPS gene were BLAT in 
UCSC genome browser showing G>A transition in mutant transcript.  
 
 
 
Figure 4.11: Schematic representation of splice site mutation in Family A. A change 
in splice donor usage at exon 4/intron 4 for the splice variant allele resulting in 
splicing of transcript 45 nucleotide down in intronic region. The resulting mRNA 
carries an additional 45 nucleotides. 
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Figure 4.12: Full transcript alignment of normal (norm) and mutant (alta) with 45 
nucleotide insertion with ClustaLW2 an online tool. 
 
 
 
 
Figure 4.13: Sequence alignment of amino acids of normal (III:9) and mutant (V:3) 
with 15 amino acid insertions in protein structure. 
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Figure 4.14: 3D-protein modelling of wild type and mutant with 15 amino acid insertion 
was generated by using SWISS MODEL workplace and visualized with PyMol Molecular 
Graphics System (http://www.pymol.org/). The location of the inserted sequence (between 
residues 212 to 228 mutant protein) is indicated with a yellow arrow. 
 
 
Figure 4.15: Full transcript sequencing result showing 947C>T transition of affected 
individual (V:7). 
 
Chapter No. 04                                                                                                                                 Results 
 
 
Mapping of Genes Involved in Neurological Disorders in Pakistani Family                                       88 
 
 
 
Figure: 4.16: DCPS catalyzes the hydrolysis of cap structure. Decapping assays are carried 
out with the indicated amounts of DCPS at the top of picture. 32P-labeled methylated cap 
structure (m7Gpppp) is used as substrate where red colour “p” in m7GpppG represented 
labelled phosphate and m7Gp as product of DCPS catalyzed reaction.  The quantitation for 
the decapping efficiency of each protein is presented as the percentage decapping using 
ImageQuant 5.2 software at the bottom of picture. 
 
Figure 4.17: Decapping assays of wild type and mutant DCPS from whole cell extract. 
The quantitation for the decapping efficiency of each protein is presented as the 
percentage decapping using ImageQuant 5.2 software.  The standard m7Gppp and 
positive control are shown at left. rDCPS are wild type control second from left. 32P-
labeled methylated cap structure (m7Gpppp) is used as substrate where red colour “p” in 
m7GpppG represented labelled phosphate and m7Gp as product of DCPS catalyzed 
reaction. 
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Figure 4.18: Western blot analysis showing expression concentration of DCPS in 
lymphoblast cell lines of generated from patient with homozygous 15 Amino Acid 
insertion in lane 1 and 4 and heterozygous individuals of Family A in lane 2 and 3. 
293T was used for positive control and GAPDH as loading control. 
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4.2:-FAMILY B 
4.2.1-Human Subjects and Clinical Findings: 
Family “B”, manifesting Non Syndromic Autosomal Recessive Intellectual 
Disability (NS-ARID), resides in District Nawabshah of Sindh Province and belongs 
to Sindhi ethnic group. Three generation pedigree consists of three affected 
individuals including two male (II:4 and III:3) and one female (III:4) (Figure 4.19). 
The genealogical relationships between parents of affected probands were cousins and 
had consanguineous marriages for several generations.  The ages, height and head 
circumference of affected individuals are given in table 4.3. Affected members of this 
family were declared as sever form of ID by psychiatrist at Sir C.J. Institute of 
Psychiatry Hyderabad Sindh, Pakistan where they were admitted for treatment. 
Table 4.3: The age, sex, head circumference and height of the affected individuals of 
Family B. 
No. Pedigree ID Sex AGE Head Circumference 
(cm) 
Height 
(inches) 
01 II:4 Male 30 57.66 60 
02 III:3 Male 10 57.00 42 
03 III:4 Female 20 55.3 54 
The range of Normal head circumference is 58cm for male and 55cm for female. 
The facial features of the affected individuals were normal (Figure 4.20). They 
had no problem in vision, hearing and muscles tonicity was normal. Their behaviour 
was friendly except III:3 who was aggressive and non-cooperative. They were 
socially well associated with other individuals of same age. Behavioural examination 
showed a slightly shyness in their demeanour. No other mental problem or seizures 
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was described by their parents when asked. There was no problem of joint laxity, 
spine curvature. Size and shape of phalanges were normal. The rotation of ear was in 
normal range. The position of pinae was above the outer canthus of eye. There were 
no freckles or marks on the skin and hair growth was normal. Prenatal and neonatal 
health of children was normal. These individuals had no bladder control however they 
learned to manage it after the age of eight. Parents noticed abnormality when the 
children reached at the age of age of five years.  
 
The clinical analysis of affected individual showed delayed ambulation and 
speech. All the affected individuals could speak a sentence or word but not clear 
enough to understand. No symptom of pes cavus was observed and both Achilles 
were tightly bilateral.  Neurological investigation showed normal cranial nerves and 
normal papillary response to light as well as normal eye movement. Ophthalmic 
examination showed no symptoms of strabismus in all effected individuals. 
Coordination and sensory examination was normal. The IQ level of these individuals 
ranges between 25-30.  
4.2.2-Molecular Assessment and Mutation analysis: 
The whole genome SNP data analysis of three affected (II:4, III:3 and III:4) 
and one normal (III:2) individual with homozygosity mapper (Seelow et al., 2009) 
showed significant HBDs on chromosome 01, 05, 07, 10, 11, 14 and 15 (Figure 4.21)  
Moreover, these candidate regions were subsequently analysed with dChip software 
(Lin et al., 2004) which excluded the loci on chromosome  05, 10, 11, 14 and 15 
because of homozygosity was shown at same loci in normal individual (Figure 4.22). 
HBD loci of chromosome 01 were excluded by whole exome sequence data analysis 
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because either the sequences of genes of this locus had reported dbSNPs or variations 
were found in non coding regions.  
The dChip data analysis identified a common homozygous interval on 7p12.1-
p11.2 among three affected individuals between markers rs9642374 and rs2944276. 
The common region was ~4.3Mb in size between 53,293,700 - 57,597,358bp 
{Feb.2009 (GRCh37/hg19)} (Figure 4.23). 
Whole Exome Sequence data obtained from the DNA of III:3 individual 
identified c.997C>T transition at exon 4 of Phosphoserine Phosphatase (PSPH) on 
chromosome 7p12.1-p11.2 (Figure 4.24). To substantiate this mutation all affected 
(II:4, III:3 and III:4) and unaffected (II:1, II:2 and III:2) individuals were sequenced 
through Sanger Sequencing (Figure 4.25). The results showed that the presence of 
mutation in two affected (II:4 and III:4) individuals whereas one affected (III:3) and 
unaffected (II:1, II:2 and III:2) members of the family were heterozygous for this 
mutation. In silico translation of PSPH transcript revealed c.997C>T transition causes 
Gly90Asp at amino acid level. 
4.2.3-Functional Studies of PSPH Gene. 
Amino acid quantification analysis of two affected individual (II:4 and III:4) 
were performed to determine the PSPH catalyzed reaction product. The Serine and 
Glycine were in normal range in II:4 individual (Table. 4.4) whereas in case III:4 
individual these both amino acids were over normal range (Table. 4.5). 
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Table 4.4: Amino Acid Profiling of the affected individual (II:4). 
Amino Acid Name Result Unit Normal Range 
Taurine 38 µmol/L (6-126) 
Aspartate 05 µmol/L (1-9) 
Threonine 199 µmol/L (102-190) 
Serine 121 µmol/L (68-160) 
Asparagine 103 µmol/L (35-63) 
Glutamate 48 µmol/L (2-57) 
Glutamine 356 µmol/L (435-721) 
Glycine 227 µmol/L (123-319) 
Alanine 431 µmol/L 182-552 
Citrulline 39 µmol/L (16-46) 
Valine 127 µmol/L (144-269) 
Cystine 20 µmol/L (35-63) 
Methionine 09 µmol/L (12-32) 
Isoleucine 32 µmol/L (34-84) 
Leucine 80 µmol/L (78-160) 
Tyrosine 44 µmol/L (35-84) 
Phenylalanine 38 µmol/L (39-74) 
Ornithine 64 µmol/L (27-98) 
Lysine 99 µmol/L (111-248) 
Histidine 50 µmol/L (67-109) 
Arginine 74 µmol/L (46-128) 
Proline 169 umol/L (88-290) 
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Table 4.5: Amino Acid Profiling of the affected individual (III:4). 
Amino Acid Name Result Unit Normal Range 
Taurine 75 µmol/L (6-126) 
Aspartate 4 µmol/L (1-9) 
Threonine 143 µmol/L (102-190) 
Serine 205 µmol/L (68-160) 
Asparagine 117 µmol/L (35-63) 
Glutamate 42 µmol/L (2-57) 
Glutamine 455 µmol/L (435-721) 
Glycine 349 µmol/L (123-319) 
Alanine 596 µmol/L 182-552 
Citrulline 37 µmol/L (16-46) 
Valine 128 µmol/L (144-269) 
Cystine 26 µmol/L (35-63) 
Methionine 14 µmol/L (12-32) 
Isoleucine 30 µmol/L (34-84) 
Leucine 76 µmol/L (78-160) 
Tyrosine 45 µmol/L (35-84) 
Phenylalanine 30 µmol/L (39-74) 
Ornithine 63 µmol/L (27-98) 
Lysine 95 µmol/L (111-248) 
Histidine 63 µmol/L (67-109) 
Arginine 107 µmol/L (46-128) 
Proline 225 µmol/L (88-290) 
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Figure 4.19: Pedigree of Family B with autosomal recessive mental retardation where 
squares represent male and square are used for female. Completely filled squares and 
circled are for affected whereas unfilled squares and circles shows unaffected 
individuals. Squares and Circles with dots show carriers. Double lines show 
consanguineous marriage. Crossed lines show deceased ones.   
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Figure 4.20:  Facial images of affected individuals (II-4 and III-3) of Family B 
without any facial dysmorphism.  
 
 
 
A) 
 
 
 
 
 
 
 
Figure 4.21: Whole Genome Homozygosity image obtained from Homozygosity 
mapper of Family B showed significant homozygous peaks on chromosome 01, 05, 
07, 10, 11, 14 and 15. Homozygus regions are represented in red lines peaks and 
heterozygous regions are with black peaks. 
 
 
 
 
 
III:3 II:4 
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Figure 4.22:  (A) The dChip analysed image of SNP marker on chromosomes  01, (B) 
Chromosome 05, (C) chromosome 07, (D) Chromosome 10, (E) Chromosome  11,  (F) 
chromosome 14 and (G) Chromosome 15. The column represents individual Data  (II:4, III:3 
and III:4 are affected and III:2 is normal) and SNP data is shown in rows The blue colour 
depicts homozygous regions and yellow colour shows heterozygous region.   
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Figure 4.23: UCSC genome browser view of the 7p12.1-p11.2 locus 
 
 
 
 
 
 
 
 
Figure: 4.24: Whole Exome Sequence data showing the substitution of C with T.  
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Figure 4.25: A) The chromatogram shows the C>T variation in PSPH gene in 
affected individuals (II:4 and III:4) of Family B). The affected individual III:3 was 
heterozygous for C>T mutation. C). Normal individuals were heterozygous carrier for 
this mutation.  
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C)
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4. 3:-FAMILY C 
4.3.1-Human Subjects and Clinical Assesment: 
The Family “C” presented in this study is from Mangoli Town near District 
Dera Murad Jamali, Balouchistan province and belongs to Brahvi ethnic group.  The 
pedigree of this family consisted of four generations with eighteen living individuals 
including six affected (III:3, III:4, III:6, III:7, III:9 and III:11) and twelve unaffected 
individuals (II:1, II:2, II:3, II:4, II:5, II:6, II:8, III:1, III:2, III:5, III:8 and III:10) 
(Figures 4.26). Interestingly, all the affected individuals were males Consanguinity is 
practised in this family since many generations due to social constrained.  The blood 
samples were obtained only from three (III:3, III:4, III:11) affected individuals and 
five unaffected (II:1, II:2, II:8, III:2 and III:10) individuals. The ages, sex, height and 
head circumference of affected individuals are mentioned in table 4.6.  
Table 4.6: The sex, ages and head circumference of affected individuals of Family C. 
S. No. 
Affected 
individuals 
Sex Ages (Years) 
Head 
circumference 
(Centimetres) 
Height 
(Inches) 
01. III:3 Male 22 58.3 63 
02. III:4 Male 25 57.8 62 
03. III:11 Male 45 58.42 63 
The range of Normal head circumference is 58cm for male and 55cm for female. 
This family was diagnosed by local psychiatrist as sever form of NS-ARID.  
All affected individuals could not speak except III:3 who could speak one word. Their 
behaviour was cooperative and seemed to be depressive. III:3 and III:4 were unable to 
go washroom, changer dress and had no bladder control. They could recognize their 
homes and parents. Their vision, hearing, limb movement, genital organs, phalanges 
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and joints were normal. Facial features, skin, hairs, ear shape was normal. Ear 
position of effected individuals was above the outer Canthus of eye and their average 
ear rotation was at normal range. These individuals were socially interactive. 
Physically these individuals were not in state of obesity (Figure 4.27).  The III:11 
individual was forty five year old. He learned to maintain himself and worked with 
his younger brother in the field.  According his parents at his young age, he had same 
characteristics like III:3 and III:4 individuals. No epilepsy and prenatal and neonatal 
were mentioned during detailed interview with parents. The estimated IQ values of 
the patients fall in the range of 20-25.  
4.3.2-Molecular Assessment and Mutation Analysis: 
Whole Genome Scan of three affected (III:3, III:4 and III:11) and one normal 
(III:2) individual was performed with Microarray (250K NspI Affymetrix). The 
homozygosity mapper identified a shared region of homozygosity-by-descent with 
significant peak among the affected individuals on chromosome 01 and 17 (Figure 
4.28). The dChip data analysis identified a common homozygous interval on 
chromosome 1q25.3-q31.1 with a contiguous run of 308 homozygous SNPs among three 
affected individuals between rs4652728 and rs10798030 markers (Figure 4.29). The 
common region was ~3.48Mb in size {Feb.2009 (GRCh37/hg19)} (Figure 4.30). 
Sanger sequencing excluded candidate genes within this region given in table 4.7. 
However, homozygosity mapper showed a homozygous region on 
chromosome 17 with less significant peak flanked by rs2097761 and rs854653 
markers. dChip data analysis showed the homozygosity in normal individual as well 
(Figure 4.29A). Therefore; this locus was excluded.   
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Table 4.7: List of genes of 1q25.3-q31.1 locus with OMIM ID and function. 
S.No 
Gene Name 
OMIM Gene Function 
Cytogene
tic 
location 
1 C1orf21 -------- Uncharacterized protein 1q25.3 
2 COLGALT2 ------- 
Transfers beta-galactose to hydroxylysine 
residues on collagen. 
1q25.3 
3 NMNAT2 608701 
Catalyze NAD (NADP) biosynthetic 
pathway. 
1q25.3 
4 RGL1 605667 Ras and Ral signaling pathways 1q25.3 
5 RNF2 608985 
Transcriptional repression of 
developmentally regulated genes 
1q25.3 
6 
TSEN15 
608756 
SEN15 is a subunit of the tRNA splicing 
endonuclease, which catalyzes the removal of 
introns, the first step in tRNA splicing 
1q25.3 
7 
ARPC5 
604227 Controls of actin polymerization in cells 
1q25.3 
8 SHCBP1L ------ --------------- 
1q25.3 
 
9 SMG7 610964 
SMG7 is involved in nonsense-mediated 
mRNA decay 
1q25.3 
 
10 NPL 611412 
Controls the cellular concentration of sialic 
acid by catalyzing the conversion of sialic 
acid into acylmannosamines and pyruvate  
1q25.3 
 
 
 
 
 
 
Figure 4.26 Pedigree of Family C with autosomal recessive mental retardation where squares 
represent male and square are used for female. Completely filled squares and circled are for 
affected whereas unfilled squares and circles shows unaffected individuals. Double lines 
show marriages between cousins and for non cousin marriage single is used. Crossed lines 
show deceased ones. 
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Figure 4.27:  Facial images, with front and side pose of patients. The facial and limbs 
photograph did not show any facial or limbs dysmorphism. 
 
 
 
 
 
 
 
 
Figure 4.28:  Whole genome homozygosity (WGH) picture of Family C showed 
HBD on chromosome 01 and 17. 
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Figure 4.29: The dChip analysed image of chromosome 01(a) and 17 (b) of Family 
D in which the individual data is presented in the form of columns (III:3, III:4 and 
III:11 are affected and II:2 is normal). The blue colour in depicts homozygous region 
and yellow colour shows heterozygous region.  
 
 
 
 
 
 
 
 
Figure 4.30: A snapshot of 1q25.3-q31.1 locus from UCSC Genome Browser. 
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4.4:-Family D 
4.4.1-Human Subjects and Clinical Findings: 
The members of the Family “D” reside in District Shikarpur and belonge to 
Balochi ethnic group. The family consisted of six generations having ten living 
affected individuals (IV:6, IV:7, IV:8, V:7, V:8, V:9, V:13, VI:1 and VI:2) with 
congenital Mirror Movement (MRMV). The pedigree was constructed after careful 
investigations and information collected from the family elders. The family members 
because of strict social customs traditionally marry within their own community 
resulting in high rate of consanguineous marriages. Abnormal phenotype appeared for 
first time in Third generation (III:10) but she died at her early age (Figure 4.31).  
Blood samples were taken from four normal (III:5, IV:9, V:3, V:15) and seven 
affected individuals (IV:6, IV:7, IV:8, V:4, V:7, V:13 and VI:2).  
The detailed physical and neurological examination showed mirror movement 
was exclusively and predominantly was observed in distal parts of forelimbs. 
Involuntary movement was noted in phalanges of hands that replicated the timing and 
type of movement being carried out by the voluntarily activated phalanges of other 
hand. Proximal parts of appendages were unaffected. The amplitude of mirroring was 
generally lesser compared with voluntary activity. Furthermore, Intensity of mirroring 
was noticed equally in both hands and phalanges. Interestingly, the severity of 
MRMV was observed higher in young children especially in females as compare to 
adult males and females. No sign and symptoms of any other neurological, 
psychological or metabolic abnormality were observed and neither was reported by 
their parents in affected individuals during interview of parents. As these individuals 
were genealogically cousins, phenotypically, the facial features of affected 
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individuals were resembled to one another. The intellectual level of affected members 
was normal and was well in their studies and participates in games. Muscle tone as 
well as sensory and motor responses was normal. Affected individuals could partially 
suppress these movements. No mirroring was identified in distal parts and proximal 
hind limbs. Pain and/or cramping during sustained manual activity were not reported 
by affected individuals. No other neurological or behavioural abnormality was 
noticed in the affected individuals. Anosmia and hypogonadism (reported in Kallman 
syndrome; MIM 308700) were not present in the family members, and reproduction is 
not affected. Typically, onset of symptoms was noted at around two to three years of 
age, however in some cases symptoms were reported anecdotally to be present much 
earlier, from two to three months (e.g. in the offspring of individual IV:5 and IV:6). 
Situs inversus was not present in tested affected family members IV:8, V:4 and VI:2. 
Also, there was no history of chronic sinusitis, bronchitis, frequent pneumonias, 
colds, ear infections, or decreased or absent pulmonary mucociliary clearance in any 
of the affected family members. Typically, onset of symptoms was noted at around 
two to three years of age, however in some cases symptoms were reported 
(anecdotally) to be present much earlier, from two to three months (e.g. in the 
offspring of individual IV:5 and IV:6).  
4.4.2-Exclusion Mapping and Molecular Assessment: 
A large Pakistani family segregating MRMV was identified and ascertained 
for genetic studies. The pedigree is complex, however it would appear that autosomal 
recessive inheritance is the most likely model of transmission (Figure 4.31). Sanger 
sequencing of known dominant genes for MM (RAD51 and DCC) did not identify a 
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mutation. Microarray analysis for CNVs using ChAS identified a putative deletion of 
DCC exon 22 in just individual IV:7 (affected), but not in any other genotyped 
affected. Quantitative real-time PCR did not validate this loss CNV in IV:7 or in any 
family members. 
Known dominant genes for MM (RAD51 and DCC) were excluded by Sanger 
sequencing. The Analysis of microarray data with homozygosity mapper identified a 
significant HBD peak on chromosome 22 (Figure 4.32). Further analysis of 
microarray genotype data indicated a ~3.3 Mb HBD region on chromosome 22q13.1 
(Chr22:36605976-39904648) (Figure 4.33). Several smaller HBD regions were also 
identified (Table 4.8) (Figure 4.32). NGen (DNASTAR) and ANNOVAR analysis of 
aligned Whole Exome Sequences (WES) reads identified very few homozygous 
coding variants not present in dbSNP build 132 (excluding synonymous amino acid 
substitutions). It was also confirmed that WES homozygous synonymous changes 
within the HBD regions were not predicted to result in a cryptic splice event using the 
splice site prediction algorithm http://www.fruitfly.org/seq_tools/splice.html. WES 
identified a potential donor splice site mutation 2 nucleotides within intron 3 of the 
dynein axonemal light chain 4 gene, DNAL4: chr22:39176929A>G; NM_005740.2 
(DNAL4_vNM_005740): c.153+2T>C. The singer sequencing results confirmed the 
presence of mutation in all affected individuals. This substitution destroys the 
canonical “GT” splice donor site (Figure 4.34), and the aforementioned splice site 
prediction algorithm indicates a shift in score from 0.78 (out of 1) for the wild type 
mRNA to <0.01 for the mutant. Sequencing of mRNA from lymphoblast cell lines 
showed that the result of this splice mutation is skipping of exon 3. Exon 2 splices 
directly to exon 4, maintaining the same reading frame (Figure 4.35). The removal of 
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exon 3 results in an open reading frame of just 77 amino acid residues instead of 105, 
effectively a deletion of 28 amino acids. The consequence of the exclusion of exon 3 
would be a deletion of 28 amino acids (residues 24 to 51 inclusive) from the 105 
(12KDa wild type) DNAL4 protein (Figure 4.36), resulting in an 8.75KDa (mutant) 
protein. 
This variant was not in any SNP databases, including dbSNP build 138, nor 
present in 1000 Genomes (http://browser.1000genomes.org/index.html; accessed Jan 
2014) or NHLBI EVS (http://evs.gs.washington.edu/EVS/; accessed Jan 2014) 
datasets. The variant creates a BsrDI restriction site, which was used to screen for the 
presence of the variant allele in Pakistani controls by RFLP-PCR. The variant was not 
identified in 200 controls, in either heterozygous or homozygous form. 
Linkage analysis across the 22q region using Simwalk2 a maximum location 
score (directly comparable to multipoint LOD score) of 6.197 was calculated for 
markers D22S280 and DNAL4 (NM_005740): c.153+2T>C (Figure 4.37). 
Comparative protein sequence analysis for DNAL4 using ClustalW2 alignment 
(http://www.ebi.ac.uk) showed it to be highly conserved across the Kingdom 
Animalia (or Metazoa). Conservation is higher than 98% identity across all 
mammalian species. Conservation appears to be particularly high across the deleted 
stretch of the protein (residues 24-51), with 54% of residues conserved across all 
species, compared to 27% for the rest of the protein (Figure 4.38).
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Table 4.8: All HBD regions (hg19) determined by ChAS analysis for MM1-4,7,8,11,12, using filter cut-off of >100 markers and 
>1Mb. Homozygous coding variants from DNASTAR NGen analysis and ANNOVAR analysis of WES data for MM1-7 are 
shown, excluding synonymous and known SNPs. Integrated Genome Viewer (IGV) was used to confirm the variant. For amino 
acid substitutions we used Condel- an integrated analysis that uses prediction from five different algorithms, including PolyPhen2, 
SIFT, and Mutation Assessor (Gonzalez-Perez and Lopez-Bigas, 2011) 
HBD regions: genomic 
coordinates (hg19) 
Size 
(Kb) 
Ref 
position 
Gene 
DNASTAR/NGen: 
Base change/amino acid 
change 
ANNOVAR: Base change/ 
amino acid change 
IGV? 
# reads) 
ConDel 
Chr5:45,356,105-46,383,335 1,027   None None   
Chr7:62,461,703-63,633,799 1,172   None None   
Chr8:99,806,627-101,011,774 1,205   None None   
Chr9:112,861,714-114,922,067 
2,060 
11316996
8 
SVEP c.7912C>T; p. D2638N c.7912C>T; p. D2638N Y (42) Neutral 
Chr10:21,762,499-22,912,743 1,150 None      
Chr10:81,172,703-82,301,802 
1,129 81928835 
ANXA11 
c.451T>C; p. T151A 
c.451T>C; p. T151A 
Y (51) Neutral 
Chr16:33,591,003-34,796,531 1,206 None      
Chr22:36,605,976-39,904,648 
3,299 
38483171 BAIAP2L  NM_025045:c.C1219T:p.P407S Y (77) Neutral 
39176929 DNAL4  NM_005740:exon4:c.153+2T>C Y (31)  
39418880 APOBEC3D c.71A>G; p. E24G c. .71A>G; p. E24G Y (96) Neutral 
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Figure 4.31: Six generation Pedigree of Family D, showing most likely recessive 
form of inheritance. Filled Circles and Squares represent affected individuals. 
Partially filled squares and circle show carrier individuals.  Double lines represent 
consanguineous marriages whereas single line is for non cousin marriages. Crossed 
lines show deceased individuals. 
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Figure 4.26: Six generation Pedigree of Family D, showing most likely recessive form of inheritance. Filled Circles and Squares show affected 
individuals. Double lines represent cousin marriages. 
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Figure 4.32: Homozygosity Mapper output, showing complete HBD only on 
chromosome 22 (indicated by red arrow) 
 
Figure 4.33: Ideogram of chromosome 22 indicating region of HBD, and the DNAL4 gene, 
indicating the location of the NM_005740.2 c.153+2T>C variant at the exon 3/intron 3 splice 
site. 
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Figure 4.34: Ideogram indicating location of the NM_005740.2 c.153+2T>C variant 
at the intron 3 donor splice site , and electopherograms showing the forward strand 
heterozygous wild type/mutant  sequence and the homozygous mutant (c.153+2T>C) 
sequence. 
 
 
Figure 4.35: Ideogrammatic representation of the resulting spliced mRNA showing 
exclusion of exon3, and the electropherogram of the resulting RT-PCR sequence of 
the exon 2/exon 4 splice junction.  
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Figure 4.36: A) Predicted 3D structures for wild type DNAL4, and B) the mutant DNAL4 
with the 28 amino acid stretch encoded by exon 3 missing. The pink bars represent the 
sequence flanking the 28 residue deletion section in the wild type model and the mutant 
model 
 
  
Figure 4.37: Linkage analysis using SIMWALK2. Position in Haldane cM is plotted on the 
x-axis, and Location Score (assuming no heterogeneity; alpha=1.0) on the y-axis. The 
significance threshold for linkage of 3.0 is indicated by the red dashed line. Maximum 
Location Score of 6.197 was achieved for the DNAL4 c.153+2T>C variant and microsatellite 
marker D22S423. 
A) B) 
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Figure 4.38. Analysis of evolutionary conservation of DNAL4 protein using ClustalW2 
alignment. The red bar above the alignment indicates the position of the 28 deleted amino 
acids. Yellow shading indicates amino acids that are conserved 100% across the species 
included in the alignment. Protein sequences used: human: NP_005731.1; rhesus: 
NP_001247540.1; pig: NP_001231596.1; elephant: XP_003419805.1; giant panda: 
XP_002914599.1; horse: XP_005606702.1; mouse: NP_059498.2; rat: NP_001009666.1; 
rabbit: XP_002711436.1; opossum: XP_001367599.1; chicken: NP_001006242.1; finch: 
XP_005421907.1; anole: XP_003221024.1; Xenopus: NP_001087464.1; zebrafish: 
NP_001003603.1; fugu: XP_003976859.1; lancelet: XP_002595410.1; sea squirt: 
XP_002126866.1; hydra: XP_002162246.1; sea urchin: XP_794465.1; Trichloplax: 
XP_002110087.1; flour beetle: XP_967210.1; fruit fly: NP_610734.1; Chlamydomonas: 
ACC68802.1.  
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 Chapter 5 
Discussion 
Neurological disorders are a diverse group of diseases associated with varying 
clinical manifestations such as severity, age of onset, prognosis and treatment 
responses. Most of the neurological disorders are induced predominantly by specific 
genetic factors that differ among varying classes of neurological diseases, some of 
which are caused by a single gene or locus i.e. monogenic disorders, while for others, 
disease predisposition is heterogeneous in nature, caused by the interplay between 
genetic and environmental factors. However, genomic variations play a main role in 
disease susceptibility, age of onset of disease and treatment options for different 
classes of neurological diseases (Foo et al., 2013).   
Therefore, the present study was aimed to map and characterize susceptibility 
genes in two neurological disorders including Intellectual Disability (ID) and Mirror 
Movement (MRMV).    
Intellectual disability or mental retardation is a leading socio-economic health 
care problem in developed countries with lifetime costs ranging from US $ 1-2 
million in Europe and the United States (Centers for Disease Control and Prevention, 
2004; Salvador-Carulla and Bertelli, 2008). International Classification of Disease 
(ICD) declared ID as the most expensive disease in terms of diagnosis (Centers for 
Disease Control and Prevention, 2004 and Polder, 2008). In spite of this, ID has 
received very little public attention as compare to other mental diseases (Salvador-
Carulla and Bertelli, 2008).  
The overall prevalence of ID in general population is 3%, but its frequency is 
higher in developing countries due to the frequent practice of consanguineous 
marriages (Ropers, 2010). Clinically, few markers are known to determine genetic 
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basis of ID (Raymond, 2006) because ID etiology remains poorly understood due to 
extensive heterogeneity of disease (Castellvi-Bel and Mila, 2001). Genetically ID is 
caused by chromosomal defects (numerical or partial aberrations), repeat expansions 
in promoter, coding regions or UTRs of genes, epigenetic modification as well as 
single gene defects (X-linked or autosomal) (Basel-Vanagaite, 2006). In the last few 
decades, considerable amount of focus was made on X-linked ID (XLID) which led to 
the identification of large number of genes and genetic variants on X chromosome. 
Compared with XLID, the molecular explication of autosomal recessive ID (ARID) is 
lagging behind because of genetic heterogeneity and the lack of clinical criteria for 
pooling smaller families with similar clinical presentation (Basel-Vanagaite, 2006). In 
addition, most research is primarily conducted in western countries, where small 
family sizes and infrequent parental consanguinity hampers the research in NS-ARID. 
In this situation, even the possibility of a genetic causation will often not be 
considered (Najmabadi et al., 2011). 
Mirror Movement (MRMV) disorder is a rare, mainly autosomal dominant 
disorder, however, it is thought that some sporadic cases may be due to recessive 
inheritance. MRMV refers to voluntary movements on one side of the body being 
mirrored by involuntary movements on the opposite side. Using linkage analysis and 
candidate gene approaches, two genes so far have been implicated to MRMV: the 
Deleted in Colorectal Carcinoma (DCC) gene on 18q21.2, which encodes a netrin 1 
receptor (Srour et al., 2010) and the RAD51 recombinase (RAD51) gene on 15q15.1, 
which is involved in the maintenance of genomic integrity (Depienne et al., 2012).  
In the present study, three families (with extensive consanguinity) inheriting 
autosomal recessive nerurodevelopmental and cognitive disorders, and one family 
with mirror movement were enrolled from different regions of Pakistan. Results from 
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the clinical and physical examination of all affected individuals of NS-ARID were 
relatively similar except two individuals (III:8 and V:7) in Family A. The Patient 
(III:8) of Family A had syndromic form of mental retardation as she had retarded 
growth with wasting muscles and visible dermatological pigmentations. The 
individual (V:7) of Family A differed from other affected (III:2 and V:3) individuals 
only in terms of hind limbs those were weak, making her unable to walk. The overall 
IQ level of all affected individuals ranged from 20-35 in the studied families. The 
growth and height was normal in all affected individuals according to the average 
head circumstance for males and females at 58cm and 55cm, respectively. 
Phenotypically, the position of the ear pinna was either above or parallel to the line of 
outer canthus of eye indicating normal cranium.  
In Family “A”, autozygosity mapping from microarray data identified a novel 
Homozygosity by Descend (HBD) locus of ~11.34Mb on chromosome 11q25.1-q25 
(chr11:123,032,803-134,376,325) flanking between rs10892975 and rs10894834 SNP 
markers. Subsequent analysis of genes in this locus with WES data revealed a splice 
donor site mutation 636+1G>A at the exon-intron junction of exon four and five of 
the Scavenger Decapping (DCPS) gene. This mutation was confirmed by Sanger 
Sequencing in two affected individuals (III:2 and V:3) whereas the individual (V:7) 
was heterozygous for this mutation. To exclude the possibility of a polymorphism at 
this position, 200 control individuals from Pakistani population were sequenced 
which did not show this pathogenic variation.  
The analysis of other exons of DCPS showed a heterozygous 947C>T 
variation in exon six of the individual (V:7). This variation was also identified in her 
mother in heterozygous form but her father was normal for this variation. 
Interestingly, 636+1G>A was not identified in her mother. In this way, individual 
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(V:7) inherited the mutant allele of 636+1G>A (splice site variant) from her father 
and the 947C>T allele from her mother, thus, inheriting compound heterozygousity in 
DCPS gene (Figure 5.1).  
The individual (III:8) of this family did not show any variation for the DCPS 
gene, although she with her parents was normal for these both mutations.  UTRs of 
the DCPS gene from affected (III-8) were also sequenced but no pathogenic sequence 
variation was identified. Thus, we can infer that the non association of DCPS in this 
loop could be due to remote consanguinity.  
To assess the effect of the splice site mutation (636+1G>A) and confirm 
missense variation (947C>T), mRNA was extracted from the Lymphoblast cell lines 
of patient and normal individuals of Family A were isolated and RT-PCR was 
performed. The resultant cDNAs were sequenced that also confirmed the presence of 
both mutations (636+1G>A and 947C>T) in all affected individuals. Sequence 
alignment of the mutant (636+1G>A) with the normal sequence revealed the addition 
of 45 nucleotides in the final transcript.  Here, it is concluded that 636+1G>A shifting 
the splice site to downstream by 45 nucleotides within the intronic region. 
Consequently, the final mRNA transcript contains an additional 45 nucleotides. In 
silico translation of the transcript showed the insertion of 15 amino acid to C- 
terminus of protein of DCPS protein, thus increasing the size of protein from 337 
amino acids to 352 amino acids in case of  in case of 636+1G>A mutant. Whereas, 
947C>T resulted in Thr316Met. 
Western blotting was used to analyze the expression of the DCPS mutant with 
the 15 amino acid insertion and compared with controls in lymphoblast cell lines 
obtained from patients and normal individuals. The results showed the expression of 
protein was significantly reduced in affected cell lines as compared to normal. This 
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suggests possible degradation of protein through misfolding recognition-associated 
degradation mechanisms in the cell. 
DCPS gene was first time mapped on chromosome 11q24.2 by Liu et al., 
(2002). Its protein is 39 KDa in size and belongs to the pyrophosphatase superfamily 
of proteins that share a motif, His-φ-His-φ-Hi, where φ represents a hydrophic amino 
acid. Histidine Triad (HIT) in DCPS is a highly conserved protein in all eukaryotes, 
as well as in other organisms. The HIT pyrophosphatase motif confers nucleotide 
binding and the hydrolysis of pyrophosphate bonds.  The central histidine of a HIT 
motif in DCPS is critical for the pyrophosphatase activity. As such mutations within 
the central histidine residue of the HIT motif can eliminate DCPS decapping activity. 
The precise role of DCPS is to convert the m7GpppN cap oligo-nucleotide into 
m7GMP generated by the 3’ to 5’ mRNA degradation by exosome (Liu et al., 2002). 
Furthermore, DCPS also participates in the 5’-3’ mRNA decay pathway by 
converting m7GDP, a product released by Dcp2, to m7GMP (Figure 5.2). In other 
words, DCPS prevents the mis-incorporation of methylated nucleotides into nucleic 
acids (van Dijk et al., 2003).  
The mutant and normal DCPS were cloned in a TA vector, sub cloned in a 
pET3a vector, and expressed in E.coli BL21. DCPS proteins from each clone were 
isolated and purified. The activity of each clone was assessed by incubating mutants 
and normal with 32-P m7Gp
*
ppG. The resulting product from DCPS catalysed 
reaction was m7GMP. The enzymatic activity/potency was tested in the presence of 
m7GDP. In vitro, mutant DCPS (636+1G>A and 947C>T) showed reduced activity 
of as compared to wild type.   
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Figure 5.1: The black and blue blocks show the wild type alleles. The green and red 
blocks represent mutant alleles. The IV:5 is heterozygous for 636+1G>A and 
homozygous for 947C>T. IV:06 is homozygous for normal allele (636G) and 
heterozygous for 947C>T. Thus, affected daughter (V-7) is getting 636+18G>A 
mutant allele from her father and 947C>T mutant allele from her mother.  
Further assessments regarding the enzymatic activity of DCPS mutants were 
performed on whole cell extracts prepared from lymphoblast cells lines of patients 
and normal individuals. Similarly, both mutants and normal DCPS protein were 
incubated with 32-P m7Gp
*
ppG, and the resulting product was resolved through TLC. 
The 15 amino acid insertion in DCPS mutants had little to no activity, whereas DCPS 
with the 947C>T mutation demonstrated reduced activity as compare to wild type. As 
these mutations do not occur in the active site of the DCPS protein, we can infer that 
reduced enzymatic activity may be caused by impaired enzyme-substrate interaction. 
Therefore, the enzyme and substrate interaction in this case needs to be investigated. 
 
IV-5 IV-6 
V-7 V-6 V-8 
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Figure 5.2: mRNA degradation pathways and subsequent m7GpppN and m7GDP cap 
decomposition by DCPS. Picture was adopted from the paper Sabine Jemielity at al., 
(2010) with little modification.  
Family “B” was affected by non Syndromic autosomal recessive ID, and 
demonstrated typical phenotypic and clinical features.  Homozygosity mapping with 
homozygosity mapper from microarray data showed autozygous regions on 
chromosome 1q21.3 and 7p12.1-p11.2.  Subsequent analysis of the genes at the 
1q21.3 locus with WES data excluded this locus because no exonic variation was 
shown by genes in this region. Sequence analysis of the genes within the 7p12.1-
p11.2 locus showed a missense mutation in exon 4 of the PSPH gene that changes 
c.997C>T (Asp90Gly) in two affected individuals. The third affected individual was 
heterozygous for this mutation.  
Human phosphoserine phosphatase (PSPH) (E.C. 3.1.3.3) is located on 
chromosome 7p11.2 (chr7:56,078,744-56,119,268). It is a phosphohydrolase and 
participates in the biosynthesis of serine from carbohydrates (Moro-Furlani et al., 
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1980). It belongs to the haloacid dehalogenase (HAD) superfamily of hydrolases, 
which comprises phosphatases, epoxide hydrolases, and L-2-haloacid dehalogenases 
(Koonin and Tatusov, 1994). The enzymatic reaction of PSPH is Mg
2+
dependent and 
results in the dephosphorylation of phospho-L-serine. This leads to the formation of a 
phosphoenzyme intermediate that is then autodephosphorylated to form L-serine, a 
direct precursor of D-serine (Dunlop and Neidle, 1999). The N-methyl-D-aspartate 
(NMDA) subtype of glutamate receptors belongs to a major neurotransmitter receptor 
family in mammalian tissues, especially in the nervous system, where D-Serine works 
as a co-agonist of the NMDA receptor. Approximately 90% of D-Serine is produced 
by PSPH from L-serine (Paudice, et al., 1998). Therefore, higher concentrations of D-
Serine are present in mammalian brain (Matsui, at al., 1995).  
The quantitative amino acid analysis of two affected patients (II-4 and III-04) 
showed different values for PSPH catalyzed product i.e. Serine and Glycine amino 
acids. The glycine and serine level of patient II-04 was within the normal range, 
whereas the levels of both amino acids were higher in III-04. However, both patients 
carry the same mutation (997C>T) and a similar phenotype, suggesting that this 
mutation has no effect on gene function. The elevated level of serine and glycine in 
III-4 could be due to different food intake by patients before sampling. Furthermore, 
analysis of WES and microarray data is underway to identify the candidate gene in 
this family. 
Family “C” showed homozygosity at a ~3.48Mb region on chromosome 
1q25.3-q31.1. Several genes in this locus, including COLGALT2, C1orf21, NMNAT2, 
RGL1 RNF2, TSEN15, ARPC5, SHCBP1L, SMG7 and NPL, were targeted for 
possible variation by Sanger sequencing, but no changes were identified. Whole 
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exome sequencing is currently underway to identify the causative mutation in this 
family. 
Family “D” is a large consanguineous Pakistani family with 11 cases of mirror 
movement reported across five generations, indicating an autosomal recessive mode 
of inheritance. Sanger sequencing was used to exclude the DCC and RAD51 gene, 
which were already reported in Iranian family and a French Canadian family 
(Depienne et al., 2012). Microarray genotyping and autozgosity mapping was 
employed to identify a shared homozygosity-by-descent region among the affected 
individuals. A single autozygous region of ~3.3Mb on chromosome 22q13.1 
(Chr22:36605976-39904648) was identified. By Sanger Sequencing several candidate 
genes within this region, including DMC1 were excluded. Whole exome sequencing 
followed my Sanger sequences identified a homozygous variants in DNAL4 gene in 
all affected individuals. 
DNAL4 protein is believed to be part of the axonemal (or ciliary and flagellar) 
complex of dynein molecules (including dynein heavy and light chains) 
(GO:0005858), and a component of the microtubule-based dynein motor complex 
(Iwasaki et al., 2005). There are just two known axonemal light chain proteins, 
DNAL1 and DNAL4, which sit at the outer edge of the complex.  
Axonemal dynein components are important for polarity. For example, in 
medaka (Japanese rice fish, Oryzias latipes), axonemal intermediate chain 2 (Dnai2) 
mutants show a defect in the left-right polarity of organs (Nagao et al., 2010). In 
humans, mutations in various dynein axonemal component genes, such as dynein 
axonemal assembly factor 2 (DNAAF2), or axonemal light chain gene, DNAL1, result 
in primary ciliary dyskinesis with or without situs inversus (Pennarun et al., 1999; 
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Omran et al, 2008). Studies of dynein components in Chlamydomonas have shown 
that knockout of LC10, the orthologue of DNAL4, show only weak disruption of 
cilial/flagellar beat (Tanner et al., 2008). Immunostaining of murine tissues showed 
strong expression of DNAL4 in apical cilia in the bronchial epithelium, and in sperm 
flagella. In the mirror movement family reported here, there is no evidence of either 
situs inversus, or primary ciliary dyskinesis. Although sperm motility was not 
checked specifically, there is clearly no evidence of a fertility issue in this family. 
This suggests that DNAL4 may only play a minor ciliary/flagellar role. Data from the 
St. Jude Brain Gene Expression Map (BGEM: http://www.stjudebgem.org) in situ 
hybridization database (Magdaleno et al., 2006) suggest, somewhat surprisingly, that 
the DNAL4 mouse ortholog, Dnal4c, is expressed at much higher levels than other 
dynein components in embryogenesis, and is prominently expressed in hippocampus, 
suggesting that DNAL4 may have additional functions unrelated to a role in the 
axoneme (Tanner et al., 2008). Data from the BioGPS database also show highest 
expression for mouse Dnalc4 (array: Affymetrix MOE430, probe: 1416870_at) in 
testis, and then nucleus accumbens, and in humans, DNAL4 is expressed highest in 
testis and thyroid, then in whole brain (array: Affymetrix U133A, probe: 204008_at). 
Protein interaction analysis using the BioGRID data repository (Biological 
General Repository for Interaction Datasets; http://thebiogrid.org/) version 3.2.108 
suggests interactions between DNAL4 and DYNLL2 (a cytoplasmic dynein light 
chain), FHL5, SCTR and GPBP1. Firstly, we note no reported interactions with other 
axonemal dynein components, yet a yeast-two-hybrid interaction with an 8kDa 
cytoplasmic light chain LC8-type 2 dynein component, DYNLL2. It is also of interest 
that BioGRID lists a number of interactions for DYNLL2, including a number of 
neuronal components such as DLG4 (known more commonly as PSD-95), DLG2, 
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DLGAP1, SHANK2, HOMER3 and GPRIN2. Secondly, there appears to be no 
obvious direct interaction link between DNAL4 (or via DYNLL2) and RAD51, DCC or 
netrin-1 (NTN1). It has recently been demonstrated that DCC links netrin-1 signalling 
to microtubules via direct binding to the neuronal β-tubulin isoform TUBB3 (Qu et 
al., 2013). TUBB3 is a microtubule component, and is known to play a crucial role in 
axonal guidance. A recent study in drosophila showed that an 8kDa cytoplasmic 
dynein light chain protein is required for axonal guidance (Phillis et al., 1996). It was 
suggested in this study that disruption of dynein function could affect microtubule 
bundling, and thereby disrupt directional axonal growth. While DNAL4 is unlikely to 
bind directly to the microtubule assembly, it is very likely that the disruption of 
DNAL4 caused by the deletion of 28 amino acids would disrupt either 
homodimerization, or interactions with the dynein complex, possibly via DYNLL2, or 
interaction between the dynein complex and cargo molecules, which could ultimately 
result in disrupted axonal growth.  
Gene ontology analysis also suggests a role for DNAL4 in the neurotrophin 
TRK receptor signaling pathway (GO:0048011), and neurotrophin signaling pathway 
(GO:0038179). The protein tyrosine phosphatase, non-receptor type 11 (PTPN11) is 
also present in the neurotrophin receptor pathways (GO:0048011 and GO:0038179), 
and is also included in the axogenesis pathway (GO:0007409) along with NTN1 and 
DCC. So, PTPN11 activity may represent a common link between DCC/netrin and 
DNAL4. 
Performing unilateral movements requires communication between cortical 
and subcortical regions spanning the brain hemispheres mainly through the corpus 
callosum that are necessary to restrict output to the primary motor cortex (M1) 
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contralateral to the intended hand movement (reviewed in Beaulé et al., 2012). 
Modulation of transcallosal interhemispheric inhibition is necessary to suppress 
mirroring, and the corpus callosum is believed to play a crucial role. The network of 
cortical and subcortical areas that are required for performing unilateral movements is 
known as the nonmirroring network, and it is believed that this area involves the 
supplementary motor area (SMA), dorsal premotor cortex (dPMC), the ipsilateral 
motor cortex (M1), and the basal ganglia, and disruption of any part of this network 
may increase the tendency towards symmetrical mirrored hand movements (reviewed 
in Beaulé et al., 2012). We suggest that the DNAL4 mutation identified in the 
Pakistani MRMV family leads to inability of DNAL4 either to homodimerize or to 
bind to DYNLL2, and therefore disrupting the function of DYNLL2, and thus the 
overall dynein complex, in retrograde transport required for netrin-1-induced axon 
outgrowth and pathfinding during development, either within commissural callosal 
regions, or within the nonmirroring network.  
Conclusion: 
In summary, the major finding of this study is the identification of DCPS as a 
novel NS-ARMR gene and DNAL4 as novel gene in MRMV in two Pakistani 
families. The functional analysis of DCPS gene and its product showed reduced in 
vitro activity providing strong evidence that functional integrity of this Scavenger 
Decapping enzyme might be a sine qua non for normal human brain development and 
function. The identification of DCPS gene is the part of an ongoing systematic effort 
to unravel the molecular causes of NS-ARMR, which will shed more light on the 
function of the human brain in health and disease. The results of this project will 
stimulate research into the role of DCPS in cognition and behavior in animal model 
and will be used in genetic testing and counselling in affected family. Functional 
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studies of DNAL4 are suggested which will add in understanding of mirror 
movement. 
Future Prospects: 
In future, study of molecular basis of ID will be important not only for the 
purposes of genetic counseling and diagnosis but also the knowledge gained can be 
expected to further our understanding of the central nervous system. Successful 
experimental drug trials in animal models of MR give hope that long-term, effective 
treatment will one day be possible for human beings as well. Behavioral studies have 
shown that a stimulating environment has a beneficial effect on cognitive ability in 
murine models of Down syndrome and fragile X syndrome. These observations imply 
that mentally retarded children stand to benefit from intensive special education that 
is provided to them as early as possible; this, in turn, underscores the importance of 
early diagnosis. 
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List of Genes involve in Non-Syndromic Autosomal Mental Retardation 
S. No. 
Gene 
Name 
Cytoband Gene Function Reference 
1 ADK 10q22.2 
Adenosine kinase regulates adenosine levels 
in the brain. 
(Najmabadi, et al., 2011) 
2 ADRA2B 2q11.1 G-protein signalling pathway in brain (Najmabadi, et al., 2011) 
3 ASCC3 6q16.3 
It encodes helicase that is part of the 
activating signal co-integrator complex, 
enhances NF-kB and AP1. 
(Najmabadi, et al., 2011) 
4 ASCL1 12q23.2 
ASCL1 encodes the bHLH factor MASH1that 
has critical role in neuronal commitment and 
differentiation. 
(Horton et al. 1999; Yun et al. 
2002, Najmabadi, et al., 2011) 
5 C11orf46 11p14.1 
C11orf46 encodes TTI2 which is required for 
the establishment of cell-cycle checkpoints 
and for DNA-damage signalling. 
(Hurov et al. 2010; 
Najmabadi, et al., 2011) 
6 C8orf41 8p12 
C8orf41 associates with RUVBL249 which is 
involved in regulation of transcription and 
interacts with HDACs. 
(Kim et al. 2005; Giannandrea 
et al. 2010; Najmabadi, et al., 
2011) 
7 C9orf86 9q34.3 
C9orf86 encodes Rab-like GTP-binding 
protein PARF that interacts with ARF. 
(Giannandrea et al., 2010; 
Najmabadi, et al., 2011) 
8 CASP2 7q34 Functions in apoptosis. (Najmabadi, et al., 2011) 
9 CCNA2 4q27 
Cyclin A2 is essential for cell cycle control (Gong et al., 2010; Najmabadi, 
et al., 2011) 
10 EEF1B2 2q33.3 
EEF1B2 encodes the elongation factor 1b that 
is involved in the transport of aminoacyl 
tRNAs to the ribosomes. 
(Najmabadi, et al., 2011) 
11 ELP2 18.q12.2 
It encodes subunit of the RNA polymerase II 
elongator complex. 
(Fellows et al., 2000; 
Najmabadi, et al., 2011) 
12 
 
ENTPD1 
 
10q24.1 
It encodes ectonucleoside triphosphate 
diphosphohydrolase which is expressed in 
CNS and may regulate synaptic transmitter 
release. 
(Najmabadi, et al., 2011) 
13 
 
FASN 
17q25.3 
This gene product synthesizes long-chain fatty 
acids from acetyl-CoA and malonyl-CoA. 
Expressed in post-synaptic density. 
(Najmabadi, et al., 2011) 
14 INPP4A 2q11.2 
It encodes inositol polyphosphate-4-
phosphatase that regulates localization of 
synaptic NMDA receptors, protects neurons 
from excitotoxic cell death. 
(Sasaki et al., 2010; 
Najmabadi, et al., 2011) 
15 AP4M1 7q22.1 
It is involved in the recognition and sorting of 
cargo protein with tyrosine-based motifs 
through plasma membrane. 
(Hirst et al. 1999; Najmabadi, 
et al., 2011) 
16 AP4E1 15q21.2 
It is involved in the recognition and sorting of 
cargo protein with tyrosine-based motifs 
through plasma membrane. 
(Hirst et al. 1999; Najmabadi, 
et al., 2011) 
17 AP4B1 1p13.2 
It is involved in the recognition and sorting of 
cargo protein with tyrosine-based motifs 
through plasma membrane. 
(Hirst et al., 1999; Najmabadi, 
et al., 2011) 
18 SLC2A1 1p34.2 
The GLUT1 (HepG2) gene encodes the major 
glucose transporter in brain, placenta, and 
erythrocytes. 
(Baroni et al., 1992; 
Najmabadi, et al., 2011) 
19 ZNF526 19q13.2 It encodes a kru¨ppel-type zinc-finger protein. (Najmabadi, et al., 2011) 
20 LARP7 4q25 
LARP7 negatively regulates transcription of 
polymerase II genes through 7SK RNP 
system. 
(Najmabadi, et al., 2011) 
21 KDM5A 12p13.3 
It encodes histone demethylases which 
demethylate histone H3 at lysine 4 and have a 
central role in the histone code. 
(Najmabadi, et al., 2011) 
Appendix I 
163 
 
22 KDM6B 17p13.1 
KDM6B encodes histone demethylases which 
demethylate histone H3 at lysine 27 and have 
a central role in the histone code. 
(Najmabadi et al., 2011) 
23 HIST1H4B 6p22.2 Belongs Histone Gene Cluster 1 (Najmabadi et al., 2011) 
24 TRMT1 19p13.2 
TRMT1 is an RNA methyltransferase which 
dimethylates a single guanine residue at 
position 26 of most tRNAs. 
(Najmabadi et al., 2011) 
25 RGS7 1q43 Regulates G protein signalling. (Najmabadi et al., 2011) 
26 POLR3B 12q23.3 
POLR3B encodes the second-largest core 
component of RNA polymerase III. 
(Najmabadi et al., 2011) 
27 CCNA2 4q27 Plays role in cell cycle. (Najmabadi et al., 2011) 
28 SCAPER  15q24.3   
Interacts with CCNA2/CDK2 complex, 
transiently maintains CCNA2 in cytoplasm. 
(Tsang et al., 2008; Najmabadi 
et al., 2011) 
29 PECR 15q24.3 
peroxisomal trans-2-enoyl-CoA reductase 
expressed in brain involve in the biosynthesis 
of unsaturated fatty acids 
(Gloerich, et al., 2006; 
Najmabadi et al., 2011) 
30 CACNA1G 17q21.33 
CACNA1G, a T-type calcium channel with a 
critical role in the generation of GABAB 
receptor-mediated spike and wave discharges 
in the thalamocortical pathway. 
(Zamponi, et al., 2010;  Singh 
et al., 2007; Najmabadi et al., 
2011) 
31 ZBTB40 1p36.12 
ZBTB40 has a role in glia cell differentiation. (So¨dersten, et al,.  2010; 
Najmabadi, et al., 2011) 
32 RALGDS 15q24.3 
This gene encodes an effector of the Ras-
related GTPase Ral, which stimulates the 
dissociation of GDP from the Ras-related 
RalA and RalB GTPases, thereby allowing 
GTP binding and activation of the GTPases 
(Zhu, et al. 2002; Najmabadi, 
et al., 2011) 
33 COQ5 12q24.31 
COQ5 encodes methyltransferase with pivotal 
role in coenzyme Q biosynthesis. Interacts 
with NAB2 which controls length of poly(A) 
tail. 
(Najmabadi, et al., 2011) 
34 
CNKSR1 
 
1p36.11 
It acts as a scaffold protein and mediates 
crosstalk between the Ras and Rho GTPase 
signalling pathways. 
(Jaffe, et al. 2004; Najmabadi, 
et al., 2011) 
35 PRMT10 4q31.23 
Protein arginine methyltransferase 10. Protein 
arginine methylation affects chromatin 
remodelling leading to transcriptional 
regulation, RNA processing, DNA repair and 
cell signalling. 
(Fisk, et al. 2010; Najmabadi, 
et al., 2011) 
36 PRRT2 16p11.2 
Interacts with SNAP25 which in turn 
assembles with syntaxin-1 and synaptobrevin 
to form exocytotic fusion complex in neurons. 
(Stelzl,et al. 2005; Najmabadi, 
et al., 2011) 
37 RALGDS 9q34.2 
effector of Ras-related RalA and RalB 
GTPases, role in synaptic plasticity. 
(Zhu, X. et al. 2002; 
Najmabadi, et al., 2011) 
38 RGS7 1q43 Regulator of G protein signalling. (Najmabadi, et al., 2011) 
39 TRMT1 19p13.2 
It encodes dimethylguanosine tRNA 
methyltransferase. 
(Jaffe, et al 2004; Najmabadi, 
et al., 2011) 
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PERFORMA 
 Performa for clinical assessment of Non-Syndromic Autosomal Mental Retardation 
 
Patient’s name: _____________________________ 
Age:  ______________________________ 
Sex (M/F): ____________ 
Telephone: ______________________________ 
Address:
 _________________________________________________________________________________________________
__________________________________________________________________ 
Patients Medication History: 
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
_________________________________________________________________________________________________________
__________________________________________________________________________________________ 
When child started to speak? 
1) Can speak a: 
I)  word ii)   sentence     iii)  delaying in speak iv)   can not speak 
 
2) Can eat independently?       Yes/No 
 
3) Can go washroom independently?     Yes/No 
 
4) Can wear clothes independently?     Yes/No 
 
5) Do he/she has bowl or bladder control?    Yes/No 
 
6) Can he/she read or write efficiently?     Yes/No 
 
7) Recognize his/her parents       Yes/No 
 
8) Recognize her home when he/she is let out    Yes/No 
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9) Watery mouth        Yes/No 
 
 
 
10) Eye Barrows 
 
a) Arched   b) Synophrys 
11) Behavior 
a) Lethargic  b) Depressive c) Aggressive 
  
 
12) Epilipsy        Yes/No 
 
13) Other neurological disorder     Yes/No 
_______________________________________________________________________________________ 
_______________________________________________________________________________________ 
 
14) Is child socially interact with other children (autism):  Yes/No 
15) Any motility impairment:      Yes/No 
 
16) Visual impairment:       Yes/No 
     
17) Hearing impairment:      Yes/No 
 
18) Is there was a disease to mother when she was pregnant: Yes/No 
 
19) Pigmentation on skin:      Yes/No 
 
20) Goiter         Yes/No 
 
21)  
 
22) Family History       Yes/No 
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Patient’s name:  Date of Birth/Age:  
Syndromic Symptoms Checklist Normal Abnormal Comments  
Facial dysmorphology         
Visual impairment? Incl. night-blindness 
  
   
Hearing impairment?        
Seizures?     
  
   
Fingers/toes: Abnormality in number?      
Fingers/toes: Abnormality in length/shape?     
Abnormal ear shape, size, rotation?       
Ear position low? (top of ear should be in line from 
eyebrow to occiput) 
   
Abnormal eye movement?       
Microcephaly? Occipitofrontal circumference? (cm)     
Macrocephaly? Occipitofrontal circumference?(cm)     
Obesity?        
Genital abnormality?        
Limb abnormality?        
Abnormal karyotype?        
Gait abnormality?        
Abnormal spine curvature? Kyphosis/scoliosis?     
Hair abnormality? Alopecia? Low/high hair line etc     
skin abnormality? Unusual freckling or other marks?    
Joint laxity?         
Neurological abnormality?      
Muscular abnormality?       
Dental abnormality?        
Speech? any? how many words? Phrases or sentences?    
Mild/moderate/severe/profound MR?    
Other clinical features of note?      
At what age was the child when abnormalities first 
identified? 
Years: Months: Details: 
Attach photos: 
Front view       Side view 
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LIST OF PRIMERS 
DcpS 
Primer 
Name 
Sequence 
5ˋ----------ˋ3 
Annealing 
Temperature 
(
˚
C) 
Product Size 
(bp) 
DcpS-E1_F 
DcpS-E1_R 
AGTTAGCAGCCCAGCCAG 
57 
341 
 GCGATGATTGGTTCACTGC 
DcpS-E2_F 
DcpS-E2_R 
TCCAGAGTCTCATCGTGGTTC 
57 
286 
 TTCCCACCATCCCATTCTC 
DcpS-E3_F 
DcpS-E3_R 
CCTGTGGCATAGAGAGTGGG 
57 
270 
 CACTCGTAAGAGGAGGCACC 
DcpS-E4_F 
DcpS-E4_R 
GGGGTATCTCTCAAGGGGTG 
57 
233 
 GACCAGCACTTACAGCAGGG 
DcpS-E5_F 
DcpS-E5_R 
GAGAACTCCAGGGTTGGCAG 
57 
251 
 CCAGGAACACACTGGAATCTG 
DcpS-E6_F 
DcpS-E6_R 
GGAGGAGGGTCTAGGTGGG 
57 
407 
 AATCTTGTCCCCACTCCTCC 
 
DCC 
Primer 
Name 
Sequence 
5ˋ----------ˋ3 
Annealing 
Temperature 
(
˚
C) 
Product 
Size 
(bp) 
DCC-E1_F 
DCC-E1_R 
TGCATGTGTGTGAGTGCTG 
57 
215 AAATGAGAAGGGAAGTGGGG 
DCC-E2_F 
DCC-E2_R 
TTCAAAGCCCTCAGCTTTTG 
57 
779 GGGCACAAGGTTTCAGTGAG 
DCC-E3_F 
DCC-E3_R 
GACGATATTTGAGAAAACAGCTTG 
57 
573 AACCTGATTGAATGCTTCGG 
DCC-E4_F 
DCC-E4_R 
CAATATCATAATCCTATACACTTGGG 
57 
472 TGTATCATGCCAAGAAATGTGG 
DCC-E5_F 
DCC-E5_R 
TTTGAGCTTTGGTGGAGGTC 
57 
375 GCAAAGCAAGGACATGTGTG 
DCC-E6_F CAGCATGCAAGTTCACATCC 57 433 
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DCC-E6_R TCTTGTCTGTAAAACCAGGGG 
DCC-E7_F 
DCC-E7_R 
TTTTATCAAACTTTGGTCTCATCTAAG 
57 
310 TATTGCCCTTGAGGGGTAGG 
DCC-E8_F 
DCC-E8_R 
GCCTTCCTACCCAATTCTTACC 
57 
293 GCCATTACCCAACCGTATTG 
DCC-E9_F 
DCC-E9_R 
TGAGCAACCTTTTGGTTCAC 
59 350 
CACTTCGCAAAGGTTCTGTG 
DCC-E10_F 
DCC-E10_R 
AAATAGGCAATTTTGGTTAATGTAAG 
58 583 
GCCCATTTACCTCTTACCACC 
DCC-E11_F 
DCC-E11_R 
CCAATTCACTGATTGCACAG 
58 328 
TCAGGAAGCCTTGAAAATGG 
DCC-E12_F 
DCC-E12_R 
ACCTGGGTTAACCTACCTAATTATC 
59 259 
AGCAGTTGGGTGAGTGAAGG 
DCC-E14_F 
DCC-E14_R 
TGAAGCTTTTGGAAACCCAG 
59 250 
CCTTTTGAAGCTGAGATAACAAG 
DCC-E15_F 
DCC-E15_R 
TTAAATGGTGTTCTGCCGTG 
59 367 
TTGAAACCATCATACCAGGG 
DCC-E16_F 
DCC-E16_R 
TCCTTTCTGAATCCAACTCACTC 
58 365 
TGAGGATTATCAGAGGATAATGATAGG 
DCC-E17_F 
DCC-E17_R 
CATGCATTTAACTCATTGTGATG 
59 429 
AACGACTCATGACAGTCCAGG 
DCC-E18_F 
DCC-E18_R 
ACTCCTCTGCTGTTTGGGAG 
59 330 
TCTAATTTCCACAGAACCTGGG 
DCC-E19_F 
DCC-E19_R 
TCCTTGAAATAAACTGTAAATGGC 
59 349 
AATAATGCCACACGAAAGGC 
DCC-E20_F 
DCC-E20_R 
TTACATTTGGGAAACCTGGG 
59 367 
GGTGCAGGGCCATTTCTAAC 
DCC-E21_F 
DCC-E21_R 
TGATATGTCAGCTTTCTTGCTAGG 
59 197 
ATGGTCCAGGTGAAAAGAGG 
DCC-E22_F 
DCC-E22_R 
AAGTAATCTGTTCTGTTATTGTGTGTG 
59 243 
ATTTGCCCCAGACACTCTTG 
DCC-E23_F 
DCC-E23_R 
TTGGTAAAACTTCTGCCACATC 
59 302 
AACGCAGAAAGAGGACCATC 
DCC-E24_F GAAAGAAAGGAAGTGCCATTG 57 345 
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DCC-E24_R ACTCCCTTGGGTTCAGAATG 
DCC-E25_F 
DCC-E25_R 
TGTAAGACTGAAAAGGCATTGG 
57 340 
TCCTCATTTCCATTTGTCCAG 
DCC-E26_F 
DCC-E26_R 
AGGATCTGAAAATTCCACCG 
57 324 
GAATGCAACATATTTTACAAGACACC 
DCC-E27_F 
DCC-E27_R 
AATGGATGCAGGGACTGTTC 
57 384 
CTAGGCCTTCTCAAGCACCC 
DCC-E28_F 
DCC-E28_R 
TCCTGGATATGGTGTATATACTTGAG 
59 299 
TGGTTTAGATGCTATTACACAGCG 
DCC-E29_F 
DCC-E29_R 
AACTAGCTGTGGCCCCG 
57 229 
GGGTAATTGGTATGCTGCAAAG 
 
RAD51 
Primer Name 
Sequence 
5ˋ----------ˋ3 
Annealing 
Temperature 
(
˚
C) 
Product 
Size (bp) 
RAD51_E2F 
RAD51_E2R 
AGATGGGGAGAGAGATGCAC 
59 225 
AAGGTTGTAATACCTTCCACTAGG 
RAD51_E3F 
RAD51_E3R 
CAAGTCTTCAAGCACCTCTGTG 
59 361 
CACCCCTGGAAAGGATAATG 
RAD51_E4F 
RAD51_E4R 
CCATTGCACACCTTGTTTTAC 
59 305 
CAGTTTTGTTTTATAACCTGGAAGC 
RAD51_E5F 
RAD51_E5R 
CATCTTTCTGATGAGCTCCAAG 
59 259 
TCCTAACAGATGCTTGCAAATAG 
RAD51_E6F 
RAD51_E6R 
GCTTGGTCAGCTGTATCAGAAATAC 
59 235 
TCTTCGGCCAAACTAACCC 
RAD51_E7F 
RAD51_E7R 
TGTCAGAAACAAATTGCTCATC 
59  248  
GCCATTACAAGATTCAGGGAAG 
RAD51-E8-9F 
RAD51-E8-9R 
AGGAAGGGACCAGAATCTGAC 
57 676 
GCATGTTAATTAGATTAGCAAGAGTTC 
RAD51-E10F 
RAD51-E10R 
CAAAGTCAGGAACGGAATTG 
59 261 
AACCCCAGGGAGCAGTG 
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RNF2 
Primer 
Name 
Sequence 
5ˋ----------ˋ3 
Annealing 
Temperature 
(
˚
C) 
Product 
Size (bp) 
E2-F 
E2-R 
TCTCTGTGTCAGAACATGCTGG 
59 
465 
 CAACATACAGAAGTCAGGAATGC 
E3-F 
E3-R 
GTGAGTTGACAATGGCAGTGGCTG 
59 
422 
 CAGCCTGGGCAAGAAAAGCGAAAC 
E4-F 
E4-R 
GCAAAGCATGGATATCGGAAAGGGG 
59 
848 
 GTGAGGATGAATGTCTGATTGGAGG 
E5-F 
E5-R 
CAGAGTACAGTGGAGCCATCC 
59 
1086 
 TGCTGGAGATACAGTGGTAACG 
E6-7F 
E6-7R 
GCTATAGCCAGCAGATTCTGGTC 
59 
963 
 CCAAGATCTGTCCATAAAAGTAATGCC 
 
PSPH 
Primer 
Name 
Sequence 
5ˋ----------ˋ3 
Annealing 
Temperature 
(
˚
C) 
Product 
Size 
(bp) 
PSPH_E1-F 
PSPH_E1_R 
CCCTGTCCCACCTAGCTCTG 
59 861 
AACTCCTCTAGGGCAGGACG 
PSPH_E2-F 
PSPH_E2_R 
TCCACTAGATGCGGTTTCAG 
59 490 
GGCACTAATATTCCCCTAACCTTC 
PSPH_E3-F 
PSPH_E3_R 
ATGAGAAAGAAATCCTGCGG 
57 
393 
 GTGAAAATTAAATCAGTAAGTGCTTG 
PSPH_E4-5-F 
PSPH_E4-5_R 
TGACATCAGAATATCCATTTAGCT 
59 
592 
 TTGTGCTTACCTCATAAATTAGACATC 
PSPH_E6-F 
PSPH_E6_R 
TTTACAAGTAAGGACAAGGTCAGTC 
59 
240 
 GAGCTTCTTTTCCGATTATACACAG 
PSPH_E7-F 
PSPH_E7_R 
TCGATGAACTGATACTTTGAGC 
59 
403 
 TGTAATTTCCAATAATTCCATTAAGC 
PSPH_E8-F 
PSPH_E8_R 
ATAAAGGGCCTTAAAATGGG 
59 
409 
 AAAAGATGAAGAAATTGCTACCC 
PSPH_E9-F 
PSPH_E9_R 
GCATGCATGATCACGTATTTG 
59 
419 
 CCCAGCAGCTATCATTTAACC 
PSPH_E10-F 
PSPH_E10_R 
TTGTTCAAAATTGAGAGTCTTGG 
59 
467 
 CCATTTCAGTGGGGTATGAG 
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C1orf21 
Primer 
Name 
Sequence 
5ˋ----------ˋ3 
Annealing 
Temperature 
(
˚
C) 
Product 
Size 
(bp) 
C1orf21E2-3F 
C1orf21E2-3R 
TTCTAGGACTTGTGCCCTGG 
59 685 
CACCTCTGTCCCTGAGGTTC 
 
 
COLGALT2 
Primer 
Name 
Sequence 
5ˋ----------ˋ3 
Annealing 
Temperature 
(
˚
C) 
Product 
Size (bp) 
E1-F 
E1-R 
AGCGGAACCTGGACTAGAGG 
59 
1039 
 GCAGTTACGTTCCATCTGTCG 
E2-F 
E2-R 
GATTTCCCTCTCTTTCATTGG 
59 
250 
 CCAAACCTGGAAGCCCTAAAG 
E3-F 
E3-R 
TGTATACAATGAGCAGTGAGTTACTTG 
59 508 
GGCCTGAAGATGAAGTCCAG 
E4.F 
E4-R 
GGTTCCATATGTCATGAGCAAG 
59 705 
ATTGGAACATAGCCACTTGATG 
E-5F 
E-5R 
TGACTTGAAAGGAATCAGTCTAGC 
59 418 
CAATTTACTGCCTCTCACTACCAG 
E-6F 
E-6R 
ACACAGTTCAGGTTCCTTCTCC 
59 260 
TATGGTCACTGTGGCAATGG 
E7-F 
E7-R 
CTCAATCCTGGAGAACTGCTG 
59 282 
AATGAACACACAAGCCTGCAC 
E-8F 
E-8R 
CAAGAGAAGGGAGAACATATTTATC 
59 
425 
 CACATCCACACTCCAATCACAT 
E-9F 
E-9R 
GATAAATATGTTCTCCCTTCTCTTG 
59 264 
GATAGCCTGCTTTCCTTTCTCC 
E-10F 
E-10R 
GATTCCAGTTATGAATCTGTGCTAC 
59 341 
GCTGTATCTCCTACTGGCTGTG 
E-11F 
E-11R 
CAAAGCTGTGCTTCATCCTTATC 
59 343 
TGGAGAGCATAATTCATGAAGAG 
E-12F 
E-12R 
GCTGTCCAGATGTGAGGTGTC 
59 770 
GGTTAGATGACTGTGACCACTAAG 
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NMNAT2 
Primer 
Name 
Sequence 
5ˋ----------ˋ3 
Annealing 
Temperature 
(
˚
C) 
Product 
Size (bp) 
E1-F 
E1-R 
TCTGCAGACACAACGAGACAC 
59 
559 
 ACAGCACGTTATCTCCAGCC 
E2-F 
E2-R 
CATTACAGAGCTGAGCGTATTG 
59 
251 
 TCTGCCAGGAACTATCAGGC 
E3-F 
E3-R 
ATGGAGGCTCATCTATCGACC 
59 
462 
 CTACTTATTGCCTCCACAAGGC 
E4.F 
E4-R 
CAAGATCTAAGCGCATGGTATG 
59 
364 
 ACAGGCTGGTCTCTCTCACAAC 
E-5F 
E-5R 
AACACCACATCTCATGCTTCTC 
59 
561 
 CCTGCCTCTCTCTGATTGTGA 
E-6F 
E-6R 
ATGAGTGCCAGTTGTGAGTTG 
59 
283 
 TGTGCACAAGTACGCACACAC 
E7-F 
E7-R 
CCAATAATTCCTGCTGAGGC 
59 
209 
 CCATGTTGCCTGTCGTGAAG 
E-8F 
E-8R 
CTGCTCTGCACACACTCAGG 
59 
331 
 TCAGAAGAAGTGAAGACAGGAGG 
E9-10F 
E9-10R 
TGCTAAGTAGTTGCTTGGTAGGAG 
59 
477 
 GCAGATGTCTGCCTGAATCTTAG 
E-11F 
E-11R 
AAGGAGTTGTGGAGGCAAGAG 
59 
361 
 ACAGTCAAGACGAGGAGATGG 
 
TSEN15 
Primer 
Name 
Sequence 
5ˋ----------ˋ3 
Annealing 
Temperature 
(
˚
C) 
Product 
Size (bp) 
E1-F 
E2-R 
GGAAGAGGGAAGTGAATCAGG 
59 372 
GTTAAGCCGCAGGTTGAGAG 
E2-F 
E2-R 
TGCTTTTGATATTTTGCCTTTG 
59 453 
TGTATCTTACCATGCAGCATTATC 
E3-F 
 
E3-R 
TCAGGTCCTTACTCAAATGTCAC 
59 349 
AGAGGTTGTCATTGTCATTCCC 
E4-F 
 
E4-R 
CTATAGCAGTGCCCATTCCTTC 
59 265 
AGAAACAGATGCTACCCACAGG 
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RGL1 
Primer Name 
Sequence 
5ˋ----------ˋ3 
Annealing 
Temperature 
(
˚
C) 
Product 
Size 
(bp) 
E2-F 
E2-R 
AAGTTGATGCCTATTATGATACTGTC 
59 
454 
 TGCTCCTGACTTACTTGTTCTCC 
E3-F 
E3-R 
CTGTTGTAAGCAGCAAGGCAG 
59 
268 
 AATGATATTCACAGAACGACAGAC 
E4-F 
E4-R 
ATAACAGGCTATGGCCTTCAAC 
59 
401 
 TCTCTCTCCGAATACCAAGTGC 
E5.F 
E5-R 
CCGATTCTCCTGCTGATAGG 
59 
509 
 TAAGCCTCTGTATGCACTATGG 
E-6F 
E-6R 
GATGAATGATCTGTTGACCACC 
59 
457 
 TTATACTCAAGCCAATCCTCCAG 
E-7F 
E-7R 
ATTGTGCTTGTGGTTGTCTCC 
59 
392 
 CAGCCTGTCTCAAGGATTCAAG 
E8-F 
E8-R 
GACAAGGCAGTGTGGAACAG 
59 
510 
 AACGAAGTGATGGAGCAGTCTC 
E-9F 
E-9R 
TGAGATGTTCAATACCATCTGACC 
59 
830 
 TCATCACTCCACAACCTTATCC 
E-10F 
E-10R 
GGCCTTATCTGTGCTTACAGTACC 
59 
302 
 TCACACTACTCTTCCTTGAATGG 
E-11F 
E-11R 
ACTTCTTACCATTGTGGCATCC 
59 
241 
 GTTGACTGAAGGTGCCAGTG 
E-12R 
E-12R 
AGACATCCTTCTCACTTGAGCC 
59 704 
TCCAGCTTGGACAACAAGAG 
E-13F 
E-13R 
GACTCTCTTCTTCCACAGTAGTCG 
59 
411 
 CTCTTGAGTCCTAGCTTCCTCAC 
E-14F 
E-14R 
AAGGAAGCCACTGTAACTTAACG 
59 
615 
 TCTTGATGCTATCAACTCAGCC 
E-15F 
E-15R 
ATATGCCAGTGGAGGTGAGG 
59 
397 
 GCTCAAGGTCATCCTGTTGAATAC 
E-16F 
E-16R 
ATGGTATCTTGATCCTGCCAAG 
59 
745 
 TCCAGTGCCTTAAGAGGTGG 
E-17F 
E-17R 
TGCAGTCTATCAGTCTTGATATCTACC 
59 
510 
 ACCTGGAACTGACACACATCC 
E-18F 
E-18R 
CAACACAAGACAGCAAGAATGAG 
59 
367 
 GTGATGGCACGGTTGTTCAC 
E19-F 
E19R 
CAGTACTGAGCTGACCTCCAC 
59 
 
348 CTTCACCAATGATCCTCGAAC 
 
Appendix III 
174 
 
TSEN15 
Primer 
Name 
Sequence 
5ˋ----------ˋ3 
Annealing 
Temperature 
(
˚
C) 
Product 
Size (bp) 
E1-F 
 
E1_R 
AGCTACCTTGGTCAGAAGGAGG 
59 
545 
 GGAGTTACTGTCTGGCTCTCAG 
E2_F 
 
E2_R 
TTGATGACCACTTGATGATTGG 
59 
 
522 
 CAGTACCAACAAGGCAGATGAG 
E3_F 
 
E3_R 
GGAATTAGATATAGGAGATGCCACC 
59 
 
661 
 AGAATGGCCGAATACAACACTC 
E4_F 
 
E4_R 
AAGATACACTTCAGATTCAGAGACAAC 59 
 
519 
 AAGTGGCAGTTCTGTGACTGAC 
E5_F 
E5_R 
GAGTAGCTGAGGTGGAATGTA AAGG 
59 
379 
 GAAGTCAACCCTCACTATGTACGTC 
 
 
DNAL4 
Primer 
Name 
Sequence 
5ˋ----------ˋ3 
Annealing 
Temperature 
(
˚
C) 
Product 
Size (bp) 
E2-F 
E2-R 
GTGTGTCTTAACTGCCAGTCCC 
201 60 
ACCTCTCTCCAGGCTGTGTG3 
      E3-F 
E3-R 
GCCTTAAGCTTGGGACAGAGAG 
276 60 
CCTAGCAGTACTGTCTGGAGCC 
E4-F 
E4-R 
CTTCCTGGAGAAGGACCTGAC 
351 60 
AAAGAAAAGACCCCAACTCTCC 
 
GTG TGT CTT AAC TGC CAG TCC CAG 59.1 
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SHCBP1L 
Primer 
Name 
Sequence 
5ˋ----------ˋ3 
Annealing 
Temperature 
(
˚
C) 
Product 
Size (bp) 
E1-F 
E1-R 
CCCTGTCCCACCTAGCTCTG 
59 838 
GCACCTCTAACAAGGTGAACG 
E2-F 
E2-R 
GTTTTCCACTAGATGCGGTTTC 
59 494 
GGCACTAATATTCCCCTAACCTTC 
E3-F 
E3-R 
ATATGAGAAAGAAATCCTGCGG 
59 395 
GTGAAAATTAAATCAGTAAGTGCTTG 
E4_5-F 
E4_5-R 
TGACATCAGAATATCCATTTAGCTC 
59 592 
TTGTGCTTACCTCATAAATTAGACATC 
E6-F             
E6-R 
TTTACAAGTAAGGACAAGGTCAGTC 
59 240 
GAGCTTCTTTTCCGATTATACACAG 
E7-F 
F7-R 
TCGATGAACTGATACTTTGAGC 
59 403 
TGTAATTTCCAATAATTCCATTAAGC 
E8-F 
E8-R 
ATAAAGGGCCTTAAAATGGG 
59 409 
AAAAGATGAAGAAATTGCTACCC 
E9-F 
E9-R 
GCATGCATGATCACGTATTTG 
59 419 
CCCAGCAGCTATCATTTAACC 
E10-F 
E10-R 
TTGTTCAAAATTGAGAGTCTTGG 
59 476 
TTGAAACTACCATTTCAGTGGG 
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DMC1 
Primer 
Name 
Sequence 
5ˋ----------ˋ3 
Annealing 
Temperature 
(
˚
C) 
Product 
Size (bp) 
E2-F 
E2-R 
CCCCTGGACAAAGGACTACTTC 
58 206 
TAGCTAACAGGGAAGGAACTTG 
E3-F 
E3_R 
AAAAGATGTGAAATAGCTGGATATG 
59 178 
TGTCCATAAGGTTGATGCTGAG 
E4-F 
E4-R 
GGAAGGAGATGGACACAGAAAC 
59 405 
CTGTTGCTTTGAAACTGAAGTG 
E5-F 
E5-R 
GCCTTCAAGGACAAGTGAACTG 
60 347 
CAAACAAACCCAAACTTCAAATG 
E6-F 
E6-R 
AACCTGTGATCTAGCAAGTGGC 
59 463 
TGAAAAGTGTTGATAAGACCCATC 
 
GCCTGAGTGAGAGCAAGACTCTG 
58 427 
GCAGCACATACATCACCTCAAGGA 
E8-F 
E8-R 
GCAACAGCAGATTCCATGTG 
59 290 
TCCCTTTGGTTTGTCTCATTACTAC 
E9-F 
E-9R 
CGGAAGATATTATGTTTTGTAGTGG 
59 230 
AAATCAGTGCTGCCAACCTTAC 
E10-11_F 
E10-11_R 
GAATGATCTTAGCCTCTGCTTC 
57 457 
CATTATATTCCAAGCTTCTCTGC 
E12-F 
E12-R 
GGATTACAGGCATGAGCCGCTGAG 
59 447 
GTCAGGCTGGTCTCCATCTCC 
E13-F 
E13-R 
AGCTCCAAAACTCACCTCACTC 
59 502 
TCAAACACACAGCATCTGGC 
E14-F 
E14-R 
CTCTGGAGATTCAGACTGATGG 
59 247 
TGAAATTGGAGACTGCTTTTCC 
 
 
 
